University of Rhode Island

DigitalCommons@URI
Open Access Dissertations
2013

REGULATION OF HEMOLYSIN GENE EXPRESSION AND THE
EFFECTS OF METABOLISM MUTATIONS ON THE VIRULENCE OF
VIBRIO ANGUILLARUM
Xiangyu Mou
University of Rhode Island, mouxiangyu@gmail.com

Follow this and additional works at: https://digitalcommons.uri.edu/oa_diss

Recommended Citation
Mou, Xiangyu, "REGULATION OF HEMOLYSIN GENE EXPRESSION AND THE EFFECTS OF METABOLISM
MUTATIONS ON THE VIRULENCE OF VIBRIO ANGUILLARUM" (2013). Open Access Dissertations. Paper
115.
https://digitalcommons.uri.edu/oa_diss/115

This Dissertation is brought to you for free and open access by DigitalCommons@URI. It has been accepted for
inclusion in Open Access Dissertations by an authorized administrator of DigitalCommons@URI. For more
information, please contact digitalcommons@etal.uri.edu.

REGULATION OF HEMOLYSIN GENE EXPRESSION AND THE EFFECTS OF
METABOLISM MUTATIONS ON THE VIRULENCE OF VIBRIO
ANGUILLARUM

BY
XIANGYU MOU

A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE
REQUIREMENTS FOR THE DEGREE OF
DOCTOR OF PHILOSOPHY
IN
CELL AND MOLECULAR BIOLOGY

UNIVERSITY OF RHODE ISLAND
2013

DOCTOR OF PHILOSOPHY DISSERTATION
OF
XIANGYU MOU

APPROVED:

Dissertation Committee:

Major Professor

David R. Nelson

Paul S. Cohen

David C. Rowley

Nasser H. Zawia
DEAN OF THE GRADUATE SCHOOL

UNIVERSITY OF RHODE ISLAND
2013

Abstract

Vibrio anguillarum is the causative agent of vibriosis, a fatal hemorrhagic
septicemic disease. V. anguillarum infects more than 50 fresh and salt-water fish
species including various species of economic importance to the larviculture and
aquaculture industry. In vibriosis, V. anguillarum invades its host fish through the
intestine and skin. Infected fish usually die with systemic infection of V. anguillarum.
Bacterial hemolysins are exotoxins that cause lysis of erythrocytes in the host and thus
the release of the intracellular heme, and are therefore identified as important
virulence factors. Moreover, hemolysins are known to also cause lysis in other cell
types, including mast cells, neutrophils and polymorphonuclear cells. Two hemolysin
gene clusters, vah1-plp and rtxACHBDE, have been previously identified and described.
The activities of the protein encoded by the plp gene were not known.

In the first manuscript, we describe the biochemical activities of the
plp-encoded protein and its role in pathogenesis. The plp gene, one of the components
in vah1 cluster, encodes a 416-amino-acid protein (Plp), which has homology to
lipolytic enzymes containing the catalytic site amino acid signature SGNH. Hemolytic
activity of the plp mutant increased 2-3-fold on sheep blood agar indicating that plp
represses vah1; however, hemolytic activity of the plp mutant decreased by 2-3-fold on
fish blood agar suggesting that Plp has different effects against erythrocytes from
different species. His6-tagged recombinant Plp protein (rPlp) was over-expressed in E.
coli. Purified and re-folded active rPlp exhibited phospholipase A2 activity against
phosphatidylcholine

and

no

activity

against

phosphatidylserine,

phosphatidylethanolamine, or sphingomyelin. Characterization of rPlp revealed broad
optimal activities at pH 5–9 and at temperatures of 30-64°C. Divalent cations and metal
chelators did not affect activity of rPlp. We also demonstrated that Plp was secreted
using thin layer chromatography and immunoblot analysis. Additionally, rPlp had
strong hemolytic activity towards rainbow trout erythrocytes, but not to sheep
erythrocytes suggesting that rPlp is optimized for lysis of phosphatidylcholine-rich fish
erythrocytes. Further, only the loss of the plp gene had a significant effect on hemolytic
activity of culture supernatant on fish erythrocytes, while the loss of rtxA and/or vah1
had little effect. However, V. anguillarum strains with mutations in plp or in plp and
vah1 exhibited no significant reduction in virulence compared to the wild type strain
when used to infect rainbow trout.

In the next manuscript, we used degenerate PCR to identify a positive
hemolysin regulatory gene, hlyU, from the unsequenced V. anguillarum genome.
The hlyU gene of V. anguillarum encodes a 92-amino acid protein and is highly
homologous to other bacterial HlyU proteins.

An hlyU mutant was constructed,

which exhibited ~5-fold decrease in hemolytic activity on sheep blood agar with no
statistically significant

decrease in

cytotoxicity of the wild

type strain.

Complementation of the hlyU mutation restored both hemolytic and cytotoxic activity.
Both semi-quantitative RT-PCR and real time RT-qPCR were used to examine
expression of the hemolysin genes under exponential and stationary phase conditions
in wild type, hlyU mutant, and hlyU complemented strains.

Compared to the wild

type strain, expression of rtx genes deceased in the hlyU mutant while expression of
vah1 and plp was not affected in the hlyU mutant.

Complementation of the hlyU

mutation restored expression of the rtx genes and increased vah1 and plp expression to
levels higher than in the wild type. The transcriptional start sites in the intergenic
regions of both vah1/plp and rtxH/rtxB genes were determined using 5’-RACE and the
binding sites for purified HlyU was discovered using DNA gel mobility shift
experiments and DNase protection assays.

In the third manuscript, we identified the hns gene, which encodes the H-NS
protein, and acts as a negative regulator of both gene clusters.

The V. anguillarum

H-NS protein shares strong homology with other bacterial H-NS proteins.

An hns

mutant exhibited increased hemolytic activity and cytotoxicity compared to the wild
type strain.

Complementation of the hns mutation restored hemolytic activity and

cytotoxicity levels to near wild type levels.

Further, expression of rtxA, rtxH, rtxB,

vah1 and plp increased in the hns mutant, and decreased in the complemented hns
mutant strain when compared to the wild type strain.

Additionally, experiments

using DNase I, showed that purified recombinant H-NS protected multiple sites in the
promoter region of both gene clusters.

The hns mutant also exhibited significantly

attenuated virulence against rainbow trout.

Complementation of the hns mutation

restored virulence to wild type levels, suggesting that H-NS regulates many genes that
affect fitness and virulence.

Previously, we showed that HlyU is a positive regulator

of expression for both gene clusters. In this study, we demonstrate that up-regulation
by hlyU is hns-dependent, suggesting that H-NS acts to repress or silence both gene
clusters, and HlyU acts to relieve that repression or silencing.

In the last manuscript, we aimed to create avirulent and immunogenic V.

anguillarum strains that can be used as a live vaccine for fish, without knocking out
any of the hemolysin genes. For this purpose, six genes (mdh, icd, sucA, sucC, sdhC,
and fumA) encoding enzymes in tricarboxylic acid (TCA) cycle and one gene (cra)
encoding a fructose metabolism repressor were identified and mutated in wild type V.
anguillarum M93Sm (serotype O2a). Among all mutants, icd mutant showed high
attenuation of virulence and lowest cell density limit in two forms of rich media. All
mutants exhibited the same or higher levels of hemolysin gene expression compared to
wild type during log phase. Further, fish that were pre-treated by immersion with icd
mutant protected rainbow trout from the subsequent challenge of V. anguillarum
M93Sm; and fish that were pre-treated with injection of the icd mutant elicited
cross-serotype immunity against the subsequent challenge of V. anguillarum NB10
(serotype O1). The results suggest the TCA cycle mutation approach is likely to be an
easy method to construct modified live vaccine for a wide variety of pathogenic
bacteria.
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PREFACE

This dissertation has been prepared in the Manuscript Format according to
the guidelines of the Graduate School of the University of Rhode Island. The first
manuscript: “Characterization of Plp, a phosphatidylcholine-specific phospholipase
and hemolysin of Vibrio anguillarum” was submitted to BMC Microbiology on
August, 12th, 2013 and is in review. The second manuscript: “HlyU is a positive
regulator of hemolysin expression in Vibrio anguillarum” was published in Journal of
Bacteriology in 2011. The third manuscript: “H-NS is a Negative Regulator of the
Two Hemolysin/Cytotoxin Gene Clusters in Vibrio anguillarum” was published in
Infection and Immunity in 2013, and the fourth manuscript: “A Vibrio anguillarum
isocitrate dehydrogenase mutant is highly attenuated and immunogenic in rainbow
trout (Oncorhynchus mykiss).” has been written in the same form as the third
manuscript and will be submitted for publication.
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Abstract
Background
Vibrio anguillarum is the causative agent of vibriosis in fish. Several extracellular
proteins secreted by V. anguillarum have been shown to contribute to virulence. While
two hemolysin gene clusters, vah1-plp and rtxACHBDE, have been previously
identified and described, the activities of the protein encoded by the plp gene were not
known. Here we describe the biochemical activities of the plp-encoded protein and its
role in pathogenesis.
Results
The plp gene, one of the components in vah1 cluster, encodes a 416-amino-acid protein
(Plp), which has homology to lipolytic enzymes containing the catalytic site amino acid
signature SGNH. Hemolytic activity of the plp mutant increased 2-3-fold on sheep
blood agar indicating that plp represses vah1; however, hemolytic activity of the plp
mutant decreased by 2-3-fold on fish blood agar suggesting that Plp has different effects
against erythrocytes from different species. His6-tagged recombinant Plp protein (rPlp)
was over-expressed in E. coli. Purified and re-folded active rPlp exhibited
phospholipase A2 activity against phosphatidylcholine and no activity against
phosphatidylserine, phosphatidylethanolamine, or sphingomyelin. Characterization of
rPlp revealed broad optimal activities at pH 5–9 and at temperatures of 30-64°C.
Divalent cations and metal chelators did not affect activity of rPlp. We also
demonstrated that Plp was secreted using thin layer chromatography and immunoblot
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analysis. Additionally, rPlp had strong hemolytic activity towards rainbow trout
erythrocytes, but not to sheep erythrocytes suggesting that rPlp is optimized for lysis of
phosphatidylcholine-rich fish erythrocytes. Further, only the loss of the plp gene had a
significant effect on hemolytic activity of culture supernatant on fish erythrocytes,
while the loss of rtxA and/or vah1 had little effect. However, V. anguillarum strains with
mutations in plp or in plp and vah1 exhibited no significant reduction in virulence
compared to the wild type strain when used to infect rainbow trout.
Conclusion
The plp gene of V. anguillarum encoding a phospholipase with A2 activity is specific
for phosphatidylcholine and, therefore, able to lyse fish erythrocytes, but not sheep
erythrocytes. Mutation of plp does not affect the virulence of V. anguillarum in
rainbow trout.
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Background
Vibrio anguillarum, a highly motile marine member of the γ-Proteobacteria , is one of
the causative agents of vibriosis, a fatal hemorrhagic septicemic disease of both wild
and cultured fish, crustaceans, and bivalves [1]. Fish infected with V. anguillarum
display skin discoloration and erythema around the mouth, fins, and vent. Necrotic
lesions are also observed in the abdominal muscle [2]. Mortality rates in infected fish
populations range as high as 30-100% [1, 3]. Vibriosis has caused severe economic
losses to aquaculture worldwide [1, 3] and affects many farm-raised fish including
Pacific salmon, Atlantic salmon, sea bass, cod, and eel [3, 4]. V. anguillarum enters its
fish host through the gastrointestinal tract (GI) and quickly colonizes this nutrient rich
environment [2, 5]. Garcia et al. [6] have shown that V. anguillarum grows extremely
well in salmon intestinal mucus and that mucus-grown cells specifically express a
number of different proteins, including several outer membrane proteins [6] and the
extracellular metalloprotease EmpA [2, 5].

Several genes have been reported to be correlated with virulence by V. anguillarum,
including the vah1 hemolysin cluster [7, 8], the rtx hemolysin cluster [9], the
siderophore mediated iron transport system [10], the empA metalloprotease [2, 5], and
the flaA gene [11]. Hemolytic activity of V. anguillarum has been considered to be the
virulence factor responsible for hemorrhagic septicemia during infection [10]. We
have identified two hemolysin gene clusters in V. anguillarum that contribute to the
virulence of this pathogen [8, 9]. One gene cluster, rtxACHBDE, encodes a MARTX
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toxin and its type I secretion system [9]. The second hemolysin gene cluster in V.
anguillarum strain M93Sm contains the hemolysin gene vah1 linked to two putative
lipase-related genes (llpA and llpB) and a divergently transcribed hemolysin-like gene
(plp) that appears to function as a repressor of hemolytic activity [8]. The plp-encoded
protein has very high sequence similarity to phospholipases found in other pathogenic
Vibrio species [8]. However, the enzymatic characteristics of Plp in V. anguillarum
were not described.

Generally, phospholipases are divided into several subgroups depending on their
specificity for hydrolysis of ester bonds at different locations in the phospholipid
molecule.

Phospholipases A (PLAs) cleave long chain fatty acids at sn-1 (PLA1) or

sn-2 (PLA2) position from phospholipid to yield lysophospholipid and free fatty acid;
phospholipases

C

(PLCs)

cleave

phospholipid

into

diacylglycerol

and

a

phosphate-containing head group; and phospholipases D (PLDs) cleave phospholipid
into phosphatidic acid and an alcohol.

It is known that some phospholipid products

are used as secondary messages, which play a central role in signal transduction [12].

In this study, we determined that plp encodes a phospholipase A2 in V. anguillarum,
and then purified recombinant Plp protein (rPlp) from E. coli to investigate
biochemical characteristics. We also described the contribution and specificity of rPlp
for hydrolysis of phospholipids, and its ability to lyse fish erythrocytes.
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Results
Identification of a putative phospholipase gene plp. Previously, a putative
phospholipase gene, plp, was identified in the vah1 hemolysin cluster of V.
anguillarum strain M93Sm [8]. The 1251-bp plp gene (Genbank accession EU650390)
was predicted to encode a protein of 416 amino acids. A BLASTx [13] search revealed
that the deduced Plp amino acid sequence exhibited homology with many lipolytic
enzymes including the phospholipase/lecithinase/hemolysin of Vibrio vulnificus
(identity, 69%; similarity, 82%); the lecithin-dependent hemolysin (LDH)/
thermolabile hemolysin (TLH) of Vibrio parahaemolyticus (identity, 64%; similarity,
80%); the lipolytic enzyme/hemolysin VHH of Vibrio harveyi (identity, 63%;
similarity, 78%); and the thermolabile hemolysin of Vibrio cholerae (identity, 62%;
similarity, 78%);

The phylogenetic tree created by the Clustal-W program from 17

Plp homologous proteins revealed that while the most closely related Plp proteins
were all from pathogenic members of the genus Vibrio, the Plp of V. anguillarum was
an outlier among the Vibrio species (Fig. 1).

According to Flieger’s classification

[14, 15], the alignment of Plp with other homologous proteins indicated that Plp could
be classified into subgroup B of this lipolytic family with its long N-terminal tail prior
to the block I [14].

Additionally, close examination of the amino acid sequences of

these enzymes revealed that the typical GDSL motif for lypolytic enzymes is not
totally conserved in all of these 17 proteins, in which leucines (L) are replaced with
isoleucines (I) in Photobacterium, Marinomonas, and Shewanella (Fig. 1).

In this

case, V. anguillarum Plp should be considered as a member of the SGNH hydrolase
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family, based on the Molgaard's suggestion that only four amino acids (S, G, N, and
H) are completely conserved among the GDSL proteins [16].

Plp affects hemolysis of fish erythrocytes. The hemolysin gene vah1 is divergently
transcribed from plp [17]. Mutation of plp increased hemolytic activity by 2-3-fold on
Trypticase soy agar plus 5% sheep blood (TSA-sheep blood) plate compared with wild
type strain (M93Sm) (Fig. 2A) [8].

Rock and Nelson [8] also demonstrated that the

plp mutant had increased vah1 transcription (by 2-4-fold), indicating that Plp is a
putative repressor of vah1. Previously, we demonstrated that a double mutant in vah1
and rtxA resulted in a hemolysis negative mutant when plated on TSA-sheep blood
agar [9]. Similar results were observed when using Luria-Bertani broth plus 2% NaCl
plus 5% sheep blood (LB20-sheep blood) agar (data not shown). However, on LB20
plus 5% rainbow trout blood (LB20-rainbow trout blood) agar, the plp mutant
exhibited a smaller zone of hemolysis compared to wild type strain M93Sm (Fig. 2B);
complementation of plp restored the hemolytic activity of the mutant strain (Fig. 2B).
Similar results were observed when using LB20 plus 5% Atlantic salmon blood agar
(data not shown), suggesting that the ability of Plp to lyse erythrocytes is dependent
upon the source of erythrocytes and, therefore, their lipid composition.

Plp has phospholipase A2 activity. Thin layer chromatography (TLC) was used to
examine the pattern of phospholipid cleavage by Plp.

BODIPY-labeled

phosphatidylcholine (BPC) was incubated with various enzyme standards, including
7

phospholipase A2 (PLA2), phospholipase C (PLC), or phospholipase D (PLD).

TLC

analysis revealed distinct cleavage patterns (Fig. 3A) by these standard enzymes
indicating that BPC was an appropriate substrate to examine Plp activity.

Cell lysate

prepared from E. coli strain S299, which contains the shuttle plasmid pSUP202-plp
that was able to complement the plp mutation in V. anguillarum [8], cleaved BPC to
yield BODIPY-lysophosphatidylcholine (BLPC) (Fig. 3B Lane 5) plus unlabeled free
fatty acid (FFA) that is not detected. The cleavage products were identical to those
generated by PLA2 (Fig. 3A) and demonstrate that Plp has phospholipase A2 activity.
Additionally, the culture supernatant from S299 had only ~5% of the activity of that in
cell lysate, indicating that Plp accumulated in the cell lysate instead of being secreted
by the E. coli strain.

No phospholipase activity was detected in PBS buffer or in E.

coli DH5α containing only the pSUP202 vector (Fig. 3B).

Further, phospholipase

A2 activity was examined in various subcellular fractions prepared from E. coli strain
S299, including cytoplasmic, cytoplasmic membrane, and outer membrane fractions.
Most Plp activity was detected in Tween-20 soluble membrane fraction, indicating
that Plp was mainly localized in the cytoplasmic membrane of E. coli S299 (data not
shown).

No BODIPY-labeled free fatty acid (FFA) (at sn-1 position) was detected

in the TLC analysis when an apolar solvent was used (data not shown), and
BODIPY-labeled LPC was not further degraded by Plp in the reaction, indicating that
Plp had no lysophospholipase or phospholipase B activity.

Enzymatic characteristics of rPlp protein. To examine the enzymatic characteristics
of Plp, the entire coding sequence of plp was cloned and inserted into the expression
8

vector pQE60, which adds a His6 (His-6×) tag to the carboxyl end of Plp.

The

over-expressed recombinant Plp (rPlp) formed inclusion bodies in E. coli. To recover
active rPlp, purification of the inclusion bodies followed by solubilization under mild
conditions and re-folding was performed (16) as described in the Materials and
Methods. Purity of refolded rPlp protein was confirmed by SDS-PAGE and silver
staining (data not shown).

The final concentration of purified rPlp protein was 8

µg/ml with a recovery of <10%.

Subsequently, the enzymatic characteristics of refolded rPlp were examined under
various chemical and physical conditions.

The enzymatic activity of rPlp was

positively correlated to its concentration from 1 µg/ml to 8 µg/ml (Fig. 4A); therefore,
4 µg/ml rPlp protein was routinely used in other activity assays. The enzymatic
activity unit of refolded rPlp (1 unit = amount of protein that cleaves 1 µmole of
BODIPY-PC per minute) was about 2,500-fold higher than standard PLA2 enzyme
extracted from porcine pancreas (Sigma# P8910), which indicated that Plp had a high
activity against the BPC phospholipid substrate.

Plp enzyme activity exhibited a

broad temperature optimum from 37ºC to 64ºC (Fig. 4B) with 75% activity retained at
27ºC and 50% activity at 20ºC.

While rPlp activity rapidly decreased at temperatures

above 70ºC, the enzyme retained full activity at 64°C for at least 1 h. The data
demonstrate that rPlp is a relatively themostable phospholipase.
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The effect of pH on enzyme activity was determined for pH values ranging from 2 to
12.

The data showed that rPlp had a broad pH optimum from pH 5.3 to pH 8.7 with

activity dropping off rapidly at pH values above and below the optimum (Fig. 4C).
rPlp activity was not affected by treatment with the chelating reagents EGTA (Fig.
4D) or EDTA (data not shown) at concentrations up to 100 mM. Additionally,
treatment with divalent metal ions, such as calcium or magnesium had no effect on
activity (data not shown).

Plp is a secreted protein in V. anguillarum.

Subcellular fractions from V.

anguillarum strains M93Sm and S262 (plp) were prepared and phospholipase A2
activity examined using BPC and TLC.

Initial studies revealed that at 37ºC

phospholipase A2 activity was detected in all cell fractions, including the culture
supernatant, periplasm, cytoplasm, cytoplasmic membrane, and outer membrane, from
both M93Sm and S262 (Fig. 5A).

However, when the assay was performed at 64ºC

(to inactivate heat labile phospholipases), phospholipase A2 activity in S262 was
significantly decreased in all fractions including the supernatant (Fig. 5B).
Additionally, when the assay was performed at 64°C for M93Sm subcellular fractions,
only the culture supernatant exhibited phospholipase activity against BPC (about
100-fold higher activity compared to the phospholipase activity of the S262
supernatant).

The data demonstrated that Plp was secreted into the culture

supernatant of V. anguillarum.

TLC results also revealed that there was at least one

other protein in V. anguillarum M93Sm exhibiting phospholipase A2 activity besides
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the secreted, heat stable Plp protein.

This was a themolabile PLA2 activity

inactivated at 64ºC.

In order to confirm that Plp was localized in the supernatant of V. anguillarum, protein
samples prepared from various subcellular fractions were separated by SDS-PAGE
and analyzed by western blot analysis using polyclonal rabbit anti-Plp antiserum.

An

immuno-reactive band of ~45 kDa was detected only in the supernatant of M93Sm,
but was absent in the supernatant of plp mutant (Fig. 5C).

Taken together with the

phospholipase A2 activity data, these data indicate that Plp is a secreted protein in V.
anguillarum.

rPlp

has

a

specific

activity

against

phosphatidylcholine.

Various

fluorescently-labeled phospholipid substrates (described in Materials and Methods)
were used to determine the specificity of the rPlp protein.

rPlp exhibited high

activity against phosphatidylcholine, cleaving BPC to yield BLPC and free fatty acid
(Fig. 3 and 6A).

However, rPlp had almost no activity against both

NBD-phosphatidylethanolamine (NBD-PE) (Fig. 6B) and NBD-phosphatidylserine
(NBD-PS) (Fig. 6C), showing only 2% and 5%, respectively, of the activity of the
standard PLA2 protein against each of the substrates.

The data indicated that the rPlp

protein

phosphatidylethanolamine

does

not

phosphatidylserine.

efficiently

cleave

either

or

Additionally, unlike the standard sphingomyelinase (Sigma),

rPlp was not able to cleave the NBD-sphingomyelin into the NBD-ceramide and
11

phosphocholine (Fig. 6D), indicating that rPlp had no sphingomyelinase activity.
Taken together, the data demonstrated that Plp is a phosphatidylcholine-specific PLA2
enzyme.

rPlp is able to lyse the fish erythrocytes directly. Membrane phospholipid
compositions are quite varied among the animal species, especially for
phosphatidylcholine.

It is known that phosphatidylcholine makes up 58% of the total

phospholipid in fish erythrocytes [18]; however, no phosphatidylcholine is found in
sheep erythrocytes [19].

In order to determine whether the differential hemolysis

observed for plp mutants of V. anguillarum (Fig. 2) is due to the activity of Plp against
PC, we tested the ability of purified rPlp to lyse Atlantic salmon erythrocytes.
Addition of recombinant Plp resulted in the lysis of Atlantic salmon erythrocytes, with
the amount of lysis directly related to the amount of rPlp added to the blood
suspension (Fig. 7).

In contrast, addition of rPlp to a suspension of sheep

erythrocytes resulted in no lysis of those cells (Fig. 7).

These data show that Plp has

phosphatidylcholine-specific phospholipase A2 activity and can directly lyse fish
erythrocytes.

Plp is one of the hemolysins of V. anguillarum.

Previously, we demonstrated

that there are two major hemolysin gene clusters in the M93Sm, the vah1 cluster [8]
and the rtxA cluster [9]. Mutation of both vah1 and rtxA completely eliminated the
hemolytic activity of M93Sm on TSA-sheep blood agar [9].
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While, mutation of the

plp gene resulted in 2-3-fold increased hemolytic activity on TSA-sheep blood agar,
with vah1 expression increased both transcriptionally and translationally in the plp
mutant, indicating that Plp is a putative repressor of vah1 [9], Plp also has hemolytic
activity against fish erythrocytes due to its phosphatidylcholine-specific activity (Figs.
6 and 7).

To investigate the relationship of the three hemolysins, culture supernatants

obtained from various V. anguillarum strains (Table 1) were used to examine the
hemolytic activity against the fish blood (Table 2).

In contrast to the strong hemolytic activity against 5% rainbow trout blood mixed with
culture supernatant from the wild type strain M93Sm, hemolytic activity of culture
supernatant from strain S262 (plp) declined by >70% (Table 2).

Additionally, all

mutants containing a knockout of plp exhibited significant declines (P< 0.05) in
hemolytic activity.

The triple hemolysin mutant, XM90 (plp vah1 rtxA) had no

ability to lyse fish erythrocytes (Table 2). However, mutations in either vah1 or rtxA,
but not plp, resulted in little or no decline in hemolytic activity against fish
erythrocytes compared to supernatants from wild type cells (Table 2).

Further,

complementation of plp restored the hemolytic activity of supernatants from both the
plp-complemented strains (XM31, plp+ and XM93, vah1 rtxA plp+) (Table 2).Taken
together, these data clearly demonstrate that Plp is the major hemolytic enzyme
responsible for the lysis of fish erythrocytes by culture supernatants of V. anguillarum.
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Plp is not a major virulence factor for V. anguillarum during fish infection. In
order to determine whether the plp gene affects virulence in fish, an infection study
was performed by inoculating rainbow trout by IP injection with either the wild type
strain M93Sm or mutant strains S262 (plp) or JR03 (vah1plp). The results of this
experiment (Fig. 8) indicated that there were no statistical differences in mortality
between the three strains.

This suggested that mutation of either or both plp or vah1

did not decrease the virulence of M93Sm. These results are consistent with our
previous observations that rtxA is a major virulence factor of M93sm and that
mutation of vah1 does not affect virulence [8], and demonstrate that Plp is not a major
virulence factor in the V. anguillarum M93Sm.

14

Discussion
In this report, we describe the characteristics of the V. anguillarum phospholipase
protein (Plp) encoded by plp, and its contribution to the hemolytic activity of V.
anguillarum.

Specifically, we show that Plp is a secreted phospholipase with A2

activity with specificity for phosphatidylcholine.

The enzyme has a broad

temperature optimum (37 – 64°C) and a broad pH optimum (pH5.5 – 8.7).
Phospholipases are broadly distributed among the Vibrionaceae and often contribute
to the virulence of the pathogenic members of this family.

For example, the TLH

(synonym: lecithin-dependent hemolysin, LDH) of V. parahaemolyticus [20-22] was
the first well-studied lecithin-dependent PLA / lysophospholipase [23].
(encoded by lec) was also identified in V. cholerae [24].

A lecithinase

Fiore et al[24] found that a

lec mutant strain was unable to degrade lecithin and the culture supernatant exhibited
decreased cytotoxicity.

However, the mutant did not exhibit decreased fluid

accumulation in a rabbit ileal loop assay, suggesting that fluid accumulation in animals
is not affected by lecithinase activity.

Additionally, the phospholipase A (PhlA) in V.

mimicus was found to exhibit hemolytic activity against trout and tilapia erythrocytes
and was cytotoxic to the fish cell line CHSE-214 [25].

Recently, the V. harveyi

hemolysin (VHH) was shown to be a virulence factor during flounder infection and
also had phospholipase activity on egg yolk agar [26].

Rock and Nelson [8] reported

that the putative phospholipase gene (plp) from V. anguillarum exhibits 69% amino
acid identity with the V. cholerae lec gene. Both plp and lec are located divergently
adjacent to a hemolysin gene (vah1 and hlyA, respectively) [8, 24].

Additionally,

data strongly suggested that functional plp repressed transcription of its adjacent
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hemolysin gene, vah1, in V. anguillarum[8].

However, the enzymatic characteristics

of Plp in V. anguillarum were not described.

Usually, phospholipases are divided into phospholipases A (A1 and A2), C, and D
according to the cleavage position on target phospholipids.

Most of lipolytic

enzymes contain a putative lipid catalytic motif (GDSL) that was previously
demonstrated in other bacterial and eukaryotic phospholipases [27]. However,
Molgaard [16] proposed that four amino acid residues (SGNH) form a catalytic site,
and are conserved in all members of the phospholipase family; therefore,
phospholipases were re-named as a SGNH family.

Multiple alignment analysis of 17

phospholipase homologues (Fig. 1) demonstrates that V. anguillarum Plp belongs to
SGNH hydrolase family, instead of GDSL family, since the GSDL motif was not fully
conserved in these proteins (Fig. 1).

Recently, it was reported that mutation of the

serine residue in the SGNH motif resulted in the complete loss of the phospholipase
and hemolytic activities of VHH in V. harveyi [28] demonstrating the importance of
this motif on the activity of phospholipase.

In contrast to the similarities of their catalytic motifs, the biochemical characteristics
of bacterial phospholipases appear to be variable. For example, V. mimicus PhlA has a
phospholipase A activity, which cleaves the fatty acid at either sn-1or sn-2 position,
but no lysophospholipase activity [25].

Two phospholipases identified from

mesophilic Aeromonas sp.serogroup O:34 show phospholipase A1 and C activity [29].
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In addition, TLH of V. parahaemolyticus has PLA2 and lysophospholipase activity,
and demonstrates a loss of activity at 55ºC for 10 min [20].

In this report, we show

that V. anguillarum Plp has PLA2 activity, and is able to maintain activity at 64ºC for
1 h (Figs. 6 and 7). Therefore, the enzymatic characteristics of specific phospholipases
are distinct even when they all belong to the SGNH hydrolase family (Fig. 1).

Phospholipases have been implicated in the pathogenic activities of a number of
bacteria [30, 31]. It is known that phospholipase activities often lead to cell destruction
by degrading the phospholipids of cell membranes [30, 32]. However, the
relationships between phospholipases and virulence are not always clear. While the
purified rPlp exhibits strong hemolytic activity against Atlantic salmon erythrocytes
(Fig. 7), Rock and Nelson [8] showed that a knock-out mutation of either the plp gene
or the vah1 gene in V. anguillarum did not affect virulence of V. anguillarum during
an infection study on juvenile Atlantic salmon. In this report, we show that when
groups of rainbow trout are infected with either a plp mutant or a plp vah1 double
mutant there is no significant difference in mortalities compared to fish infected with
the wild type strain.

Our data suggest that neither plp nor vah1 are major virulence

factors during pathogenesis of salmonids. It was also reported that the deletion of
lecithinase (Lec) activity in V. cholerae did not significantly diminish fluid
accumulation in the rabbit ileal loop assay, indicating the lecithinase activity does not
contribute significantly to enterotoxin activity [24].

In contrast, the direct IP

injection of purified V. harveyi VHH protein caused the death of flounder with an
LD50 of about 18.4 µg protein/fish [26].

The rPhlA of V. mimicus also has a direct
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cytotoxic effect on the fish cell line CHSE-214 [25] suggesting that this phospholipase
is a virulence factor during fish infection.

In addition, the lecithinase purified from

A. hydrophila (serogroup O:34) has been shown to be an important virulence factor to
rainbow trout and mouse [29].

Generally, the hemolytic activity of phospholipases is dependent upon the hydrolysis
of the phospholipids that reside in the erythrocyte membrane.

Erythrocytes contain

various phospholipids including phosphatidylcholine (PC), phosphatidylethanolamine
(PE), phosphatidylserine (PS), phosphatidylinositol (PI), and sphingomyelin (SM).
PC makes up 58% of the total erythrocyte phospholipids in the Atlantic salmon [33],
but only 34% and 1% in rabbit and sheep erythrocytes, respectively [19].

Taken

together with the high specificity of rPlp for PC (Fig. 6), it was not surprising that rPlp
was able to lyse the fish erythrocytes, but not sheep erythrocytes (Fig. 7), and that the
plp mutant had decreased hemolytic activity on LB20-fish blood agar (Fig. 2).

Our

results are consistent were those reported for V. mimicus PhlA[25] and V. harveyi
VHH [26], in which PhlA and VVH specifically lyse the fish erythrocytes.

We have previously reported that there are two hemolysin gene clusters in V.
anguillarum M93Sm, the vah1-plp cluster and rtxACHBDE cluster [9] and have
described their regulation by H-NS and HlyU [17, 34].

Mutation of both vah1 and

rtxA results in the loss of all hemolytic activity on TSA-sheep blood agar [9], which is
consistent with the data reported here that Plp has no activity on sheep erythrocytes.
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We have also previously demonstrated that Plp is a putative repressor of Vah1, since
mutation of plp increases vah1 expression by 2-3 fold [8].

In this report, we

examined the hemolytic activity of various hemolysin mutants using freshly collected
Rainbow trout blood (Table 2) to investigate the relationships among three hemolysins
of V. anguillarum.

While culture supernatants from two of the three single mutants

(JR1 and S123) and one of three double mutants (S183) exhibited ≥94%of the
hemolytic activity as supernatants from the wild type strain M93Sm (Table 2), the
hemolytic activity of one single mutant (S262, plp) and two double mutants (JR03, plp
vah1 and S187, plp rtxA) were reduced to 28%, 14%, and 12% of that in M93Sm,
respectively.

Our data indicate that only the loss of the plp gene has a significant

effect on hemolysis of fish erythrocytes by V. anguillarum culture supernatant, while
the loss of rtxA and/or vah1 has little effect. Further, supernatant from the hemolysin
triple mutant XM90 (vah1 rtxA plp) exhibits no hemolytic activity on fish blood
compared to M93Sm (Table 2), indicating that Vah1, RtxA, and Plp are responsible
for all secreted hemolytic activity by V. anguillarum.

Finally, complementation of

any plp mutant with plp (in trans) restores hemolytic activity to V. anguillarum culture
supernatant (Table 2).
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Conclusion
V. anguillarum Plp is a secreted hemolysin with phosphatidylcholine-specific
phospholipase

A2

activity.

The

ability

of

Plp

to

digest

the

abundant

phosphatidylcholine found in the membrane of fish erythrocytes causes their lysis. The
three hemolysins, Plp, Vah1 and RtxA, account for all hemolytic activity in V.
anguillarum culture supernatant under the experiment conditions described in this
study.

Finally, infection studies in rainbow trout demonstrate that the plp and vah1

genes are not required for virulence.
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Methods
Bacterial strains, plasmids, and growth conditions. All bacterial strains and
plasmids used in this report are listed in Table 1.

V. anguillarum strains were

routinely grown in Luria-Bertani broth plus 2% NaCl (LB20) [35], supplemented with
the appropriate antibiotic, in a shaking water bath at 27°C.

E. coli strains were

routinely grown in Luria-Bertani broth plus 1% NaCl (LB10).

Antibiotics were used

at the following concentrations: streptomycin, 200 µg/ml; ampicillin, 100 µg/ml
(Ap100); chloramphenicol, 20 µg/ml (Cm20) for E. coli and 5 µg/ml (Cm5) for V.
anguillarum; kanamycin, 50 µg/ml (Km50) for E. coli and 80 µg/ml (Km80) for V.
anguillarum; tetracycline, 15 µg/ml (Tc15) for E. coli, 1 µg/ml (Tc1) for V.
anguillarum grown in liquid medium, and 2 µg/ml (Tc2) for V. anguillarum grown on
agar plates.

Insertional mutagenesis. Insertional mutations were made by using a modification of
the procedure described by Milton et al.[25]. Briefly, primers (Table3) were designed
based on the target gene sequence of M93Sm. Then a 200-300 bp DNA fragment of
the target gene was PCR amplified and ligated into the suicide vector pNQ705-1
(GenBank accession no. KC795685)after digestion with SacI and XbaI.The ligation
mixture was introduced into E. coli Sm10 by electroporation using BioRad Gene
Pulser II (BioRad, Hercules, CA).Transformants were selected on LB10 Cm20 agar
plates. The construction of the recombinant pNQ705 was confirmed by both PCR
amplification and restriction analysis. The mobilizable suicide vector was transferred
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from E. coli Sm10 into V. anguillarum by conjugation. Transconjugants were selected
by utilizing the chloramphenicol resistance gene located on the suicide plasmid. The
incorporation of the recombinant pNQ705was confirmed by PCR amplification.

Allelic exchange mutagenesis. The allelic exchange rtxA mutation in V.
anguillarum S264 was made by using a modification of the procedure described by
Milton et al.[25].The 5′region of rtxA was amplified using the primer pair pm256 and
pm257 (Table3), digested with XhoI and XbaI, and then cloned into the region
between the XhoI and XbaI sites on pDM4 (GenBank accession no. KC795686),
deriving pDM4-rtxA5’. The 3′ region of rtxA was amplified using the primer pair
pm258 and pm259 (Table3), digested with XbaI and SacI, and then cloned into the
region between the XbaI and SacI sites on the pDM4-rtxA5’. The resulting
pDM4-rtxA5’-rtxA3’ was transformed into E. coli Sm10 to produce the transformant
strain S252, which was mated with V. anguillarum S171 (vah1). Single-crossover
transconjugants were selected with LB20 Kan80 Sm200 Cm5 plates and, subsequently,
double-crossover transconjugants were selected with LB20 Kan80 Sm200 5% sucrose
plates. The resulting V. anguillarum colonies were transferred to TSA-sheep blood
agar (Northeast Laboratories Service, Waterville, ME) and screened for non-hemolytic
colonies (vah1 rtxA). The resulting colonies were checked for the desired allelic
exchange using PCR amplification.

Complementation of mutants. The various mutants were complemented by cloning
the appropriate target gene fragment into the shuttle vector pSUP202 (GenBank
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accession no. AY428809) as described previously by [8]. Briefly, primers (Table 3)
were designed with EcoRI and AgeI sites and then used to amplify the entire target
gene plus ~500 bp of the 5’ and ~200 bp 3’flanking regions from genomic DNA of V.
anguillarum M93Sm. The DNA fragment was then ligated into pSUP202 after
digestion with EcoRI and AgeI, and the ligation mixture was introduced into E. coli
Sm10 by electroporation using a BioRad Gene Pulser II. Transformants were selected
on LB10 Tc15 Ap100 agar plates. The complementing plasmid was transferred from E.
coli Sm10 into the V. anguillarum mutant by conjugation. Transconjugants were
selected by tetracycline resistance (Tc2). The transconjugants were then confirmed by
PCR amplification and restriction digestion.

Bacterial conjugation. Bacterial conjugations were carried out using the procedure
modified from by Varina et al [36]. Briefly, 100 µl V. anguillarum grown overnight
was added into 2.5 ml nine salts solution (NSS) [37]; 100 µl E. coli culture overnight
was added into 2.5 ml 10 mM MgSO4. The resulting V. anguillarum and E. coli
suspension was mixed, vacuum filtered onto an autoclaved 0.22-µm-pore-diameter
nylon membrane (Millipore, USA.), placed on an LB15 agar plate (LB-plus-1.5%
NaCl), and allowed to incubate overnight at 27°C. Following incubation, the cells
were removed from the filter by vigorous vortex mixing in 1 ml NSS. Cell suspensions
(70 µl) were spread on LB20 plated with appropriate antibiotics and the plates were
incubated at 27°C until V. anguillarum colonies were observed (usually 24 to 48 h).
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Cloning, over-expression, purification, and refolding of the Plp protein. The
whole length of the plp gene (stop codon not included) was amplified by PCR with a
sense primer introducing a BamHI site and an antisense primer introducing BglII site,
respectively. Genomic DNA extracted from V. anguillarum M93Sm was used as
template. The amplified PCR product was digested with BamHI and BglII, and ligated
into a pQE60 (QIAGEN, USA) vector, which was also cut with BamHI and BglII.
The ligation mix was transformed into E. coli M15 (pREP4) and clones with
pQE60-plp were selected on LB10 agar containing kanamycin and ampicillin. A clone
harboring plasmid pQE60-plp was selected and the plasmid DNA sequence isolated
from the clone confirmed by sequencing. The clone was designated as S269.
Subsequently, E. coli strain S269 was grown at 37°C in 500 ml LB10 broth to OD600 =
0.5, and isopropyl-β-D-thiogalactopyranoside (IPTG) was added to the culture (final
concentration, 1 mM) to induce the expression of Plp. Then, the induced E. coli cells
grown for 4 h at 37 °C were harvested at 8000 × g for 10 min.
stored at -20°C overnight to improve lysis.

The cell pellet was

Inclusion bodies of Plp were crudely

purified using Cellytic B reagent (Sigma, USA).

Refolding of Plp protein from the

inclusion body preparation was carried out using a modification of the method
described by Santa et al [38].

Briefly, 500 µl of purified inclusion body (2 mg

protein/ml) was completely solubilized in 1ml of 50 mM Tris buffer (pH 12)
containing 2 M urea. The solubilized Plp was diluted into 20 ml dilution buffer (50
mM Tris–HCl, pH8.0; 0.2 M glycine; 10% glycerol; 2 M urea; 0.5 mM EDTA, and
0.2 mM DTT) at 4 °C.

No aggregation was observed during the dilution.

The

diluted Plp protein was dialyzed with the addition of 500 ml 50 mM Tris–HCl (pH8.0)
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until the total dialysis volume up to 3 L.

The dialyzed Plp protein was concentrated

with QIAGEN Ni-NTA Protein Purification Kit (QIAGEN) under native purification
condition according to the instructions of the manufacturer.

Hemolytic assays.

The hemolytic activity of V. anguillarum strains was measured

by two methods.

First, single V. anguillarum colonies were transferred onto

TSA-sheep blood agar, LB20-sheep blood agar (LB20 agar plus 5% sheep blood with
heparin, obtained from Hemostat Laboratories) or LB20-fish blood agar (LB20 agar
plus 5% rainbow trout or Atlantic salmon blood with heparin). Hemolytic activity of
each colony was determined by measuring hemolytic zone surrounding the colonies
after 24 h at 27°C.

Additionally, the level of hemolytic activity was also quantitated

using a microcentrifuge tube assay.

The tubes contained 500 µl 5% erythrocytes

(fish or sheep, suspended in 10 mM Tris-Cl, pH 7.5 – 0.9% NaCl buffer) were mixed
with 500 µl of bacterial supernatant or rPlp and incubated for 20 h at 27ºC.

The

samples were centrifuged at 1500 × g for 2 min at 4Cº, and the optical density of the
resulting supernatant was read at 428 nm.

Phospholipase

assay

and

thin-layer

chromatography

(TLC)

analysis.

Phospholipase assays were performed in vitro with a BODIPY-phosphatidylcholine
(BPC

or

2-decanoyl-1-(O-(11-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-prop
ionyl)amino)undecyl)-sn-glycero-3-phosphocholine;
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Invitrogen),

NBD-phosphatidylethanolamine

(NBD-PE,

N-(NBD-Aminododecanoyl)L-1,2-dihexanoyl-sn-glycero-3-phosphoethanolamine;
Sigma),

NBD-phosphatidylserine

(NBD-PS

or

1-Palmitoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sn-Glycero3-Phospho-L-Serine;

Avanti

Polar

Lipid),

NBD-sphingomyelin

(NBD-SM,

N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-Sphingosine-1-Phospho
choline; Avanti Polar Lipid).

20 µM phospholipid substrates (10 µl) were reacted

with an equal volume (10µl) of various samples, and incubated at different conditions,
as described for each experiment.

For some experiments, purified standard

phospholipases were used: PLA2 (Sigma) from porcine pancreas, PLC (Sigma) from
Clostridium perfringens, and PLD (Sigma) from cabbage.
were analyzed by thin-layer chromatography (TLC).

The reaction products

Briefly, 20µl of 1-butanol was

added to the above reaction mixes (20 µl), followed by vigorous vortex mixing for 30
s and centrifugation (10,000 × g, 1 min). The upper lipid extract layer (5 µl) was
loaded onto a plastic-backed silica gel G60 plate without fluorescent indicator (Sigma)
and

air-dried

for

20

min.

TLC

was

performed

either

with

chloroform-methanol-water-acetic acid (45/45/10/1 by vol.) when BODIPY-PC was
used as the substrate, or with chloroform-methanol-acetic acid (60/20/1 by vol.) when
NBD-PE, NBD-PS, or NBD-SM used as the substrates.

For some experiments, an

apolar solvent (n-hexane (70): diethyl ether (30): acetic aid (4)) was used.
Fluorescence was detected and quantified using a Typhoon 9410 laser scanner.
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Subcellular fractionation. V. anguillarum cells were fractionated as described
previously [6] and the subcellular location of Plp determined.

Briefly, 100 ml

NSS-washed overnight grown bacteria cells were resuspended in 10 ml of ultrapure
water for 20 min to cause osmotic shock and centrifuged (10,000 × g, 5ºC, 10 min) to
collect the periplasmic fraction (the supernatant). The remaining pellets were washed
twice with ultrapure water and lysed by sonication. The sonicated cells were
centrifuged (10,000 × g, 5ºC, 20 min) to remove cell debris and any unlysed cells, and
the supernatant cell lysate was separated by ultracentrifugation (200,000 × g, 1 h, 4ºC)
to yield the cytosolic (supernatant) and membrane (pellet) fractions. The membrane
fraction was treated with 1% Sarkosyl to obtain Sarkosyl-soluble (inner membrane)
and -insoluble (outer membrane) fractions. Protein concentration in various fractions
was measured using BCA protein determination kit (Pierce).

Preparation of polyclonal antibody. Truncated Plp protein was over-expressed and
purified to serve as the antigen to create polyclonal antibody against Plp.

Briefly,

primer Pm212 and Pm213 (listed in Table 3) were used to amplify central portion of
the plp gene, which encodes the truncated Plp protein (amino acid 93 to 293).

PCR

product was ligated into pQE30UA vector (QIAGEN), and transformed into E. coli
M15 and transformants were selected on LB10 agar containing kanamycin and
ampicillin. Plasmid DNA was purified and the sequence confirmed by DNA
sequencing.

Protein purification was performed under denaturing conditions

according to the instructions of the manufacturer (QIAGEN, USA) and protein purity
was determined by SDS-PAGE and Coomassie blue staining.
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Subsequently, the

purified truncated Plp was used as antigen to prepare polyclonal antibody in two New
Zealand White rabbits (Charles River Lab, MA).

Briefly, 1 ml purified antigen

(concentration = 100 µg/ml) was vigorously mixed with 1 ml TiterMax Gold adjuvant
(Sigma) into a homogeneous suspension.

About 10 ml of blood was withdrawn from

the rabbits before immunization as a control.

For the first injection, antigen-adjuvant

mix was subcutaneously injected at 4 sites (over each shoulder and thigh; 100 µl/site).
The rabbits were boosted with single injections of antigen-adjuvant (100 µl) at day 28,
42, and 56.

Blood was withdrawn 7-10 days after the 2nd and 3rd boosts to test the

titer of antiserum using the western blot analysis. Antiserum with a high titer (> 1:
10,000) was aliquoted and stored at -70ºC.

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
Western blot analysis.

Purified proteins or other protein samples were separated in

10% SDS-polyacrylamide gels.

Prestained protein standards (Bio-Rad) and Laemmli

sample buffer (Sigma) were used in all gels.

Electrophoresis was performed at 100 V

for 60-90 min. Gels were stained with either Coomassie blue G-250 or silver stain
(Pierce, USA) to visualize the protein bands. Alternatively, proteins were transferred
to nitrocellulose membranes for western blot analysis using the mini-Protean II system
(Bio-Rad).

Protein transfers were performed as described by Towbin et al [39] at

100 V for 1 h.
milk.

Nitrocellulose membranes were blocked with the addition of 5% skim

Detection of specific protein bands was accomplished by reacting the blot with

the 1:5000 diluted anti-Plp antibody, followed by the addition of the secondary
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antibody goat anti-rabbit IgG conjugated with peroxidase, and then developed by
TMB Development Liquid (Sigma, USA).

DNA sequence and analysis.

All DNA sequencing was done at the URI Genomics

and Sequencing Center (University of Rhode Island, Kingston, RI), using an ABI
3170xl Genetic Analyzer unit (Applied Biosystems).

Multiple alignment and

phylogenic tree were analyzed using the Clustal-W method in DNA-STAR
Lasergene7 program.

Fish infection studies.

Various V. anguillarum strains were tested for virulence with

rainbow trout (Oncorhynchus mykiss) by intraperitoneal (IP) injection as described by
Mou et al [29].

Briefly, V. anguillarum cells grown in LB20 supplemented with

appropriate antibiotics for 22 h at 27°C were harvested by centrifugation (9,000 × g, 5
min, 4°C), washed twice in NSS, and resuspended in NSS (~2 × 109 cells ml-1).
Initial cell density was estimated by measurement of optical density at 600 nm.

The

actual cell density of NSS suspensions was determined by serial dilution and spot
plating.

All fish were examined prior to the start of each experiment to determine

that they were free of disease or injury.

Fish were anesthetized with tricaine

methanesulfonate (Western Chemical, Ferndale, WA), with 100 mg/L for induction
and 52.5 mg/L for maintenance.
100 µl NSS vehicle.

V. anguillarum strains were IP-injected into fish in

Fish that were between 15 and 25 cm long were injected with

bacteria diluted with NSS at various doses or NSS only as negative control.
29

Five fish

were used for each experimental group.

Fish inoculated with different bacterial

strains were maintained in separate 10-gallon tanks with constant water flow (200
ml/min) at 19 ± 1 ºC.
cross-contamination.

The tanks were separated to prevent possible

Death due to vibriosis was determined by the observation of

gross clinical signs and confirmed by the recovery and isolation of V.
anguillarum cells resistant to the appropriate antibiotics from the head kidney of dead
fish.

Observations were made for 14 days.

All fish used in this research project

were obtained from the URI East Farm Aquaculture Center.

All fish infection

protocols were reviewed and approved by the University of Rhode Island Institutional
Animal Care and Use Committee (URI IACUC reference number AN06-008-002;
protocols renewed 14 January 2013).
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Figure 1. The phylogenetic tree (A) and amino acid sequence alignment (B) of V.
anguillarum Plp with members of the SGNH family.

Sequences of the 16 closest

matches to Plp are aligned along the five conserved blocks of the SGNH family
(Block IV not shown).

The rectangle bars above the alignment indicate the amount

of conservation of amino acid residues. The four residues conserved in all SGNH
family members are boxed.

35

36

Figure 2.

Hemolytic activity of M93Sm and S262 (plp) on TSA-sheep blood agar

(A) and LB20 + 5% rainbow trout blood agar (B).
S262

A single colony of M93Sm and

was transferred onto each of the blood agars and incubated at 27ºC for 24 h.

The zones of hemolysis were measured and the diameters were given in the figure.
This is a representative experiment from 3 replicate trials.
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Figure 3.

Thin-layer chromatography (TLC) demonstrates phospholipase A2

activity of Plp.

BODIPY-labeled phosphatidylcholine (BPC) was incubated with

various standard enzymes or sample preparations for 1 h at 37ºC.
lipids were extracted and separated by TLC.

Subsequently, the

(A) The cleavage patterns of BPC by

standard proteins PLA2, PLC, and PLD were able to distinguish the different
phospholipase activities.

(B) Cleavage patterns of BPC by supernatants (lanes 2 and

3) and cell lysates (lanes 4 and 5) from E. coli DH5α containing cloned plp (lanes 3
and 5) or just the cloning vector pSUP202 (lanes 2 and 4).
incubated

in

the

presence

of

PBS

buffer.

Lane 1 contains only BPC
BLPC,

BODIPY-labeled

lysophosphatidylcholine; PA, phosphatic alcohol; PBt, phosphaticbutanol; DAG,
di-acylglycerol.
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Figure 4. Effects of chemical and physical conditions on rPlp activity.

(A) The

enzymatic activity was proportional to rPlp concentration between 1 µg/ml to 8 µg/ml.
(B) The effect of temperature on rPlp activity indicated that rPlp activity was optimal
at 37ºC and stable up to 64ºC.

(C) The pH effect on rPlp protein indicated that the

optimal pH for rPlp activity ranged from 5 to 9.
on rPlp activity.

41

(D) EGTA did not have any effect
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Figure 5.

Plp is a secreted protein.

The phospholipase activity assays of various

cell fractions prepared from wild type (wt) strain M93sm and plp mutant strain S262
(plp-) were performed at 37ºC (A) and 64ºC (B).

PBS buffer, LB20, and PBS buffer

+ 1% sarcosylate were served as negative controls. The refolded rPlp protein (PLP +)
served as positive control.

The top spots on each chromatogram are the BPC

substrate and the bottom spots are the BLPC reaction product.

The proteins from the

same cell fractionation preparations were analyzed by SDS-PAGE and Western blot
analysis (C) as described in the Materials and Methods. The refolded rPlp protein was
served as positive control.
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Figure 6.

rPlp has specific activity against phosphatidylcholine.

BPC, NBD-PE,

NBD-PS, and NBD-Sm were used as phospholipid substrates to examine the
specificity of rPlp. Phosphate-buffered saline (PBS) was used as a negative control,
and PLA2 enzyme from porcine pancreas as a positive control.

TLC analysis

showed that rPlp only cleaved BPC into BLPC and FFA (A), but could not cleave
other phospholipids (B, C, and D).
BLPC:

BODIPY-labeled

BPC: BODIPY-labeled phosphatidylcholine;

lysophosphatidylcholine;

NBD-PE:

NBD-labeled

phosphatidylethanolamine; NBD-LPE: NBD-labeled lysophosphatidylethanolamine;
NBD-PS: NBD-labeled phosphatidylserine; NBD-FFA: NBD-labeled free fatty acid;
NBD-SM: NBD-labeled sphingomyelin; NBD-CE: NBD-labeled ceramide.
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Figure 7.

Lysis of Atlantic salmon erythrocytes by recombinant Plp protein (rPlp).

500 µl 5% fish (triangle) and sheep (square) erythrocytes were incubated with various
concentration rPlp at 27°C for 20 h.
nm.

The lysis of erythrocytes was measured at 428

Erythrocyte resuspension buffer (10mM Tris-HCl, 0.9% NaCl, pH7.2) was used

as negative control.

All values were calculated from three independent experiments.

Error bars show one standard deviation.
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Figure 8. Fish infection experiment. Survival rate of rainbow trout injected IP with
wild type and mutant

strains of V. anguillarum strains at doses of A) 3 x 106, B) 3 x

105 or C) 3 x 104 CFU/fish. No statistically significant difference was observed
between the strains.
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TABLE 1. Bacterial strains and plasmids used in this study.
Strain or
plasmid
V. anguillarum
strains
M93sm
JR1

Description

Reference

Spontaneous Smr mutant of M93 (serotype O2a)

[2]

Smr Cmr vah1; insertional vah1 mutant of M93Sm

[8]

XM21

Smr Cmr Tcr vah1+; vah1 complement strain of JR1

This study

S262

Smr Cmr plp; insertional plp mutant of M93Sm

This study

XM31

Smr Cmr Tcr plp+; plp complement strain of S262

This study

S123

Smr Cmr rtxA; insertional rtxA mutant of M93Sm

[9]

JR3

Smr Cmr Kmr vah1 plp; insertional vah1mutant of
JL01

[8]

S183

Smr Cmr Kmr vah1 rtxA; insertional rtxA mutant of
S171

[9]

XM62

Smr Cmr Kmr Tcr vah1+ rtxA; vah1 complement
strain of S183

This study

S187

Smr Cmr Kmr plp rtxA; insertional rtxA mutant of
JL01

This study

XM90

Smr Cmr Kmr vah1 plp rtxA; insertional plp mutant of
S264

This study

XM93

Smr Cmr Kmr Tcr vah1 plp+ rtxA; plp complement
strain of XM90

This study

JL01

Smr Kmr plp; mini-Tn10Km insertion into plp

[8]

S171

Smr Kmr vah1; allelic exchange vah1 mutant

[9]

S264

Smr Kmr vah1 rtxA; allelic exchange vah1 and rtxA
mutant

This study

thi thr leu tonA lacY supE recA RP4-2-Tc::Mu::Km
(λ pir)

[40]

E. coli strains
Sm10
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S253

Kmr Cmr; Sm10 containing plasmid pNQ705-plp

This study

S118

Kmr Cmr; Sm10 containing plasmid pNQ705-rtxA

[9]

S250

Kmr Cmr; Sm10 containing plasmid pDM4-rtxA5'

This study

S252

Kmr Cmr; Sm10 containing plasmid
pDM4-rtxA5'-rtxA3'

This study

U21

Kmr Apr Tcr; Sm10 containing plasmid
pSUP202-vah1

This study

U31

Kmr Apr Tcr; Sm10 containing plasmid pSUP202-plp

This study

M15

NalS StrS RifS thi– lac– ara+ gal+ mtl– F– recA+ uvr+ lon+
(pREP4)

QIAGEN,
USA

S238

Kmr Apr; M15 containing plasmid pQE30UA-plp

This study

S269

Kmr Apr; M15 containing plasmid pQE60-plp

This study

Kmr Apr; Cloning vector

Invitrogen,
USA

Plasmid
PCR2.1

Cmr; suicide vector with R6K origin

[41]

pNQ705-vah1

Cmr; for insertional vah1mutation

[8]

pNQ705-plp

Cmr; for insertional plp mutation

This study

pNQ705-rtxA

Cmr; for insertional rtxA mutation

[9]

Cmr SacBCr; suicide vector with R6K origin

[11]

pNQ705-1

pDM4

pDM4-rtxA5'-r
Cmr SacBCr; for allelic exchange rtxA mutation
txA3'
pSUP202

Cmr Apr Tcr; E. coli – V. anguillarum shuttle vector

pSUP202-vah1 Apr Tcr; for complementation of vah1

This study
[40]
This study

pSUP202-plp

Apr Tcr; for complementation of plp

This study

pQE-30 UA

Apr; expression vector with N-terminal His6-tag

QIAGEN,
USA
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pQE30UA-plp

Apr; for expression of rPlp that is used to make
anti-Plp

This study

pQE60

Apr; expression vector with C-terminal His6-tag

QIAGEN,
USA

pQE-60-plp

Apr; for expression of rPlp for enzymatic activity
analysis

This study
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Table 2.

Hemolytic activity of culture supernatant from V. anguillarum wild-type

and various V. anguillarum mutant strains against rainbow trout blood cells
Hemolytic Activity (% of Wild-Type control
V. anguillarum strain or treatment
± SD) a

a

M93Sm

1.00 (±0.12)

JR1 (vah1)

0.98 (±0.16)

XM21 (vah1+)

1.20 (±0.28)

S262 (plp)

0.28 (±0.09)b

XM31 (plp+)

0.99 (±0.04)

S123 (rtxA)

0.94 (±0.22)

JR03 (plp vah1)

0.14 (±0.09)b

S183 (vah1 rtxA)

1.51 (±0.29)

XM62 (vah1+ rtxA)

0.73 (±0.03)

S187 (plp rtxA)

0.12 (±0.09)b

XM90 (vah1 rtxA plp)

-0.04 (±0.09)b

XM93 (vah1 rtxA plp+)

1.33 (±0.01)

Water (positive control)

1.15 (±0.16)

Hemolytic activity assays carried out using the tube assay method as described in the

Materials and Methods.

Hemolysis by M93Sm was given the value of 1.00.

The

data are representative of two independent experiments, each with three replicates, ±
one standard deviation (SD).
b

Statistically different from hemolytic activity for M93Sm (P< 0.05).
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TABLE 3. Primers used in this study
Sequence (5' to 3',
underlined sequences are
designed restriction sites)
ATCGAGGATCCATGAA
ACTAATGACGTTATTG

Purpose and description

Reference

For whole Plp protein,
forward

This study

Pm263

ATCGAAGATCTTTGAA
ATTGAAATGACGCGAG

For whole Plp protein,
reverse

This study

Pm212

GACACCTCACAATATG
AAATAAAA

For truncated Plp protein,
forward

This study

Pm213

TTTGAGCTGCGGGGCTT
TGGTTGC

For truncated Plp protein,
reverse

This study

Pm261

ATCGAGAGCTCGCAGA
ATCGTGACTGACGCCG

For
insertional
plp
mutation, forward, with
SacI site

This study

SD
Lip/Heme
R1

GCTAGTCTAGAACGGA
TACCACCTCAGA

For
insertional
plp
mutation, reverse, with
XbaI site

[8]

pr1

GGGGAATTCTTATTCAA
ATTGAAATGACGCGAG

For plp complement,
forward, with EcoRI site

This study

pr2

GGGACCGGTGAATACC
CATTTTTTATTTTTTC

For plp complement,
reverse, with AgeI site

This study

pr3

GTTGAATTCGTATTTTC
TGCAATCGCCATG

For vah1 complement,
forward, with EcoRI site

This study

pr4

GGGACCGGTCTATTTTA
TAATAAATTGAATACC
AT

For vah1 complement,
reverse, with AgeI site

This study

Pm256

ATCGACTCGAGCTGGA
GAAGATGTACTCTGCG

For allelic exchange rtxA
mutation, flanking the 5'
region, forward, with
XhoI site

This study

Pm257

ATCGATCTAGACGTATC
ATCTACAGCTTTTGC

For allelic exchange rtxA
mutation, flanking the 5'
region, reverse, with XbaI
site

This study

Primers
Pm262
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Pm258

ATCGATCTAGATTATAT
TAATCATGTCTTTTATG
GG

For allelic exchange rtxA
mutation, flanking the 3'
region, forward, with
XbaI site

This study

Pm259

ATCGAGAGCTCCTGATT
GCCTAGCAGTAGCCC

For allelic exchange rtxA
mutation, flanking the 3'
region, reverse, with SacI
site

This study

pr7

CAGGAAACAGCTATGA
CCATGATTACG

For sequencing of the
DNA fragment inserted in
pCR2.1 TA-ligation site

This study

pr8

CTACGGGCTTGAGCGT
GACAATC

For sequencing of the
DNA fragment inserted in
pSUP202 AgeI site

This study

pr25ex

GCTGTCCCTCCTGTTCA
GCTACTGACGGGGTGG
TGCG

For sequencing of the
DNA fragment inserted in
pNQ705-1 Multi-cloning
site

This study
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Abstract
The two hemolysin gene clusters previously identified in V. anguillarum, the
vah1 cluster and the rtxACHBDE cluster, are responsible for the hemolytic and
cytotoxic activities of V. anguillarum in fish.

In this study, we used degenerate PCR

to identify a positive hemolysin regulatory gene, hlyU, from the unsequenced V.
anguillarum genome.

The hlyU gene of V. anguillarum encodes a 92-amino acid

protein and is highly homologous to other bacterial HlyU proteins.

An hlyU mutant

was constructed, which exhibited ~5-fold decrease in hemolytic activity on sheep
blood agar with no statistically significant decrease in cytotoxicity of the wild type
strain. Complementation of the hlyU mutation restored both hemolytic and cytotoxic
activity.

Both semi-quantitative RT-PCR and real time RT-qPCR were used to

examine expression of the hemolysin genes under exponential and stationary phase
conditions in wild type, hlyU mutant, and hlyU complemented strains.

Compared to

the wild type strain, expression of rtx genes deceased in the hlyU mutant while
expression of vah1 and plp was not affected in the hlyU mutant.

Complementation of

the hlyU mutation restored expression of the rtx genes and increased vah1 and plp
expression to levels higher than in the wild type. The transcriptional start sites in the
intergenic regions of both vah1/plp and rtxH/rtxB genes were determined using
5’-RACE and the binding sites for purified HlyU was discovered using DNA gel
mobility shift experiments and DNase protection assays.
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Introduction
Vibrio anguillarum is a marine member of the class Gammaproteobacteria.

This

highly motile gram-negative bacterium is the causative agent of warm-water vibriosis,
a fatal hemorrhagic septicemic disease in fish, crustaceans, and bivalves (1).

The

mortality rate from V. anguillarum infections ranges from 30% to 100% (1).
Infections by these bacteria have resulted in severe economic losses to aquaculture
worldwide (1, 21) and affect many farm-raised fish including Pacific salmon, Atlantic
salmon, sea bass, cod, and eel (1, 4, 5, 21).
Hemolytic activity has been considered to be a virulence factor for V.
anguillarum and is thought to contribute to the hemorrhagic septicemia characteristic
of vibriosis (7, 16).

Rock and Nelson (16) reported that the vah1 hemolysin gene

cluster contains at least two genes, vah1 and plp, that affect hemolytic activity.

Vah1

is a putative pore-forming hemolysin, which causes vacuolization of target cells (10).
It was suggested that pore-forming hemolysins, like HlyA in E. coli, cause direct lysis
of blood cells by disrupting the membrane integrity (13).

Mutations in the

divergently transcribed plp result in both increased expression of vah1 and increased
hemolysis, suggesting that Plp is a putative repressor of vah1 transcription (16).
Additionally, restoration of plp by complementation restores the wild-type level of
vah1 transcription and hemolysis (16). Plp is a phosphatidylcholine (PC)-specific
PLA2, which causes lysis of PC–rich fish erythrocytes (9).
Besides the vah1 cluster, a second hemolysin gene cluster, rtxACHBDE, was
identified in the V. anguillarum (10).

This gene cluster contains rtxA, which encodes

a potent MARTX toxin and the specialized Type I Secretion System (T1SS) genes
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(rtxDBE) responsible for the secretion of the RtxA hemolysin/cytotoxin.

A mutant

containing mutations in both vah1 and rtxA completely lost hemolytic activity on
sheep blood agar (10).

Additionally, RtxA also exhibits cytotoxic activity and causes

Atlantic salmon kidney (ASK) cells to round and die (10).
HlyU, a member of SmtB/ArsR family, is a metal-regulated transcriptional
regulatory protein (17).

It has been reported that HlyU is a positive regulator of

hemolysin and toxin genes in Vibrio species.

In V. cholerae, the HlyU protein

positively regulates expression of hemolysin gene hlyA, as well as the
HlyA-co-regulated gene, hcp (22, 23). Williams et al (22) reported that a mutation in
hlyU attenuates V. cholerae O17 in the infant mouse cholera infection model.
Recently, HlyU was also identified in V. vulnificus, and appears to be a positive
regulator of virulence genes (8, 11).

Kim et al (8) reported that HlyU of V. vulnificus

may be one of the master regulators of in vivo virulence gene expression.
Specifically, in a V. vulnificus hlyU mutant cytotoxic activity against HeLa cells was
nearly abolished and the LD50 dose of V. vulnificus in mice by intraperitoneal infection
was increased by 10- to 50-fold (8).

Liu et al (11) also demonstrated that HlyU was

required for virulence of RtxA1, a homologue of RtxA of V. anguillarum in V.
vulnificus CMCP6.

In V. vulnificus, HlyU acted as a competitor that antagonized the

binding of H-NS, a repressor of rtxA1, in the upstream region of the rtxA1 operon so
that the presence of HlyU resulted in derepression of rtxA1 (12).
In this report, we identified the hlyU homologue in V. anguillarum by degenerate
PCR and constructed an hlyU mutant strain and its complement.

The hemolytic

activity and cytotoxicity of the mutant were determined and compared to the wild type

60

and complemented strains.

We also identified the transcriptional start site of genes in

both the vah1 cluster and rtxA operon and localized the HlyU binding sites to the
upstream region of the two hemolysins by gel mobility shift and DNase protection
assays.

Additionally, the amounts of transcription from various hemolysin genes,

including vah1, plp, rtxA, rtxH and rtxB were determined in the hlyU mutant and its
isogenic wild-type parent and complement by real-time RT-PCR.
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Materials and Methods
Fish cell line, bacterial strains, plasmids and growth conditions. Atlantic salmon
kidney (ASK) cells (ATCC CRL-2747) were cultured at 20ºC in Leibovitz-15 medium
containing 100 µg/ml ampicillin, 100 µg/ml streptomycin, and 20% Fetal bovine
serum (FBS, Invitrogen, USA).
are listed in Table 1.

All bacterial strains and plasmids used in this report

V. anguillarum strains were routinely grown in Luria-Bertani

broth plus 2% NaCl (LB20) (6), supplemented with the appropriate antibiotic, in a
shaking water bath at 27°C.

Overnight cultures of V. anguillarum, grown in LB20,

were harvested by centrifugation (8,000 × g, 10 min), and the pelleted cells washed
twice with Nine Salt Solution (NSS) (6).

Washed cells were resuspended to

appropriate cell densities in experimental media.
the text for each experiment.

Specific conditions are described in

E. coli strains were routinely grown in Luria-Bertani

broth plus 1% NaCl (LB10) (18).

Antibiotics were used at the following

concentrations: streptomycin, 200 µg/ml (Sm200); ampicillin, 100 µg/ml (Ap100);
chloramphenicol, 20 µg/ml (Cm20) for E. coli and 5 µg/ml (Cm5) for V. anguillarum;
kanamycin, 50 µg/ml (Km50) for E. coli and 80 µg/ml (Km80) for V. anguillarum;
tetracycline, 15 µg/ml (Tc15) for E. coli and 2 µg/ml (Tc2) for V. anguillarum.

Degenerate PCR. Degenerate PCR was used to identify the hlyU gene in V.
anguillarum.
various

Previously sequenced hlyU genes including their flanking genes from

Vibrio

species

(http://www.ncbi.nlm.nih.gov),

were
and

obtained
aligned

from
using

the

CLUSTW

NCBI

website

program

(20).

Degenerate primers (Table II) were designed from the conserved regions (Fig. 1), and
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used to amplify the possible hlyU gene from V. anguillarum M93Sm genomic DNA.
The PCR products were separated and purified from a 1% agarose gel and then
subcloned into PCR2.1 vector (Invitrogen, USA).

Colonies containing the cloned

hlyU in PCR2.1 were selected on LB10 plates plus Ap100 and Km50 and the presence
of hlyU confirmed by plasmid purification and DNA sequencing.

Insertional mutagenesis of hlyU.

Insertional mutagenesis by homologous

recombination was used to create a gene interruption within the hlyU gene by using a
modification of the procedure described by Milton and Wolf-Watz (14).

Briefly,

primers (Table 2) were designed based on the hlyU gene sequence of M93Sm
(GenBank accession no. HQ149334). Then a 161-bp hlyU DNA fragment was PCR
amplified by using primer pair Pm297 and Pm298 (Table 2) and cloned into the
suicide vector pNQ705 by using SacI and XbaI restriction sites to yield the pNQ705
derivative plasmid, which was confirmed by both PCR amplification and restriction
analysis.

The mobilizable suicide vector was transferred from E. coli Sm10 (λpir)

into V. anguillarum M93Sm by conjugation (14).

Transconjugants were selected by

utilizing the chloramphenicol resistance gene located on the suicide plasmid.

The

incorporation of the suicide vector into the hlyU gene was confirmed by PCR analysis,
as described previously (14).

The resulting V. anguillarum hlyU mutant was

designated S305 (Table 1) for future use.

Complementation of the hlyU mutant.

The mutant was complemented by cloning

the appropriate hlyU gene fragment into the shuttle vector pSUP202 (GenBank
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accession no. AY428809) as described previously by Rock and Nelson (16).

Briefly,

primers (Table 2) were designed and EcoRI sites were introduced at the 5’ end of
primers. The primer pair was then used to amplify the entire hlyU gene plus ~500 bp
of the 5’ and 3’flanking regions from genomic DNA of V. anguillarum M93Sm.

The

PCR product was cloned into the PCR2.1 vector (Invitrogen, USA) and digested with
EcoRI restriction enzyme and the DNA fragments separated on a 1% agarose gel.
Subsequently, the gel-purified PCR fragment was ligated into pSUP202 after digestion
with EcoRI and the ligation mixture introduced into E. coli Sm10(λpir) by
electroporation with BioRad Gene Pulser II.
LB10-Ap100 agar plates.

Transformants were selected on

The complementing plasmid,

pSUP202-hlyU plasmid,

was transferred from E. coli Sm10 into the V. anguillarum hlyU mutant (S305) by
conjugation using the procedures described previously (16).

The transconjugants

were confirmed by PCR amplification and restriction digestion.

Hemolytic activity assay. Hemolytic activities of various V. anguillarum strains were
determined by measuring the diameter of β-hemolysis on TSA plus sheep blood agar
plates after 24 h at 27°C as previously described (16).

Cytotoxicity assay.

Cytotoxic activity of V. anguillarum strains was determined by

changes to cell morphology or by measurement of released lactate dehydrogenase
(LDH).

ASK cells were seeded into a six-well microtiter plate (Costar) in

Leibovitz’s L-15 medium supplemented with 20% fetal bovine serum and grown at
20°C to a cell density of ~2 ×105 cells ml-1. V. anguillarum cultures grown overnight
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were harvested, washed twice in NSS, and resuspended in NSS (at a cell density of ~2
× 109 cells ml-1). Washed bacterial cells were added to ASK cells at multiplicities of
infection (moi) = 100, and incubated at 20°C for 4 h.

Changes in cell morphology

were assessed and photographed by viewing live cells with an inverted microscope
(Nikon TE2000 model).

To determine the released LDH, a CytoTox-ONE™

Homogeneous Membrane Integrity Assay Kit (Promega, USA) was used.

Briefly,

ASK cells were seeded into a 96-well white wall microtiter plate (Costar) as described
above at a cell number of 20,000 cells /well.

NSS-washed bacterial cells were added

to each well at moi=10, 20, 50, and 100, and then incubated at 20°C for 4 h. The assay
measures the generation of the fluorescent resorufin product, which is proportional to
the amount of LDH at 560 nmExcitation/590 nmEmission.

RNA isolation.

Exponential-phase cells (~0.5 × 108 CFU ml-1) and stationary-phase

cells (2 × 109 CFU ml-1) of various V. anguillarum strains were harvested by
centrifugation.

Total RNA was isolated using the RNeasy kit (QIAGEN, USA)

according to the manufacturer’s instructions. All purified RNA samples were
quantified spectrophotometrically by measuring absorption at 260 nm and 280 nm
using a NanoDrop® spectrophotometer and stored at -75ºC for future use.

Semi-quantitative RT-PCR and Real-time RT-qPCR.

Total RNA was isolated

from exponential and stationary growth phase V. anguillarum cells as described above.
All RNA samples were treated with DNase and 100 µg RNA used as the template for
reverse transcription (RT)-PCR.

RT-PCR was performed using Brilliant SYBR
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Green single-step quantitative RT-PCR (qRT-PCR) Master Mix (Stratagene).
Briefly, gene-specific primers (Table 2) were used to reverse transcribe the specific
cDNA from RNA templates, and the resulting cDNA was used as the template with
which to amplify the specific DNA product, using 25-cycle regular PCR to give a
semi-quantitative determination of the original RNA amount.

Genomic DNA (100

µg) extracted from wild-type strain M93Sm was used as the positive control. The
thermal profile was 50°C for 30 min and 95°C for 15 min and then 25 cycles of 95°C
for 30 s, 55°C for 30 s, and 72°C for 30 s. PCR product was visualized in a 1%
agarose gel use a 100-bp DNA molecular weight ladder (Promega) as a standard.

All

Real-time quantitative RT-PCR (RT-qPCR) were performed using an Mx3005 or
Mx4000 Multiplex Quantitative PCR System (Stratagene, USA).
the same as the semi-quantitative RT-PCR (Table 2).

Primers used were

Quantitation of various

mRNAs was performed using Brilliant SYBR Green Single-Step QRT-PCR Master
Mix (Stratagene) with 10 ng of total RNA in 25 µl reaction mixtures. The thermal
profile was 50°C for 30 min, 95°C for 15min, and then 40 cycles of 95°C for 30 s and
55°C for 30 s. Fluorescence was measured at the end of the 55°C-step during every
cycle.

Samples were run in triplicate plus no-RT control and no-template control.

5’RACE assay.

Total RNA was isolated from exponential phase V. anguillarum

cells grown in LB20 using the RNeasy Kit (QIAGEN).

To identify the

transcriptional start site, RNA was subjected to 5’-rapid amplification of cDNA ends
(5’-RACE) using the 2nd generation 5’-RACE kit (2).
listed in Table 2.

Primers used in RT-PCR are

Briefly, 5 µg of RNA was used to generate specific first-strand
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cDNA from target mRNA (vah1, plp, rtxH, or rtxB) in a reverse transcriptase reaction
with a gene specific primer.

Poly(A) tails were added to the 3’- cDNA end using

dATP and terminal deoxynucleotidyl transferase (or in some cases, poly(G) tails were
added with dGTP and terminal deoxynucleotidyl transferase).

A PCR product was

amplified from the tailed cDNA by using a 5’ RACE anchor primer (AP) (Table 2)
and the primer specific for that sequence.

The PCR product was cloned into PCR2.1

cloning vector (Invitrogen, USA), and plasmids from appropriate transformants were
purified and sequenced.

DNA sequence and analysis.

All DNA sequencing was done at the RI Genomics

and Sequencing Center (University of Rhode Island, Kingston, RI), using an ABI
3170xl Genetic Analyzer unit (Applied Biosystems).

Multiple alignment and

phylogenic tree were analyzed using the Clustal-W method in DNA-STAR
Lasergene7 program.
Overexpression and purification of the V. anguillarum HlyU protein. The DNA
fragment encoding HlyU was PCR amplified using primers Pm303 And Pm304 (Table
2), and cloned into the 6×His tag expression plasmid, pQE30-UA (QIAGEN, Inc),
generating the plasmid pQE30-UA/HlyU which encodes HlyU with an N-terminal
fusion tag. The correct recombinant clone confirmed by sequencing was used for
expression of His-tagged HlyU protein in E. coli M15 (S301). Ten milliliters of
overnight bacteria culture growing at 37°C in Luria broth supplemented with 50 µg/ml
kanamycin and 100 µg/ml ampicillin was inoculated in 250 ml of the same fresh
medium. When the OD600 reached 0.6, 1 mM IPTG was added to induce the
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expression of HlyU protein. After bacteria were grown for an additional 5 h at 37°C,
the cells were collected by centrifugation (8000 ×g, 10 min) and the cell pellets
resuspended in 5 ml lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole,
pH8.0).

The cell suspension was incubated with lysozyme (0.5 mg/ml) on ice for 30

min, and then sonicated (six bursts, 20 s per burst with 30 s intervals on ice).

The

resulting cell lysate was centrifuged (10,000 ×g, 20 min) and the soluble supernatant
containing HlyU-His6 was collected. The recombinant protein was then purified from
this fraction by affinity chromatography using Ni-nitrilotriacetic acid resin (QIAGEN,
Inc) according to the manufacturer's instructions. The concentration of the purified
HlyU protein was determined by measuring the absorbance at 280 nm using a
Nanodrop ND-1000 spectrophotometer (Thermo Scientific).

Gel Mobility Shift assay. The gel mobility shift assay was performed using a
digoxigenin gel shift kit (second generation; Roche, Indianapolis, IN). Three
fragments (a, b and c) from the rtxH/rtxB intergenic region and five fragments (d, e, f,
g and h) from the plp/vah1 intergenic region were amplified by PCR and then 3′ end
labeled with digoxigenin-11-ddUTP using terminal deoxynucleotidyl transferase.
After the labeling efficiency was determined, each of the labeled probes (0.4 ng for
fragment a, b and c, 0.2 ng for fragment d, e, f, g and h) was incubated with 350 ng
purified HlyU protein in 20 µl binding buffer (100 mM HEPES, pH 7.6, 5 mM EDTA,
50 mM (NH4)2SO4, 5 mM dithiothreitol, 1% (wt/vol) Tween 20, 150 mM KCl). For
competition analysis, labeled probe (0.4 ng for fragment a, b and c, 0.2 ng for
fragment d, e, f, g and h) and 350 ng HlyU protein were incubated with 100 ng/µl
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unlabeled specific probe. The binding reactions were carried out at room temperature
for 15 min, and then samples were separated by 6% polyacrylamide DNA retardation
gel (Invitrogen, Carlsbad, CA).

The DNA-protein complex was transferred to

positively charged nylon membrane by electroblotting, and then immunological
detection and chemiluminescent signal detection were carried out according to the
instructions of the manufacturer (Roche, Indianapolis, IN).

DNase I protection assay.

The DNA probes for the DNase I protection assay were

amplified from V. anguillarum genomic DNA using PCR using primers (Integrated
DNA Technologies, Inc.) shown in Table 3. Thus, two rtxH/rtxB intergenic region
probes (4 and 5) were labeled with 6-FAM at 5’ end on the upper strand and the lower
strand, respectively.

The two plp/vah1 intergenic probes (2 and 3) were also labeled

with 6-FAM at 5’ end on the upper strand and the lower strand, respectively.
assay was carried out using a method modified from Zianni et al (25).

The

Briefly, 40 ng

of a DNA probe and various amounts of rHlyU (up to 1.88 µg) were incubated at 37°C
in a total volume of 20 µl, containing Binding Buffer (4 µl, 5x conc.) from the DIG
Gel Shift Kit, (2nd Generation, Roche Applied Science), for 1 h.

The DNA – protein

complex was then digested by adding 0.001 U RQ1 RNase-free DNase (Promega
Corporation) in a total volume of 23 µl containing reaction buffer (2.3 µl, 10x conc.)
at 37°C for 1 min.

The reaction was stopped by adding 2.6 µl stop solution (10×

concentration) followed by heating (95°C, 10 min).

The DNA was purified using a

QIAquick PCR Purification Kit (QIAGEN, Inc) using a QIAcube and its standard
protocol, except that the elution volume was adjusted to 30 µl.
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The DNA in the

elutant (5 µl) was added to 10 µl Hi-Di Formamide containing 0.1 µl GeneScan 600
LIZ size standard (Applied Biosystems) and the mixture was submitted to capillary
electrophoresis fragment analysis (Rhode Island Genomics and Sequencing Center).
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Results
Identification of the hlyU gene in V. anguillarum.

Previous studies

indicated that the hlyU gene is a conserved transcriptional regulator in many Vibrio
species (11, 12, 22, 23). We hypothesized that HlyU could be a putative regulator of
the two hemolysin gene clusters in V. anguillarum.

In order to identify the unknown

hlyU gene in V. anguillarum, several hlyU genes from Vibrio species, including V.
cholerae, V. vulnificus, V. fischeri, and V. parahaemolyticus, were compared using
freely available software and database from the Integrated Microbial Genomes (IMG)
website (http://img.jgi.doe.gov).

The comparison revealed that the flanking genes of

hlyU were identical among these Vibrio species and encoded a transcriptional activator
protein NhaR and a ribosomal protein S20P (Fig. 1).

Conserved regions (sequence

data obtained from http://www.ncbi.nlm.nih.gov) from both flanking regions were
aligned (Fig. 1), and degenerate PCR primers (Table 2) were designed and used to
perform degenerate PCR to amplify the putative hlyU gene and flanking DNA from V.
anguillarum.

A single PCR reaction product was obtained by degenerate PCR (Fig.

2) and was purified, cleaned, cloned, and sequenced.

As expected, DNA sequence

data revealed that the PCR product included the intact 294-bp hlyU gene homologue
(GenBank accession number HQ149334), which encodes a predicted protein with 97
amino acids, a molecular mass of 11,095 Da, and strong homology to HlyU proteins
found in a variety of Vibrio species including Vibrio furnissii (97% similarity and 92%
identity), Vibrio coralliilyticus (95% similarity and 91% identity), V. cholerae (93%
similarity and 86% identity), V. parahaemolyticus (92% similarity and 88% identity),
and V. vulnificus (94% similarity and 87% identity).
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Mutation in hlyU decreases hemolytic activity.

An insertional mutation by

single crossover homologous recombination in the hlyU gene was obtained.

The

hemolytic activity of the hlyU mutant was determined and found to decrease about
5-fold compared with wild type strain M93Sm on sheep blood agar (Fig. 3).
Complementation of the hlyU mutant restored the hemolytic activity, which was even
higher than wild type (Fig. 3), indicating that HlyU is a positive regulator of hemolysis
in V. anguillarum.
Mutation in hlyU has no significant effect on cytotoxicity.

One hemolysin

gene, rtxA, has been shown to be a major virulence factor for V. anguillarum (10).
Previous studies revealed that RtxA has strong cytotoxic activity against Atlantic
salmon kidney (ASK) cells, and causes cells to round-up, detach, and die (10).
However, experiments showed that ASK cells still rounded up and died when
incubated with S305, M93Sm, or S307 cells (Fig. 4A) at a moi = 100 for 4 h,
indicating the mutation in hlyU did not completely knock out the cytotoxicity of V.
anguillarum.

Indeed, the LDH release assay revealed that S305 retained ~75-80% (P

> 0.1) of cytotoxicity at all moi values compared to the wild type strain M93Sm (Fig.
4B) confirming that the mutation of hlyU had only a small, but statistically
insignificant effect on cytotoxicity.

As a negative control, the rtxA vah1 double

mutant strain S183 exhibited no cytotoxicity compared to wild type strain M93Sm
(Fig. 4B), confirming that rtxA and vah1 are the major cytotoxins in V. anguillarum
(10).

When strain S307 was assayed for cytotoxic activity by the LDH release assay,

the activity was restored to same levels seen in M93Sm (Fig. 4B).
HlyU positively regulates hemolysin genes at the transcriptional level.
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Semi-quantitative RT-PCR and real-time qRT-PCR were performed to determine the
expression levels of hemolysin genes, including vah1, plp, rtxA, rtxH, and rtxB, in the
wild-type strain (M93Sm), hlyU mutant (S305), and the hlyU complement (S307)
during both exponential and stationary growth phases. Previously, we demonstrated
that the rtx gene cluster contains two divergently co-transcribed sets of genes: rtxHCA,
with rtxH promoter proximal; and rtxBDE, with rtxB promoter proximal (10). As
shown in Fig. 5, RNA expression of rtxH, rtxA, and rtxB decreased in the hlyU mutant
compared to wild type expression levels during both exponential and stationary
phases, indicating that the transcriptional level of rtx genes were down-regulated in the
absence of HlyU.

Indeed, complementation of the hlyU mutation up-regulated the

expression of rtx genes back to wild type levels (or higher) indicating that HlyU
positively regulates the expression of rtx genes.

Real time qRT-PCR data also

revealed that in the hlyU mutant during exponential and stationary phase, respectively,
expression of rtxA decreased by 7.94- and 20-fold; expression of rtxB decreased by
3.56- and 8.07-fold; and expression of rtxH decreased by 5.9- and 15.1-fold (Table 4).
The data strongly suggest that HlyU is a positive regulator of rtx gene expression,
playing an important role in the expression of rtx genes during both exponential and
stationary phase.

In fact, the data show that the mutation in hlyU has a larger effect

on stationary phase expression of rtx genes than on exponential phase expression.
Additionally, expression of the same rtx genes increased to levels higher than wild
type in the hlyU complement (Table 4), indicating the over-expression of hlyU
positively regulates the expression of rtx genes.
In contrast to rtx genes, expression of genes in the vah1 cluster, including vah1
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and plp, exhibited little or no decrease in the hlyU mutant by the semi-quantitative
RT-PCR experiments (Fig. 5).

Measurement of expression for vah1 and plp by

real-time qRT-PCR were consistent with data from the semi-quantitative experiments
showing no significant changes in expression in the hlyU mutant (Table 4), indicating
that the absence of HlyU does not affect either vah1 or plp expression.

However,

when the expression of vah1 and plp were examined by both semi-quantitative
RT-PCR (Fig. 6) and qRT-PCR (Table 4) in the hlyU complement (S307), we
observed that expression of both genes increased.

Specifically, expression of vah1 in

S307 increased over wild type (M93Sm) levels by 11.6- and 26.3-fold during
exponential and stationary phase, respectively; and expression of plp increased over
levels in M93Sm by 8.32- and 86.2-fold during exponential and stationary phase,
respectively.

These data indicate that over-expression of HlyU can positively

regulate expression of vah1 and plp.
Mapping transcriptional start sites of hemolysin genes.

Since it had been

reported that HlyU is a DNA binding protein (17) that positively regulates hlyA
(homologue of vah1) in V. cholerae (23) and rtxA1 (homologue of rtxA) in V.
vulnificus (11), we wanted to determine possible HlyU binding sites in the vah1 gene
cluster and rtxACHBDE cluster in V. anguillarum.

The transcriptional start sites of

both hemolysin clusters were identified using 5’RACE.

In the vah1 gene cluster

there is a 508-bp intergenic region between the divergent plp and vah1 genes. The
5’-RACE results demonstrated that the region between the +1 sites of plp and vah1
was 318 bases long (Fig. 6A).

The +1 transcriptional start site (A) of plp is 73 bases

prior to its start codon, with a predicted -35 and -10 promoter sequence of:
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TTGATT-N13-ATAAAT (Fig. 6A). The divergent hemolysin gene, vah1, had a
transcriptional start site (G) 119 bases before the vah1 start codon, with a predicted
-35 and -10 promoter sequence of TTGTGT-N16-TATTAA (Fig. 6A).
For the rtx gene cluster, the intergenic space between the divergent rtxH and
rtxB genes is 325-bp.

5’RACE results show that the region between the

transcriptional start sites of rtxH and rtxB is 187 bp (Fig. 6B).

The +1 transcriptional

start site (G) of rtxH is 103 bases prior to its start codon, with a predicted -35 and -10
promoter sequence of: TTGCGT-N15-TATAAT (Fig. 7B).

The divergent rtxA

transporter gene, rtxB, was found to have a transcriptional start site (C) 34 bases
before the rtxB start codon, with a predicted -35 and -10 promoter sequence of
TTGAGC-N18-TATAAT (Fig. 6B).

Analysis of the predicted promoter regions of

these two hemolysin clusters revealed strong similarities to a σ70 consensus promoter:
TTGACA-N17-TATAAT.

Additionally, the putative ribosomal binding site (RBS)

for all genes was also located upstream of the ATG start codons (Fig. 6A and B).
HlyU binds to the intergenic promoter regions of the hemolysin gene
clusters.

Previously, Liu et al (11) demonstrated that HlyU binds to the promoter

region of the rtxA1 operon of V. vulnificus.

In an effort to determine whether HlyU

acted in a similar fashion to help regulate expression of the hemolysin gene clusters in
V. anguillarum, we carried out gel mobility shift experiments using purified
HlyU-His6 protein.

Briefly, the purified protein (350 ng) was reacted with each of

the three DIG-labeled DNA sub-fragments amplified from the intergenic region
between rtxH and rtxB (Fig. 7A) and with each of the five DIG-labeled DNA
sub-fragments amplified from the intergenic region between plp and vah1 (Fig. 7C).
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DNA mobility shift experiments were performed on the HlyU + DIG-labeled DNA
mixtures.

The results revealed that HlyU bound to fragment b of the rtxH-rtxB

intergenic region (Fig. 7B) and to fragment f of the plp-vah1 intergenic region (Fig.
7D).

When unlabeled competitor DNA was added to each of these reactions, binding

was decreased or abolished.
In an effort to more closely characterize the binding sites of HlyU for each
hemolysin gene cluster, each of the two DNA sub-fragments that bound HlyU was
examined by a DNase I protection assay as described in the Materials and Methods.
The results of these experiments revealed that HlyU protected an 18-bp region
(5’TAATAAAAATCTTAAAAA3’) in fragment b
repeats of TAAAA.
bp

upstream

from

(Fig. 8A) with two 5-bp direct

This region starts 103 bp upstream of the +1 site of rtxH and 67
rtxB.

Similarly,

HlyU

protected

a

22-bp

region

(5’AATAAAAATATCAATAAAATTA3’) in fragment f (Fig. 8B) with the same two
5-bp direct repeats of TAAAA.

The binding region in sub-fragment f starts 192 bp

upstream of plp and 106 bp upstream of +1 site for vah1.
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Discussion
Hemolytic activity of V. anguillarum has been considered to be the virulence
factor responsible for hemorrhagic septicemia during infection (1, 5).

We previously

reported that there are two major hemolysin gene clusters in V. anguillarum M93Sm
(10, 16).

The vah1 cluster consists of 4 genes, plp, vah1, llpA, and llpB gene.

Vah1

is a putative pore-forming hemolysin, which shows strong homology to HlyA of V.
cholerae.

HlyA integrates into the erythrocyte membrane to cause lysis (13).

The

plp gene, divergent to the vah1 gene, encodes a hemolysin with phospholipase A2
activity specific for phosphatidylcholine and is highly conserved among members of
the Vibrionaceae as a lecithinase/thermolabile hemolysin.

Plp has the ability to lyse

fish erythrocytes because of the abundance of phosphatidylcholine in their membranes
(9).

Additionally, mutations in plp result in increased expression of vah1 (16).

The

second hemolysin gene cluster in V. anguillarum is the rtxACHBDE cluster (10), in
which rtxHAC is divergently transcribed from rtxBDE.

The V. anguillarum RtxA is

a major virulence factor for V. anguillarum with both hemolytic and cytotoxic activity
(10).

While mutations of both vah1 and rtxA are required for the complete loss of

hemolytic activity on sheep blood agar (10), mutations in plp, vah1, and rtxA are
required for a 90% loss of hemolytic activity against fish erythrocytes.
genes encode proteins that are major hemolysins in the fish host (9).

Thus all three
However, prior

to this study, little was known about the regulation of these hemolysins in V.
anguillarum.
It has been reported that HlyU regulates the expression of hemolysins in
Vibrio species. In V. cholerae, HlyU positively regulates the expression of hemolysin
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HlyA (23) and the HlyA co-regulated gene hcp (24).

It was also suggested that

mutation of hlyU attenuates the virulence of V. cholerae O17 in the infant mouse
cholera infection model (22).

Recent evidence suggests that HlyU is a master

regulator of virulence in V. vulnificus, as several virulence factors, including vah1 and
rtxA1, a homologue of rtxA of V. anguillarum, appear to be regulated by HlyU (8,
11).

Therefore, we hypothesized that the hlyU gene in V. anguillarum might encode

a regulator for both hemolysin clusters in V. anguillarum.

In this study, we used

degenerate PCR to discover the unknown hlyU gene from the V. anguillarum
genome. The experiment successfully identified an hlyU gene (Fig. 2) from V.
anguillarum with strong homology to other hlyU genes in Vibrio species.
HlyU is a member of SmtB/ArsR protein family.

Some members of this

transcriptional regulator family, such as NolR of Rhizobium meliloti, SmtB of
Synechococcus sp. strain PCC 7942, and ArsR of Staphylococcus aureus, act to
repress target gene expression by binding metal ions to a metal binding site located on
the repressor protein to enhance binding to the DNA binding site (19).

However,

recent studies suggested that HlyU in V. cholerae acts as a positive regulator because
of the absence of the metal binding site on HlyU (17).

Further, the crystal structure

of HlyU from V. vulnificus strain CMCP6, recently solved by Nishi et al (15),
confirmed that HlyU has no metal binding site.

Analysis of the HlyU amino acid

sequence using the ClustalW program reveals that the V. anguillarum HlyU, as well as
other Vibrio species (V. cholerae, V. vulnificus, V. fischeri, and V. parahemolyticus),
does not contain a metal binding site and probably has similar binding characteristics
to the homologues found in V. cholerae and V. vulnificus.
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Evidence suggests that mutation of hlyU has a strong effect on virulence.

For

example, a mutation in hlyU attenuates V. cholerae O17 virulence in the infant mouse
cholera infection model (22).

In V. vulnificus, the LD50 increased about 104-fold in a

hlyU mutant using the iron-overloaded mouse infection model (11) or the iron-normal
mouse infection model (8).

Additionally, cytotoxic activity was lost in an hlyU

mutant of V. vulnificus (11).

However, we found that in V. anguillarum cytotoxicity

of the hlyU mutant remained relatively high according to both the LDH release assay
and observations of morphological changes in ASK cells exposed to the hlyU mutant
(Fig. 4).

These observations indicate that rtxA was still expressed in the hlyU mutant,

even though rtxA expression was significantly decreased in the mutant (Fig. 5 and
Table 4).

While our data indicate that HlyU is a positive regulator of rtxA, rtxH, and

rtxB, these genes are still expressed in the absence of HlyU in V. anguillarum.

It is

interesting to note that transcription of rtxA, rtxH, and rtxB in the wild type strain and
hlyU mutant all decrease during stationary phase (Table 4).

This may suggest that

either greater amounts of HlyU are required during stationary phase or that hlyU
expression may be repressed during stationary phase.
Additionally, cytotoxicity data were consistent with the hemolytic activity
assay, in which the hlyU mutant did not completely eliminate the hemolysis on the
sheep blood agar (Fig. 3), indicating that the hemolysins were expressed in the mutant.
Interestingly, real-time RT-PCR data showed that the hlyU mutant did not effect the
expression of vah1 and plp compared to the wild type strain (Table 4).

However, the

observation that over-expression of HlyU in the hlyU complement dramatically
increased expression of both vah1 and plp, suggests that vah1 and plp are regulated by
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HlyU in a different manner than the rtx gene cluster.

This is supported by our

previous observation that plp null mutations increase hemolysin activity and vah1
transcription (16).

Thus the results presented here suggest that in addition to HlyU

one or more other factors may regulate the hemolysins/cytotoxins of V. anguillarum.
While HlyU is a positive regulator of V. cholerae hlyA (22, 23), there is no
experimental evidence to demonstrate that HlyU binds to the hlyA promoter region.
Therefore it is still unclear if HlyU is a direct transcriptional activator binding to the
hlyA promoter region, or if it interferes with an unknown repressor of hlyA to cause
de-repression of hlyA by HlyU (17).

The later assumption was recently supported by

the study in V. vulnifucus where HlyU was found to bind to the upstream region of
rtxH, which competes with the binding site of rtxA1 repressor H-NS (12).

Similar to

V. anguillarum, expression of rtxH and rtxA1 in V. vulnificus are regulated by the
same rtxH proximal promoter. Therefore, it was suggested that the absence of HlyU
would increase the H-NS binding, which repressed the expression of rtxA1 in V.
vulnificus (12).

It is reasonable to think that a similar situation might exist in the

both hemolysin clusters of V. anguillarum.
In this study, transcriptional start sites of both hemolysin clusters were
identified, and promoter regions for the potential HlyU binding were targeted (Fig. 6).
We found that the central regions of the intergenic sequence for each hemolysin gene
cluster contains a conserved binding site for HlyU, as determined by both DNA
mobility shift experiments (Fig. 7) and DNase I protection assays (Fig. 8).

The two

binding sites are quite similar (Fig. 8); the intergenic rtxH-rtxB protected binding
region is 18 bp long, while the intergenic plp-vah1 region is 22 bp long and both have
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identical 5-bp direct repeats of TAAAA, strongly suggesting that HlyU binds as a
dimer as suggested by Saha and Chakrabarti (17).

In fact, the direct repeat may be a

bit longer than 5 bp.

If one uses an imperfect match, the direct repeat is 7-bp:

(A/T)TAAAA(A/T).

Additionally, examination of the sequences immediately

adjacent to the protected regions reveals that both the rtxH-rtxB and the plp-vah1
intergenic regions contain 25-to 26-bp regions that are nearly identical with 10-bp
inverted repeats at each end (Fig. 6).

The rtxH-rtxB intergenic region contains

identical 10-bp inverted repeats at each end of its 25-bp region with a nucleotide
sequence of: ATAATAAAAA.

Similarly, the plp-vah1 intergenic region has nearly

identical 10-bp inverted repeats at each end of the 26-bp region.

The nucleotide

sequence of the plp proximal repeat is: 5’-TTAATAAAAA-3’.

The nucleotide

sequence of the vah1 proximal repeat is: 3’-ATATTAAAAT-5’.

Further,

comparison between the HlyU binding sites identified here and the site identified by
Liu et al (12) reveals that in both cases HlyU binds to AT-rich regions upstream of the
transcriptional start sites of the regulated hemolysin genes.

However, Liu et al (10,

12) found that HlyU bound far upstream (-376 to -417 bp) of the transcriptional start
site of the rtxA1 operon.

In contrast, we have located HlyU binding somewhat closer

to the start transcription sites of rtxH-rtxB and plp-vah1.

The binding site of HlyU is

104 bp and 68 bp upstream of the rtxH and rtxB +1 sites, respectively, and 150 bp and
145 bp upstream of plp and vah1 +1 sites, respectively.

While we have not yet

demonstrated H-NS repressor binding to these regulatory regions in V. anguillarum,
the shorter distance between HlyU binding sites and the transcriptional start sites in V.
anguillarum compared to V. vulnificus may indicate that V. anguillarum has fewer
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H-NS binding sites than the five sites found for the V. vulnificus rtxA1 regulatory
region (12).
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Table 1. Bacterial strains and plasmids used in this study.
Strains

Genotype and features

References

M93Sm

Spontaneous Smr mutant of M93 (serotype
J-O-1)

(3, 4)

S305

Smr Cmr; M93Sm hlyU mutant

This study

S307

Smr Cmr Tetr; M93Sm hlyU complement

This study

S183

Smr Cmr Kanr; M93Sm rtxA vah1 double
mutant

(10)

Sm10

thi thr leu tonA lacY supE recA
RP4-2-Tc::Mu::Km (λ pir)

(14)

M15

NalS StrS RifS thi– lac– ara+ gal+mtl– F–
recA+uvr+ lon+ (pREP4, KmR)

V. anguillarum

E. coli

Qiagen, USA

Plasmid
pNQ705-1

Cmr; suicide vector with R6K origin

(14)

pSUP202

E. coli – V. anguillarum shuttle vector

(14)

PCR2.1

Cloning vector

Invitrogen, USA

pQE30UA

Expression vector with N-terminal His6-tag

QIAGEN, USA
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Table 2.

Primers used in this study.

Primers

Sequence (5’ to 3’)

Description

Pm301

AGYTAYGARATGYTNGATA
Degenerate hlyU F
CGTNAAYTA

Pm302

CGTCGYCAGCAYAAYGCTA
Degenerate hlyU R
GCCGTCGYTC

Pm297

ACTGAGAGCTCGGTGTTGT
TAAAGGCTATGGC

hlyU insertional mutation F

Pm298

ATCGATCTAGAGTATCCAC
TAACCCATCTCTT

hlyU insertional mutation R

R vah1 RT (BF)

GGCTCAACCTCTCCTTGTA
ACCAA

5’ RACE vah1

plpF RT

CAGACGACCACCAGTAACC
ACTAA

5’ RACE plp

Pm112

TGGTTGTAAGCCGCAGCAC

5’ RACE rtxH

Pm163

GGGGTATCTGAGTCACATG
GATGAATT

5’ RACE rtxB

Primer AP

GACCACGCGTATCGATGTC
GACTTTTTTTTTTTTTTTTV

5’ RACE anchor primer

Pm303

ATGGAAAAAAATTCCGCTA
AAGCA

Entire HlyU protein F

Pm304

CTAGCGGCAGTATAAACCG
TGTAA

Entire HlyU protein R

Pm305

CCCGGATCCGCAACTTATC

88

hlyU complementation F

GGTCAGATTGATG

Pm306

a

CCCGGATCCGATGCGCACT
TACATGAAGAAAAC

hlyU complementation R

Restriction sites for SacI (GAGCTC), XbaI (TCTAGA), EcoRI (GGATCC) are

underlined.

V=A, C, or G; N=A, C, T, or G; R= A or G; Y=C or T
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Table 3.

List of primers used to amplify DNA probes in DNase I protection

assay.
Intergenic Probe
Region
Name

Probe
#4

Probe
Length

Primer
Name

Primer
Sequence

Primer 5’ Primer
Label
Strand

Pm414

CAGTGGCT
CATAAAAG 6-FAM
CAGTTGC

rtxH sense
strand

Pm318

CAGCGGTA
AGTAGACT
GATA

none

rtxB sense
strand

Pm315

CTCAGACA
TAAATAAA
TCACC

none

rtxH sense
strand

Pm415

CAGCGGTA
AGTAGACT
6-FAM
GATAAGCA
ATG

rtxB sense
strand

Pm412

CCGTATTT
TCTGCAAT
CGCCATGG

plp sense
strand

Pm322

AAAATAAA
AGGACATT
none
GGTTTTTT
GG

vah1 sense
strand

Pm327

GTATTTTC
TGCAATC
GCCATG

none

plp sense
strand

Pm413

CACCTTTG
TGGCGAAT

6-FAM

336 bp

rtxH/rtxB

Probe
#5

Probe
#2

394 bp

496 bp

plp/vah1

Probe
#3

6-FAM

468 bp
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vah1 sense

TATTAATA
GATCTT
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strand

Table 4. Real time qRT-PCR analysisa

rtxA
expression

RNA copy
number

Relative change
(n-fold) in
expression

rtxB
expression

RNA copy
number

Relative change
(n-fold) in
expression

rtxH
expression

RNA copy
number

V.
anguillarum
strainb

Log phase

Stationary
phase

M93Sm

2.74×104±1300

8.88×103±252

S305

3.45×103±800

S307

1.18×105±424

4.47×102±15
1.48×104±123
7

M93Sm

1

1

S305
S307

- 7.94±0.4
4.30±0.01

-20.00±0.6
1.68±0.14

M93Sm

3.40×104±2298

2.92×104±736

S305

9.54×103±596

S307

9.83×104±6045

3.62×103±141
3.60×104±777
1

M93Sm

1

1

S305
S307

-3.56±0.2
2.89±0.18

M93Sm

4.74×104±0

S305

7.43×103±643
1.46×105±1060
6

-8.07±0.3
1.23±0.3
1.93×104±933
3
1.18×103±410

S307
Relative change
(n-fold) in
expression

vah1
expression

RNA copy
number

Relative change
(n-fold) in
expression

2.96×105±707

M93Sm

1

1

S305
S307

-5.90±0.5
3.08±0.2

-15.1±6
14.6±0.03

M93Sm

3.17×102±56

5.57×102±302

S305

3.36×102±17

S307

3.66×103±556

6.92×102±58
1.47×104±157
2

M93Sm

1

1

S305
S307

1.06 ±0.05
11.6 ±1.7

1.24±0.1
26.3 ±2.7
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plp
expression

RNA copy
number

Relative change
(n-fold) in
expression

a

M93Sm

2.70×102±34

6.83×102±46

S305

4.22×102±62

S307

2.25×103±445

3.27×102±53
5.92×104±346
7

M93Sm

1

1

S305
S307

1.56 ±0.05
8.32 ±1.1

-2.08 ±0.01
86.2 ±7.8

The data presented is a representative experiment of two independent experiments.

Each sample is the average of three replicates.
b

V. anguillarum strains: M93Sm (wild type), S305 (hlyU mutant), and S307 (hlyU

complement).
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Figure 1. The protein alignments of the hlyU flanking genes, encoding ribosomal
protein S20P (A) and the transcriptional regulator NahR (B), in five Vibrio-related
bacterial species. The rectangle bars above the alignment indicate the relative amount
of conservation of amino acid residues. The black boxed regions were used to design
the degenerate primers according to their original DNA sequences. The black arrows
shows the orientation of primers.
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Figure 2.

The degenerate PCR product was amplified from V. anguillarum M93Sm

genomic DNA using primer pair Pm301/Pm302.

The PCR product was separated

and visualized in a 1% agarose gel using a Promega® 1 kb DNA ladder as the size
standard, and was 1.6 kbp long.

The PCR product was purified, cleaned, and cloned

into PCR2.1 vector, and then transformed into E. coli DH5α strain. The plasmid,
purified from the appropriate colony, was sequenced.
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Figure 3.

Hemolytic activity of V. anguillarum strains M93Sm (wild type), S305

(hlyU mutant) colonies, and S307 (hlyU complement) transferred onto 5% TSA-sheep
blood agar, and incubated at 27ºC for 24 h.

Relative hemolytic activity was

determined by measuring the β-hemolysis zone surrounding each colony.
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Figure 4. The hlyU mutation and its complement did not significantly effect the
cytotoxicity of V. anguillarum against ASK cells. (A) ASK cells were incubated with
various strains of V. anguillarum at moi =100 for 4 h at 20ºC.

Data showed that

strain S305 (hlyU mutant) still caused ASK cells to round-up, as did wild type strain
M93Sm and strain S307 (hlyU complement).

ASK cells treated with NSS buffer

(mock) exhibited no rounding or detachment during the course of the experiment. The
photograph magnification was 100×. (B) LDH release from ASK cells treated with
wild type M93Sm (), hlyU strain S305 (), hlyU complement S307 (), and
rtxA/vah1 double mutant S183 (○) at various moi (20, 50, 100, and 200) for 4 h.
LDH release was measured in Relative Fluorescence Units (RFU), and then calculated
to yield % cytotoxicity according to the instructions of the manufacturer.

The

incubation time at 0 was the base level of LDH in ASK cells treated with NSS buffer.
Data are the representative of three separate experiments done with three replicates.
Error bars show standard deviation of average. *, The statistical difference of strain
S305 from the wild type treated data (P>0.1).
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Figure 5.

HlyU regulates both hemolysin clusters positively at the transcriptional

level. Semi-quantitative RT-PCR was used to determine the expression levels of rtxA,
rtxB, rtxH, vah1, and plp with 100 µg of RNA extracted from V. anguillarum cells
grown to exponential phase (A) and stationary phase (B).

Data show that the

expression of rtxA, rtxB, and rtxH decreased in the hlyU mutant (S305).

However,

expression of vah1 and plp did not decrease in S305, but did increase in the hlyU
complement (S307).

The M93Sm genomic DNA was used as positive control (+).

RT-PCR reactions with no added reverse transcriptase used as negative controls
showed no amplified bands (data not shown). The DNA molecular size standards (Std)
are a 100 bp Promega® DNA ladder.
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Figure 6.

Intergenic regions of the rtxACHBDE gene cluster (A) and vah1/plp gene

cluster (B).

The transcriptional start sites of hemolysin genes are indicated by solid

triangle marked with a +1.

The -10 and -35 promoter sequences of hemolysin genes

are indicted by underlined nucleotides labeled as -10 and -35 and are predicted to be
σ70 promoters.

Black arrows indicate that start codons of genes. Lines indicating

ribosomal binding sites of hemolysin genes are labeled RBS.

The boxed sequences

represent inverted repeats located with the HlyU-DNase I protected sequences, which
are indicated as protected region.
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Figure 7.

DNA gel mobility shift demonstrating binding of purified HlyU to

intergenic regions of the rtxACHBDE operon (A and B) and the vah1/plp gene cluster
(C and D).

DIG-labeled DNA fragments of the intergenic region between rtxH and

rtxB (A) and between plp and vah1 (C) were obtained by PCR amplification.
Individual DIG-labeled fragments (0.4 ng) were reacted with no additions (lane 1),
350 ng HlyU (lane 2), and 350 ng HlyU + 100 ng unlabeled DNA fragment (lane 3);
Panel B – fragments a, b, and c from the intergenic regions of the rtxACHBDE operon;
and Panel D – fragments d, e, f, g, and h from the intergenic regions of the vah1/plp
gene cluster.

106

107

Figure 8.

Capillary electrophoresis of 6-FAM labeled DNA fragments b (A) and f

(B) from DNase protection assays in the presence (grey traces) and absence (black
traces) of HlyU demonstrating that HlyU binds to specific sequences in fragments b
and f of the rtxACHBDE and plp/vah1 intergenic regions, respectively, and protects
against DNase I digestion.

DNA fragments b and f were prepared and labeled with

6-FAM, reacted with HlyU (0 or 1.88 µg) followed by DNase I, and then analyzed by
DNA fragment analysis as described in the Materials and Methods.
black lines show the binding regions.
below the double black line.

The double

The binding region sequences are shown

Underlined bases indicate those that are higher in the

presence of HlyU (grey trace) than in its absence (black trace).
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Abstract
Hemolysins produced by V. anguillarum have been implicated in the
development of hemorrhagic septicemia during vibriosis, a fatal fish disease.
Previously, two hemolysin gene clusters were identified in V. anguillarum, the
vah1-plp gene cluster and the rtxACHBDE gene cluster, which are responsible for the
hemolysis and cytotoxicity of V. anguillarum.

In this study, we identified the hns

gene, which encodes the H-NS protein, and acts as a negative regulator of the both
gene clusters.

The V. anguillarum H-NS protein shares strong homology with other

bacterial H-NS proteins.

An hns mutant exhibited increased hemolytic activity and

cytotoxicity compared to the wild type strain.

Complementation of the hns mutation

restored hemolytic activity and cytotoxicity levels to near wild type levels.

Further,

expression of rtxA, rtxH, rtxB, vah1 and plp increased in the hns mutant, and
decreased in the complemented hns mutant strain when compared to the wild type
strain.

Additionally, experiments using DNase I, showed that purified recombinant

H-NS protected multiple sites in the promoter region of both gene clusters.

The hns

mutant also exhibited significantly attenuated virulence against rainbow trout.
Complementation of the hns mutation restored virulence to wild type levels,
suggesting that H-NS regulates many genes that affect fitness and virulence.
Previously, we showed that HlyU is a positive regulator of expression for both gene
clusters. In this study, we demonstrate that up-regulation by hlyU is hns-dependent,
suggesting that H-NS acts to repress or silence both gene clusters, and HlyU acts to
relieve that repression or silencing.
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Introduction
Vibrio anguillarum is the causative agent of vibriosis, a fatal hemorrhagic
septicemic disease.

V. anguillarum infects more than 50 fresh and salt-water fish

species including various species of economic importance to the larviculture and
aquaculture industry, such as salmon, rainbow trout, turbot, sea bass, sea bream, cod,
eel, and ayu (1).

Infections by this bacterium have a mortality rate of 30% to 100%

resulting in severe economic losses to aquaculture worldwide (2).
The ability of V. anguillarum to infect and cause disease in fish is dependent
upon several virulence factors and their proper regulation (3).
factors is hemolytic activity.

One of these virulence

In V. anguillarum M93Sm there are two known gene

clusters that encode at least three hemolysins (4, 5). Rock and Nelson (4) reported
that the vah1-plp hemolysin gene cluster (Fig. 1A) contains at least two genes, vah1
and plp, that affect hemolytic activity.

Vah1 (encoded by vah1) is a putative

pore-forming hemolysin causing vacuolization of target cells with strong amino acid
sequence

identity

to

fluvialis hemolysin (5).

Vibrio

cholerae EI

Tor

hemolysin

(hlyA)

and V.

Mutations in the divergently transcribed plp result in both

increased expression of vah1 and increased hemolysis of sheep’s blood, suggesting
that Plp (encoded by plp) is a putative repressor of vah1 transcription (4).
Restoration of plp by complementation restores the wild-type level of vah1
transcription and hemolysis (4).

Plp is a phosphotidylcholine (PC)-specific PLA2,

which causes lysis of PC–rich fish erythrocytes (L. Li et al., unpublished data).
These observations suggest that Plp plays a dual role both as a repressor and as a
phospholipase.

A second hemolysin gene cluster, rtxACHBDE (Fig. 1B), was
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identified in V. anguillarum (5).

This gene cluster contains rtxA, which encodes a

multifunctional autoprocessing repeat-in-toxin (MARTX) toxin, and specialized T1SS
genes (rtxDBE) responsible for the secretion of RtxA.

RtxA exhibits cytotoxic

activity causing Atlantic salmon kidney (ASK) cells to round and die (5).

Loss of

rtxA function results in avirulence (5), while mutation of vah1 causes slight
attenuation of V. anguillarum virulence (4).

Mutations in both vah1 and rtxA lost

98% cytotoxicity in ASK cells, suggesting Vah1 and RtxA are the major two
cytotoxin when ASK cells are treated with V. anguillarum (6).

These observations

strongly suggest that the RtxA hemolysin is a major virulence factor of V.
anguillarum, while vah1 plays a more minor role in virulence.
The histone-like nucleoid structuring protein (H-NS) is a conserved global
regulator that belongs to a family of small nucleoid-associated proteins, including the
factor for inversion stimulation (FIS), the heat-unstable protein (HU), and the
integration host factor (IHF) (7).

It is reported that function of H-NS is based on

self-oligomerization and binding to DNA motifs to create DNA–protein–DNA bridges
that can impede the movement of RNA polymerase (8).

H-NS has been shown to

repress expression of several virulence genes, including cholera toxin ctx (9, 10) and
exopolysaccharide biosynthesis (vps) genes in V. cholerae (10, 11), the RTX toxin
gene (rtxA1) in V. vulnificus (12), and T3SS1 genes in V. parahaemolyticus (13).

In

many bacterial species, repression by H-NS can be relieved by other regulators, and
each bacterial system has developed specific approaches to attenuate the H-NS
repressive action (8).

In V. vulnificus, HlyU acts as a competitor that antagonizes the

binding of H-NS, resulting in derepression of rtxA1 (12).
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Transcriptional silencing

of V. cholerae tcpA and ctx promoters by H-NS is antagonized by the AraC-like
transcriptional regulator ToxT and IHF (10, 14, 15).

While there is no report

regarding H-NS in V. anguillarum, we hypothesize that H-NS is a regulator of the two
hemolysin gene clusters in V. anguillarum.
In this study, we identified the sequence of an hns homologue in V.
anguillarum using the V. anguillarum M93Sm draft genome, and subsequently
constructed several hns mutant strains, including an hns mutant, an hns/hlyU double
mutant,an hns/hlyU double mutant with hns complemented and an hns/hlyU double
mutant with hlyU complemented.
strains were determined.

The hemolytic activity and cytotoxicity of these

The expression levels of various hemolysin genes,

including vah1, plp, rtxA, rtxH and rtxB in these strains were also quantified.
Additionally, the H-NS binding sites in the intergenic regions in both hemolysin gene
clusters were localized.

Finally, the virulence of the hns mutant and hns

complemented strains was tested in rainbow trout (Oncorhynchus mykiss) and
compared to the virulence of the wild type strain.
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Materials and Methods
Identification of genes in V. anguillarum.

V. anguillarum M93Sm draft genome

(unpublished data) was annotated by the RAST (Rapid Annotation using Subsystem
Technology) service (http://rast.nmpdr.org/rast.cgi) using the default settings (16).

Fish cell line, bacterial strains, plasmids and growth conditions.

Atlantic salmon

kidney (ASK) cells (American Type Culture Collection (ATCC) Manassas, VA) were
cultured at 20ºC in Leibovitz-15 medium containing 100 µg/ml streptomycin, and
17% fetal bovine serum (FBS) (Life Technologies, Grand Island, NY).
strains and plasmids used in this report are listed in Table 1.

All bacterial

V. anguillarum strains

were routinely grown in Luria-Bertani broth plus 2% NaCl (LB20) (17), supplemented
with the appropriate antibiotic, in a shaking water bath at 27°C.
routinely grown in Luria-Bertani broth plus 1% NaCl (LB10).

E. coli strains were
Antibiotics were used

at the following concentrations: streptomycin, 200 µg/ml (Sm200); ampicillin, 100
µg/ml (Ap100); chloramphenicol, 20 µg/ml (Cm20) for E. coli and 5 µg/ml (Cm5) for V.
anguillarum; kanamycin, 50 µg/ml (Km50) for E. coli and 80 µg/ml (Km80) for V.
anguillarum; tetracycline, 15 µg/ml (Tc15) for E. coli, 1 µg/ml (Tc1) for V.
anguillarum grown in liquid medium, and 2 µg/ml (Tc2) for V. anguillarum grown in
solid medium.

Insertional mutagenesis.

Insertional mutations were made by using a modification

of the procedure described by Milton et al. (18). Briefly, primers SD_hns(F) and
SD_hns(R) (Table 2) were designed based on the target gene sequence of M93Sm.
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Then a 200-300 bp DNA fragment of hns was PCR amplified and ligated into the
suicide vector pNQ705 (GenBank accession no. KC795685) after digestion with SacI
and XbaI.

The ligation mixture was introduced into E. coli Sm10 by electroporation

using BioRad Gene Pulser II (BioRad, Hercules, CA).
on LB10 Cm20 agar plates.

Transformants were selected

The construction of pNQ705-hns was confirmed by both

PCR amplification and restriction analysis.

The mobilizable suicide vector was

transferred from E. coli Sm10 into V. anguillarum M93Sm by conjugation (18).
Transconjugants were selected by utilizing the chloramphenicol resistance gene
located on the suicide plasmid.

The incorporation of pNQ705-hns was confirmed by

PCR amplification.

Construction of hns/hlyU double mutant.

The hns/hlyU double mutant was

constructed by allelic exchange of hns, followed by insertional mutation of hlyU.
The allelic exchange mutation was made by using a modification of the procedure
described by Milton et al. (18).

Briefly, the plasmid pDM4 (GenBank accession no.

KC795686) was used to construct the hns::Km allelic exchange mutant as described
previously (18).

The 5′ region of hns was amplified using the primer pair pr40 and

pr41 (Table 2), digested with XhoI and XbaI, and then cloned into the region between
the XhoI and XbaI sites on pDM4.

The 3′ region of hns was amplified using the

primer pair pr42 and pr37 (Table 2), digested with XbaI and SacI, and then cloned into
the region between the XbaI and SacI sites on the derivative pDM4 containing the 5’
region of hns.

Finally, the kanamycin resistance gene was amplified from the

TOPO2.1 vector (Life Technologies) with the primer pair pr38 and pm173 (Table 2),
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digested with XbaI, and inserted into the XbaI site between the 5′ and 3’ hns regions
on the derivative pDM4.

The resulting pDM4-hns::Km was transformed into E.

coli Sm10 to produce the transformant strain D112, which was mated with V.
anguillarum M93Sm.

Single-crossover transconjugants were selected with LB20

Kan80 Sm200 Cm5 plates and, subsequently, double-crossover transconjugants were
selected with LB20 Kan80 Sm200 5% sucrose plates.

The resulting V.

anguillarum mutants were checked for the desired allelic exchange using PCR
amplification and then subjected to insertional mutation of hlyU as described above.

Complementation of the mutants.

The various mutants were complemented by

cloning the appropriate target gene fragment into the shuttle vector pSUP202
(GenBank accession no. AY428809) as described previously by Rock and Nelson (4).
Briefly, primers hns_comp(F) and hns_comp(R) (Table 2) were designed with a PstI
site added at the 5’ end of each primer.

The primer pair was then used to amplify the

entire target gene plus ~500 bp of the 5’ and ~200 bp 3’ flanking regions from
genomic DNA of V. anguillarum M93Sm.

The DNA fragment was then ligated into

pSUP202 after digestion with EcoRI and AgeI, and the ligation mixture was
introduced into E. coli Sm10 by electroporation using a BioRad Gene Pulser II.
Transformants were selected on LB10 Tc15Ap100 agar plates.

The complementing

plasmid was transferred from E. coli Sm10 into the V. anguillarum mutant by
conjugation (18).

Transconjugants were selected by utilizing the tetracycline

resistance gene located on the plasmid.

The transconjugants were then confirmed by

PCR amplification and restriction digestion.
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Hemolytic activity assay.

The blood agar hemolysis assay was carried out using the

method described by Rock et al. (4).

Briefly, V. anguillarum colonies were

transferred onto blood agar plates and hemolytic activity was determined by
measuring the diameter of β-hemolysis on plates containing Trypticase soy agar (TSA)
plus either 5% sheep (Northeast Laboratories Service, Waterville, ME) or 5% trout
blood after 24 h at 27°C.

Trout blood was taken from live, healthy, farm-raised

rainbow trout (Oncorhynchus mykiss) using a 3 ml sterile syringe supplemented with
10 µl 0.5M Disodium EDTA (Sigma-Aldrich).

The blood was then stored on ice and

used in casting plates within 6 hours.

Cytotoxicity assay.

This assay was carried out using a modification of the method

described by Li et al. (6).

Cytotoxic activity of V. anguillarum strains was

determined by measurement of released lactate dehydrogenase (LDH).

ASK cells

(20,000 cells/well for assays using V. anguillarum supernatants and 10,000 cells/well
for assays using washed V. anguillarum cells) were seeded into a 96-well tissue
culture plate and incubated in Leibovitz’s L-15 medium supplemented with 17% FBS
at 20°C for 24 h to allow cells to attach.
were centrifuged (9,000 × g, 5 min, 4°C).

V. anguillarum cultures grown for 18 h
The resulting culture supernatant was

harvested and filter-sterilized using 22 m filters (Millipore Corp., Billerica, MA).
The bacterial pellet was washed twice in nine salts solution (NSS) (19) and
resuspended in fresh NSS (at ~2 × 109 cells ml-1).

V. anguillarum culture supernatant

(50 µl) was added to wells containing ASK cells plus 50 µl pH =7.4 phosphate
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buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM
KH2PO4) and incubated at 20°C for 6 h.

Washed bacterial cells were added to ASK

cells at multiplicities of infection (MOI) = 200 and incubated at 20°C for 4 h.

To

determine the release of LDH, a CytoTox-ONE Homogeneous Membrane Integrity
Assay Kit (Promega, Madison, WI) was used following the manufacturer’s
instructions.

The assay measures the generation of the fluorescent resorufin product,

which is proportional to the amount of LDH at 560 nmExcitation/590 nmEmission.
Fluorescence was read by a Stratagene MX3005P QPCR System at 550 nmExcitation/570
nmEmission.

RNA isolation.

Exponential phase cells (~0.5 × 108 CFU ml-1) and stationary phase

cells (2 × 109 CFU ml-1) of various V. anguillarum strains were treated with
RNAprotect

Bacteria

Reagent

manufacturer’s instructions.

(QIAGEN,

Valencia,

CA),

following

the

Total RNA was isolated using the RNeasy kit and

QIAcube (QIAGEN) following the manufacturer’s instructions.

All purified RNA

samples were quantified spectrophotometrically by measuring absorption at 260 nm
and 280 nm using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher
Scientific, Pittsburgh, PA) and stored at -75ºC for future use.

Real-time quantitative RT-PCR (qRT-PCR).

qRT-PCR was used to quantify

various mRNAs using an Mx3005 Multiplex Quantitative PCR System and the
Brilliant II SYBR Green Single-Step QRT-PCR Master Mix (Agilent Technologies,
Wilmington, DE ), with 10 ng of total RNA in 25 µl reaction mixtures.
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The thermal

profile was 50°C for 30 min, 95°C for 15 min, and then 40 cycles of 95°C for 30 s and
55°C for 30 s.
cycle.

Fluorescence was measured at the end of the 55°C-step during every

Samples were run in triplicate along with no-RT and no-template controls.

All experiments were repeated at least twice.

Over-expression and purification of the V. anguillarum H-NS protein. The DNA
fragment encoding H-NS was PCR amplified by using Pm416 and Pm417 (Table 2)
and cloned into a six-His tag expression plasmid, pQE30-UA (QIAGEN), generating
the plasmid pQE-30 UA/H-NS (Table 1), which encodes H-NS with an N-terminal
fusion tag.

The correct recombinant clone (confirmed by sequencing) was used for

expression of His-tagged H-NS protein in E. coli M15.

Expression and purification

of rH-NS was carried out using a modification of the procedures described in Li et al.
(6).

Briefly, 10 ml of an overnight bacterial culture growing at 37°C in Luria broth

supplemented with 50 µg/ml kanamycin and 100 µg/ml ampicillin, was added to 250
ml of the same fresh medium.

When the OD600 reached 0.6, 1 mM IPTG was added

to induce the expression of the H-NS protein.

After bacteria were grown for an

additional 5 h at 37°C, the cells were collected and lysed by sonication under
non-denaturing conditions.

The soluble supernatant containing rH-NS was then

purified from this fraction by affinity chromatography using Ni-nitrilotriacetic acid
resin columns (QIAGEN), according to the manufacturer's instructions.

The

concentration of the purified rH-NS protein was determined by measuring the
absorbance at 280 nm using a Nanodrop ND-1000 spectrophotometer (Thermo
Scientific).

The purity of the rH-NS was assessed by SDS-polyacrylamide gel
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electrophoresis with only a single band visible following staining with Coomassie
blue.

DNase I protection assay.

DNA probes for the intergenic region of each of the

hemolysin gene clusters were amplified from V. anguillarum genomic DNA using
PCR (Table 2).

Probes were labeled with 6-FAM at the 5’ end of a certain strand of

each probe (Fig. S1).
al. (6).

The assay was carried out using a method modified from Li et

Briefly, 7.5 × 1011 copies of DNA probe and various amounts of rH-NS (up

to 3 µM) were incubated for 1 h at 27°C in a total volume of 20 µl, containing 4 µl of
5× binding buffer, 1 µg poly-L-lysine, and 1 µg poly [d(I-c1)] (DIG Gel Shift Kit, 2nd
Generation, Roche Applied Science, Indianapolis, IN ). The DNA-protein complex
was then digested by adding 0.005 U RQ1 RNase-free DNase (New England Biolabs,
Ipswich, MA) in a total volume of 25 µl containing 2.5 µl of 10× concentrated
reaction buffer at 37°C for 15 min. The reaction was stopped by heating (95°C, 10
min).

The DNA was purified using a QIAquick PCR Purification Kit (QIAGEN)

using a QIAcube and its standard protocol, except that the elution volume was
adjusted to 30 µl. The DNA in the eluate (3 µl) was added to 9 µl Hi-Di Formamide
containing 1 µl GeneScan 600 LIZ size standard (Applied Biosystems) and the
mixture was submitted to capillary electrophoresis fragment analysis (Rhode Island
Genomics and Sequencing Center).
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GC content plotting.

GC content of the two gene clusters (shown in Fig. 1) were

plotted using the GC-Profile program (http://tubic.tju.edu.cn/GC-Profile) (20) using
the following settings (Halting parameter = 1; Minimum length to segment = 100 bp).

Fish infection studies.

Various V. anguillarum strains were tested for virulence with

rainbow trout (Oncorhynchus mykiss) by intraperitoneal (IP) injection.

Briefly, V.

anguillarum cells grown in LB20 supplemented with appropriate antibiotics for 22 h
at 27°C were harvested by centrifugation (9,000 × g, 5 min, 4°C), washed twice in
NSS, and resuspended in NSS (~2 × 109 cells ml-1).

Initial cell density was estimated

by measurement of optical density at 600 nm.

The actual cell density of NSS

suspensions was determined by serial dilution and spot plating.

All fish were

examined prior to the start of each experiment to determine that they were free of
disease or injury.

It should be noted that all the negative control fish survived.

Fish

were anesthetized with tricaine methanesulfonate (Western Chemical, Ferndale, WA),
with 100 mg/L for induction and 52.5 mg/L for maintenance.
were IP-injected into fish in 100 l NSS vehicle.

V. anguillarum strains

Fish that were between 15 and 25

cm long were injected with bacteria diluted with NSS at a dose of ~4×105 CFU/fish, or
NSS only as negative control.

Ten fish were used for each experimental group.

Fish inoculated with different bacterial strains were maintained in separate 10-gallon
tanks with constant water flow (200 ml/min) at 19 ± 1 ºC.
to prevent possible cross-contamination.

The tanks were separated

Death due to vibriosis was determined by

the observation of gross clinical signs and confirmed by the recovery and isolation of
V. anguillarum cells resistant to the appropriate antibiotics from the head kidney of
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dead fish.

Observations were made for 14 days.

All fish used in this research

project were obtained from the URI East Farm Aquaculture Center.

All fish

infection protocols were approved by the URI IACUC.

Statistical analysis.

Two-tailed Student's T-tests assuming unequal variances were

used for statistical analyses for all experiments except for the fish infection experiment
(P values of <0.05 were considered statistically significant.

For fish infection

experiments, a Kaplan-Meier survival analysis with log rank significance test was
performed on fish survival percentage (P values of <0.05 were considered statistically
significant).
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Results
Identification of hns in V. anguillarum.

The V. anguillarum hns gene (GenBank

accession number KC795684) was found in the RAST annotation of V. anguillarum
M93Sm draft genome (unpublished data).

It encodes for a predicted 137 amino acid

protein with a molecular mass of 15,299 Da and has strong homology to H-NS
proteins found in a variety of Vibrio species including Vibrio harveyi (92% similarity
and 84% identity), Vibrio coralliilyticus (84% similarity and 76% identity), V.
cholerae (90% similarity and 82% identity), V. parahaemolyticus (90% similarity and
85% identity), and V. vulnificus (93% similarity and 87% identity).

Mutation of hns increases hemolytic activity.

It was previously shown that V.

anguillarum wild type cells exhibit β-hemolysis on 5% TSA-sheep blood agar (5).
When the hemolytic activity of the hns mutant (M114, hns-) was tested on 5%
TSA-sheep blood agar, it was found that mutation of hns resulted in increased
hemolysis when compared to the wild type (M93Sm) (Fig. 2).

Further, when the hns

mutation was complemented (M116, hns+), hemolysis was reduced to levels below
wild type (Fig. 2), suggesting that H-NS is a negative regulator of at least one of the
two hemolysins, RtxA and Vah1.

The lower hemolytic activity was probably due to

the overexpression of H-NS since pSUP202 is a multicopy plasmid.

Mutation of hns increased cytotoxicity against Atlantic salmon kidney (ASK)
cells.

It was previously demonstrated that both vah1 or rtxA contribute to the

cytotoxicity of V. anguillarum cells against ASK cells (5).
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In order to determine

whether hns acts to regulate cytotoxic activity, we tested the cytotoxic activity of both
culture supernatants and washed cells from the hns mutant (hns-) and the
complemented hns mutant (hns+) and compared their activities against culture
supernatant and washed cells from the wild type (M93Sm).

The results show that

mutation of hns significantly increased the cytotoxicity of both V. anguillarum culture
supernatant by >40%, and cells (MOI 200) by ~80% against ASK cells compared to
wild type V. anguillarum M93Sm.

Complementation of the hns mutation decreased

cytotoxicity significantly of both culture supernatant and cells against ASK cells
compared to the cytotoxic activities of the hns mutant (Fig. 3A and B).

These data

support the suggestion that hns negatively regulates at least one of the two
hemolytic/cytotoxic activities encoded by rtxA and vah1.

H-NS negatively regulates hemolysin genes at the transcriptional level.

Since the

two hemolysin/cytotoxin gene clusters are each organized into two divergent
transcriptional units (Fig. 1) with intergenic regions shown to bind HlyU (6), we
wanted to investigate the effects of H-NS upon the expression of the various genes
within the gene clusters.

Real-time qRT-PCR was performed to quantify expression

of members of the hemolysin gene clusters, including vah1, plp, rtxA, rtxH, and rtxB,
in the wild-type strain (M93Sm), hns mutant (hns-), and the hns complement (hns+)
during both exponential and stationary growth phases.

Real time qRT-PCR data

revealed that in the hns mutant during exponential and stationary phase, respectively,
when compared to the wild type, expression of rtxA increased by 2.91- and 2.14-fold;
expression of rtxB increased by 1.28- and 1.43-fold; and expression of rtxH increased
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by 4.56- and 2.39-fold; and expression of vah1 increased by 16.21- and 20.01-fold;
and expression of plp increased by 31.27 and 36.88-fold (Fig. 4 and Table S1).
Further, complementation of the hns mutation down-regulated the expression of these
genes back to or below wild type levels.

The data strongly suggest that H-NS is a

negative regulator of gene expression from both the rtxACHBDE and vah1-plp gene
clusters.

Mutation of hns does not affect the expression of hlyU.

Since HlyU had

previously been shown to bind to the intergenic regions of both hemolysin gene
clusters to increase their transcription (Li et al. 2011), we wanted to determine
whether mutation of hns would affect hlyU transcription.

Real-time qRT-PCR was

performed to measure the expression of hlyU in the wild-type strain (M93Sm), the hns
mutant (hns-), and the hns complement (hns+) during exponential and stationary
growth phases (Fig. S2A).

No statistically significant difference in expression of

hlyU was found between M93Sm and both the hns mutant (hns-) and the hns
complement (hns+) in either log phase or stationary (Fig. S2A).

These results rule

out the possibility that H-NS regulates hemolysin gene expression by regulating the
expression of hlyU.

Up-regulation of hemolysin genes by hlyU is hns-dependent.

As noted above, Li

et al. (6) showed that an hlyU mutant (S305, hlyU-) had decreased hemolytic activity
on sheep blood agar compared to wild type, and that complementation of hlyU (S307)
resulted in increased activity compared to the wild type.
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In an effort to determine the

roles of hns and hlyU in the regulation of hemolysin gene transcription, we examined
the hemolytic activity and measured the transcription of hemolysin genes (vah1, plp,
rtxA, and rtxB) in each hemolysin transcriptional unit.

The first set of these

determinations was carried out in cells lacking a functional hlyU: the hlyU mutant
(hlyU-), the hns/hlyU double mutant (ES114, hns-/hlyU-), and the hns/hlyU double
mutant with hns complemented (ES116, hns+/hlyU-); determinations of hemolytic
activity and hemolysin gene expression were also done for wild type M93Sm (Fig. 5).
Hemolytic activity in the hlyU mutant decreased compared to that of wild type
M93Sm, as previously reported by Li et al. (6).

In contrast, hemolytic activity in the

hlyU/hns double mutant increased over that in M93Sm and when hns was
complemented in the double mutant, hemolysis decreased to levels seen in the hlyU
mutant (compare Fig. 5A with Fig. 2).

Changes in transcription of rtxA, rtxB, vah1,

and plp corresponded with the changes in hemolysis (Fig. 5B and Table S1).
Specifically, transcription of each gene (rtxA, rtxB, vah1, and plp) increased in the
absence of a functional hns and decreased in the presence of a functional hns.
The second set of determinations was carried out in cells lacking a functional
hns: the hns mutant (hns-), the hns/hlyU double mutant (hns-/hlyU-), and the hns/hlyU
double mutant with hlyU complemented (ES115, hns-/hlyU+); determinations of
hemolytic activity and hemolysin gene expression were also done for wild type
M93Sm (Fig. 6).

In absence of a functional hns, hemolytic activity increased

regardless of the presence or absence of hlyU (Fig. 2 and Fig. 6A).

Determination of

hemolysin transcription by RT-qPCR corresponded with the hemolysis assay (Fig. 6B).
In absence of hns, rtxA and rtxB expression increased over levels in wild type cells.
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For rtxA, all increases were >2-fold and significant (P<0.05).
were small (generally <2-fold) and generally not significant.

For rtxB, increases
The presence or

absence of hlyU had little or no effect (<2-fold) on rtxA and rtxB gene expression (Fig.
6B and Table S1).

Similarly, in the absence of a functional hns, expression of both

vah1 and plp increased >9-fold in both exponential and stationary phase cells
regardless of the presence or absence of a functional hlyU (Fig. 6B and Table S1).
As with the rtxACHBDE gene cluster, our data show that in absence of hns, the
complement of hlyU (hns-/hlyU+) only exhibited minimal changes in expression of
both vah1 and plp (around 2-fold) over the hns- strain and almost no change in vah1
and plp expression between the two strains (Fig. 6B and Table S1).

These data

indicate that up-regulation of hemolysin genes by hlyU is hns-dependent.

H-NS binds to the intergenic region of both hemolysin gene clusters.

Previously,

Li et al. (6) demonstrated that HlyU binds to the intergenic regions between the
divergently transcribed genes of each of the two hemolysin gene clusters to upregulate
gene expression.

In an effort to determine whether H-NS acted in a similar fashion

to help regulate expression of the hemolysin gene clusters in V. anguillarum, we
carried out DNase I protection assays as described in the Materials and Methods.
The results of these experiments revealed that rH-NS protected multiple regions in
both rtxB/H and vah1/plp intergenic regions (Fig. 7). These regions are AT-rich
(72-74% AT) and correspond to other H-NS binding sites described in other bacteria
(21-27) (Fig. 8). The H-NS binding sites cover the promoter regions of all four genes
(rtxB, rtxH, plp, vah1) with little or no overlap with the HlyU binding site in each of
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the intergenic regions (Fig. 8) (6).

In the vah1/plp intergenic region, rH-NS bound to

five sites, covering the -10 and -35 regions of both plp and vah1 promoters, but did not
cover the HlyU binding site.

In the rtxB/H intergenic region, rH-NS bound to six

sites, covering the -35 region of both rtxB and rtxH promoters.

In addition, rH-NS

also bound to a seventh site just within the rtxB coding sequence.

The rH-NS also

was found to protect the three rtxB-proximal bases of the HlyU binding site (Fig. 8).

The vah1-plp and the rtxACHBDE gene clusters are unlikely to have been
horizontally acquired. Recently, it was reported that a major role of H-NS proteins is
to silence horizontally acquired genetic elements distinguished by AT-rich sequences
(25-27).

This raised the question of whether either or both of the hemolysin gene

clusters (rtxACHBDE and vah1-plp) might be xenogenic in origin.

We examined the

GC content of the two gene clusters and compared them to the average GC content of
the whole genome of V. anguillarum.

The result of this examination revealed that

the GC content of the rtxACHBDE gene cluster is 47.3% and the GC content of the
vah1-plp gene cluster is 42.5%.

Both values are very similar to the average GC

content of the whole genome (44.51%) of V. anguillarum (28).

The intergenic

regions do have low GC/elevated AT percentages, with the plp-vah1 intergenic region
at 26% GC and the rtxB/H region at 28% GC (Fig. 1).

Additionally, examination of

the

(GenBank

published

V.

anguillarum

775

genome

assembly

ID

GCA_000217675.1 ) revealed that the placement of the hemolysin genes in relation to
the surrounding genes, within 7.5 kbp to 10 kbp of DNA flanking each gene cluster, is
the same as that found in strain M93Sm.

Further, we saw no evidence of any tRNA
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genes, tranposases, interrupted genes, or pseudogenes in these surrounding regions.
Finally, when we examined the codon usage patterns for the hemolysin genes and
compared them to the chromosome in which each is found (rtx genes in choromosome
I and plp and vah1 in chromosome II), no significant differences were found.

These

observations suggest that while the two hemolysin gene clusters are negatively
regulated by H-NS, they were not horizontally acquired.

The hns mutant has attenuated virulence against rainbow trout.

Since the

expression of both hemolysin gene clusters is affected by H-NS, we tested the
virulence of M93Sm, hns-, and hns+.

Groups of ten rainbow trout were infected by

IP-injection as described in the Materials and Methods with the wild type M93Sm.
hns-, or hns+ stains of V. anguillarum in NSS at a dose of ~4 × 105 CFU/fish, or with
NSS only as a negative control.

All M93Sm infected trout died by day 4, while 60%

of hns- infected trout died by day 14.

These results (Fig. 9) show that there was a

significant difference (P = 0.005) in the virulence of the M93Sm wild type and the hns
mutant.

Complementation of hns restored virulence back to wild type levels with

90% mortality by day 4.

Thus there was a significant difference (P = 0.029) in the

virulence of the hns+ and hns- strains, and no significant difference (P = 0.413)
between the wild type and hns+ strains.
At first glance, the decline in virulence for the hns mutant would appear to be
counterintuitive, since both hemolysin gene clusters are up regulated in the hns mutant.
However, hns is considered important for bacterial fitness by properly regulating
virulence and other genes during growth (26, 27).
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To determine whether the loss of

hns affected the growth of V. anguillarum, we tested the growth of M93Sm, hns-, and
hns+ in LB20 (Fig. S3).

While the three strains grew to nearly identical cell

densities (OD600 = 1.04 (M93Sm), 0.97 (hns-) and 0.97 (hns+) at stationary phase,
hns- had a longer generation time compared to the wild type (58 min vs. 48 min, P
<0.05).

However, complementing the hns mutation did not result in a shorter

generation time than the hns- (60 min vs. 58 min), suggesting there is no correlation
between virulence in fish and fitness in LB20 for these three strains.
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Discussion
Vibriosis caused by V. anguillarum has been recognized as a major problem
for salmonid culture due to the significant economic loses it causes (29).

While these

bacteria use a variety of virulence factors including: iron transport/siderophore
systems

(30),

the

EmpA

metalloprotease

(31,

32),

motility

(33,

34),

lipopolysaccharides (LPS) (33, 34), and exopolysaccharides (EPS) (35), it is the
hemolysins/cytotoxins that directly kill host cells (4, 5) and are thought to be the major
contributors to the hemorrhagic septicemia that is characteristic of vibriosis (2).
Previously, we identified and described three hemolysin/cytotoxin genes in V.
anguillarum M93Sm, vah1 (4, 36), rtxA (5) and plp (4) (Li, Mou, and Nelson
unpublished data).

The three hemolysin genes (and associated transport genes) are

organized into two gene clusters (Fig. 1).

Additionally, both hemolytic activity and

expression of the three hemolysin genes, vah1, plp and rtxA, are all higher in log phase
than in stationary phase (6).

Recently, we reported that HlyU positively regulates the

expression of both hemolysin gene clusters by specifically binding to the vah1/plp and
the rtxB/H intergenic regions (6).
In this study, we examined the role of H-NS in the regulation of hemolysin
activity and gene expression in V. anguillarum M93Sm.

Initially, the hns homologue

in V. anguillarum was identified using the V. anguillarum M93Sm draft genome and
an hns mutant and an hns complement strain were constructed.

Mutation of hns

resulted in increased hemolytic activity on 5% TSA-sheep blood agar, while
complementation of the hns mutation reduced hemolysis to levels below wild type
(Fig. 2).

Mutation of hns also increased the cytotoxicity of both V. anguillarum
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culture supernatant (diluted 1:1 with PBS) and V. anguillarum cells (at MOI = 200)
against ASK cells, while complementation of the hns mutation reduced cytotoxic
activity (Fig. 3).

Transcription of the three hemolysin genes (and related rtx genes)

in the presence and absence of hns corresponded with hemolysin and cytotoxin
activity, with increased transcription in the hns mutant and decreased transcription in
the hns complement (Fig. 4 and Table S1).

These data show that H-NS is a negative

regulator of hemolytic and cytotoxic activity by acting as a repressor of hemolysin
gene expression.
The results presented here correspond with the well-documented role of
H-NS as a repressor and silencer of many genes in Gram-negative bacteria, especially
in the repression of virulence genes (8).

Recently, Liu et al. (12) demonstrated that

expression of rtxA1 in Vibrio vulnificus is repressed by H-NS and that HlyU acts as an
anti-repressor by interfering with H-NS binding to the upstream regulatory region of
rtxA1.

Specifically, data from competitive gel mobility shift assays between HlyU

and H-NS showed HlyU could displace H-NS from the promoter, binding at a low
concentration and that H-NS needs a much higher concentration to displace the bound
HlyU (12).

Similarly, our data show that H-NS represses expression from both

hemolysin gene clusters in V. anguillarum regardless of the presence of hlyU and that
up-regulation of hemolysin gene expression by HlyU is dependent upon the presence
of hns (Figs. 5 & 6, Table S1).

These observations strongly suggest that in V.

anguillarum H-NS functions to repress transcription of both hemolysin gene clusters
and that HlyU acts as an anti-repressor.

Additionally, both gene clusters are arranged

as divergently transcribed genes with one HlyU binding site in the center of each
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intergenic region (Fig. 8; see also Fig. 7 in Li et al (6)) flanked by 2-4 H-NS binding
sites that extend towards the promoter sites (Fig. 8).
(Fig. 8) are AT-rich.

The sites protected by rH-NS

The five H-NS binding sites in the vah1/plp intergenic region

have A+T% that range from 64.5% to 84.3 %, while the seven H-NS protected sites in
the rtxB/H intergenic region have A+T% that range from 47.4% to 81.25%.
contrast, the flanking structural genes have much lower A+T%.

In

The A+T% for plp =

57% and for vah1 = 55.7%; the A+T% for rtxACH = 51.6% and for rtxBDE = 54.5%
(Fig. 1).

This reveals an interesting discontinuity between the structural genes and

the intergenic regulatory regions.

A similar discontinuity is also seen between the rtx

structural genes and the intergenic regions in V. vulnificus and V. cholerae.
Additionally, that the structural genes have an A+T% nearly identical to the whole
genome of V. anguillarum (55.49%) suggests that these virulence genes were not
horizontally acquired.

This is further supported by the observations detailed above

that there is no evidence for any tRNA genes, tranposases, interrupted genes or
pseudogenes in the 7.5 to 10 kbp of DNA flanking the hemolysin gene clusters.
Further, codon usage in the hemolysin genes is not significantly different from that of
the chromosomes in which each gene cluster resides.
It has been suggested that self-oligomerization and binding of H-NS to
AT-rich DNA to form DNA–protein–DNA bridges impedes the movement of RNA
polymerase, thus repressing gene expression (8).
by different mechanisms (8).

In V. cholera, the binding site of the transcriptional

activator ToxT overlaps with H-NS binding sites.
activates transcription (15).

H-NS repression may be reversed

ToxT displaces H-NS and directly

In contrast, the activation of pagC and ugtL transcription
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from H-NS-mediated repression in Salmonella enterica requires both SlyA and PhoP
with SlyA displacing H-NS and PhoP acting as a transcriptional activator (37). There
are several SlyA and H-NS binding sites in the pagC promoter region with little or no
overlap between the sites (37).

In V. vulnificus, the binding site of the anti-repressor

HlyU is far upstream of the start transcription site (-376 to -417) for the rtxA1 operon
and overlaps with two H-NS binding sites (12).

Binding of HlyU to DNA relieves

the H-NS repression at all H-NS binding sites of the rtxA1 promoter region (12).

Our

results demonstrate that in V. anguillarum, HlyU relieves H-NS repression, but does
not act to directly activate transcription.
activator of hemolytic activity.

We have not yet identified a transcriptional

However, our data do indicate that transcription from

both hemolysin gene clusters is higher during exponential growth than during
stationary phase.

Additionally, the binding sites for HlyU and H-NS for the V.

anguillarum intergenic rtxHB region are much closer to the +1 start transcription sites
than in V. vulnificus CMCP6.

In V. vulnificus the five H-NS binding sites are at -289

to -459 nt from the start transcription site of rtxH (vv20481) (12), while the H-NS
binding sites in V. anguillarum are between -23 to -100 for rtxH proximal sites and
+42 to -70 from the +1 site for rtxB proximal sites (Fig. 8).

These differences

probably reflect the relative sizes of the intergenic regions for each organism.

In V.

vulnificus CMCP6, the intergenic region between rtxH and rtxB is 1028 nt, while in V.
anguillarum M93Sm the intergenic region is only 325 nt.

It would be interesting to

examine the H-NS and HlyU binding sites in the rtx intergenic region of V. vulnificus
YJ016, which is only 362 nt.
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Although mutation of hns resulted in increased expression and activities of
the three hemolysins (RtxA, Vah1 and Plp), the overall virulence of the hns mutant is
slightly attenuated in rainbow trout.
Escherichia coli.

Similar results were observed in uropathogenic

Mice injected intravenously with 108 CFU of the hns mutant had a

higher survival rate compared to the wild type, although the mutant showed a higher
level of alpha-hemolysin expression and activity (38).

Our data suggest there is no

correlation between virulence in fish and fitness in LB20, but it should be noted that
growth in LB20 is very different from growth in fish.

It is likely that the removal of

H-NS-mediated repression/gene silencing results in an unfavorable alteration of
virulence gene expression and a reduction in fitness in the host environment.
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Table 1. Bacterial strains and plasmids used in this study.
Strain or
plasmid

Genotype and feature(s)

Reference

V.
anguillarum
strains

M93Sm

Spontaneous Smr mutant
of M93 (serotype J-O-1),
virulent

(31)

S305

hlyU mutant

SmR CmR

(6)

M114

hns mutant

SmR CmR

This study

M116

hns complement

SmR CmR TetR

This study

ES114

hns/hlyU double mutant

SmR CmR

KmR

This study

ES115

hns/hlyU double mutant,
hlyU complement

SmR CmR TetR KmR

This study

ES116

hns/hlyU double mutant,
hns complement

SmR CmR TetR KmR

This study

E. coli strains

Sm10

thi thr leu tonA lacY supE
recA RP4-2-Tc::Mu::Km
(λ pir)

KmR

(39)

M15

NalS StrS RifS thi– lac–
ara+ gal+mtl– F–
recA+uvr+ lon+ (pREP4,
KmR)

KmR

QIAGEN
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D112

E. coli Sm10 with
pDM4-hns5'-Kan-hns3'

CmR

KmR

This study

Plasmid

pNQ705-1

pNQ705-hns

Cmr; suicide vector with
R6K origin
For hns insertional
mutantion

(40)

This study

pSUP202

E. coli – V. anguillarum
shuttle vector

(39)

pSUP202-hly
U

For complementation of
hlyU

(6)

pSUP202-hns

For complementation of
hns

This study

pDM4

Cmr Kanr SacBCr; suicide
vector

(18)

pDM4-hns5'Kan-hns3'

For hns deletion
mutantion

This study

pQE-30 UA

Expression vector with
N-terminal His6-tag

QIAGEN

For expression of rH-NS

This study

pQE-30
UA/H-NS

145

Table 2. Primers used in this study.
Sequence (5' to 3',
Primers
underlined sequences are
engineered restriction sites)
SD_hns( GCTAGGAGCTCCAGCTT
F)
GAAGAAGCACTAGA
SD_hns( GCTAGTCTAGACCAGAA
R)
AGTGCAGAAATTAA
hns_com GCTAGCTGCAGTCGGCG
p(F)
ATAAAACCTTTCAC
hns_com GCTAGCTGCAGGTTTAC
p(R)
CTGAACGTGACGAC
TTAAATCTCGAATTCTTC
Pm416
TAGAGATTTACC
ATGTCTGAATTAACAAA
Pm417
AACTCTACTTAAT
CGGCTACTCGAGAGATT
pr40
TACCTGCATCAAGTTG
CGGCTATCTAGAGCACT
pr41
TTCTGGTGAAACTAAG
CGGCTATCTAGAATTAA
pr42
TGCGCTTACATCAATA
CGGCTAGAGCTCAGAAG
pr37
CACTAGATAAATTAAC
CGGCTATCTAGAGAAAA
pr38
GCTTGAACACGTAGAA
ACTGATCTAGATCAGAA
Pm173
GAACTCGTCAAGAAG
RT
GACCGCCGAATCGATGA
vah1-R1 TGAATC
GGTAGGACTGATGCCCA
pvah1JR
CCTACAA
CAGACGACCACCAGTAA
plpF RT
CCACTAA
GCAATCATGATGACCCA
plpR RT
GCAACAG
GGAAATTATTCCGCCGA
Pm111
CGATGGA
GCCGATACCGTATCGTT
Pm112
ACCTGAA
GTGATGGTAGAAAACCT
Pm285
GCGG
ATGTCTGAGAAATTTGT
Pm286
CCAAACA
iPCR
CCGCTAACCGCATTGAT
rtxB R
ATTAAGCTTGGC

Description
hns insertional mutation,
forward, Sac I
hns insertional mutation,
reverse, Xba I
hns complement, forward,
Pst I
hns complement, reverse,
Pst I

Reference
This study
This study
This study
This study

hns ORF, forward

This study

hns ORF, reverse

This study

hns 5' region, forward,
Xho I
hns 5' region, reverse,
Xba I
hns 3' region, forward,
Xba I
hns 3' region, reverse, Sac
I
kanamycin resistant gene,
forward, Xba I
kanamycin resistant gene,
reverse, Xba I

This study
This study
This study
This study
This study
This study

vah1 qRT-PCR, forward

(4)

vah1 qRT-PCR, reverse

This study

plp qRT-PCR, forward

(4)

plp qRT-PCR, reverse

(4)

rtxA qRT-PCR, forward

(5)

rtxA qRT-PCR, reverse

(5)

rtxH qRT-PCR, forward

This study

rtxH qRT-PCR, reverse

This study

rtxB qRT-PCR, forward

This study
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Pm104
Pm297
Pm298

TCACAATCGCCCCAACT
TGCCTTG
ACTGAGAGCTCGGTGTT
GTTAAAGGCTATGGC
ATCGATCTAGAGTATCC
ACTAACCCATCTCTT

Pm412

CCGTATTTTCTGCAATC
GCCATGG

Pm324

CACATATTGACTGATTA
TAATTTTATTGATATT

pr323a

AGGGTTTTTATAAATCC
TAATTTAGATA

Pm320
Pm327

GAATACCCATTTTTTATT
TTTTCAGACC
GTATTTTCTGCAATCGC
CATG

Pm413

CACCTTTGTGGCGAATT
ATTAATAGATCTT

Pm414

CAGTGGCTCATAAAAGC
AGTTGC

Pm318
Pm315
Pm415

CAGCGGTAAGTAGACTG
ATA
CTCAGACATAAATAAAT
CACC
CAGCGGTAAGTAGACTG
ATAAGCAATG

rtxB qRT-PCR, reverse

This study

hlyU qRT-PCR, forward

(6)

hlyU qRT-PCR, reverse

(6)

vah1 promoter region
(probe 1), forward,
5'-labled with 6-FAM
vah1 promoter region
(probe 1), reverse
plp promoter region
(probe 2), forward,
5'-labled with 6-FAM
plp promoter region
(probe 2), reverse
vah1/plp (probe 3)
intergenic region, forward
vah1/plp (probe 3)
intergenic region, reverse,
5'-labled with 6-FAM
rtxB/H intergenic region
(probe 4), forward,
5'-labled with 6-FAM
rtxB/H intergenic region
(probe 4), reverse
rtxB/H intergenic region
(probe 5), forward
rtxB/H intergenic region
(probe 5), reverse,
5'-labled with 6-FAM
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(6)
(6)
This study
(6)
(6)
(6)

(6)
(6)
(6)
(6)

Figure 1.

V. anguillarum hemolysin genes are arranged in two gene clusters: A) the

vah1-plp gene cluster and B) the rtxACHBDE gene cluster. The GC content of each
gene cluster is shown.
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Figure 2.

Hemolytic activity of V. anguillarum wild type (M93Sm), hns mutant

(hns-) and hns complement (hns+) on TSA-5% sheep blood agar after 24 h at 27°C.
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Figure 3. Cytotoxicity experiment. A) Cytotoxicity of culture supernatant from V.
anguillarum wild type (M93Sm), hns mutant (hns-) and hns complement (hns+)
against Atlantic salmon kidney (ASK) cells after 6 h at 20°C.

B) Cytotoxicity of

washed cells of V. anguillarum wild type (M93Sm), hns mutant (hns-) and hns
complement (hns+) against Atlantic salmon kidney (ASK) cells after 4 h at 20°C at
MOI 200.

Asterisks (*) represent P <0.05 between two bracketed strains. Error bars

represent 1 standard deviation.
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Figure 4.

qRT-PCR analysis. Expression of rtxA, rtxB, rtxH, plp, and vah1

determined by qRT-PCR analysis of V. anguillarum wild type (M93Sm), hns mutant
(hns-), and hns complement (hns+) during logarithmic (Log) and stationary (Sta)
phase.

The data presented are a representative experiment from two independent

experiments.

Each sample is the average of three replicates.

Asterisks (*) represent

P <0.05 between two bracketed strains. Error bars represent 1 standard deviation.
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Figure 5. Repression of H-NS does not require hlyU. A) Hemolytic activity of V.
anguillarum wild type (M93Sm), hlyU mutant (hlyU-), hns/hlyU double mutant
(hns-/hlyU-) and hns/hlyU double mutant with hns complemented (hns+/hlyU-) on
TSA-5% sheep blood agar after 24 h at 27°C.

B) Expression of rtxA, rtxB, plp, and

vah1 determined by qRT-PCR analysis of V. anguillarum wild type (M93Sm), hlyU
mutant (hlyU-), hns/hlyU double mutant (hns-/hlyU-) and hns/hlyU double mutant
with hns complemented (hns-/hns+) during logarithmic (Log) and stationary (Sta)
phase.

The data presented are a representative experiment from two independent

experiments.

Each sample is the average of three replicates. Asterisks (*) represent P

<0.05 between two bracketed strains. Error bars represent 1 standard deviation.
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Figure 6. Activation of HlyU requires hns. A) Hemolytic activity of V. anguillarum
wild type (M93Sm), hns mutants (hns-), hns/hlyU double mutant (hns-/hlyU-) and
hns/hlyU double mutant with hlyU complemented (hns-/hlyU+) on TSA-5% sheep
blood agar after 24 h at 27°C.

B) Expression of rtxA, rtxB, plp, and vah1 determined

by qRT-PCR analysis of V. anguillarum wild type (M93Sm), hns mutants (hns-),
hns/hlyU double mutant (hns-/hlyU-) and hns/hlyU double mutant with hlyU
complemented (hns-/hlyU+) during logarithmic (Log) and stationary (Sta) phase.
The data presented are a representative experiment from two independent experiments.
Each sample is the average of three replicates. Error bars represent 1 standard
deviation.
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Figure 7.

Dnase I protection assay. Capillary electrophoresis of 6-FAM labeled

DNA (A) probe 1 and (B) probe 2 from the vah1/plp intergenic region, and (C) probe
4 from the rtxB/H intergenic region from DNase protection assays in the presence
(black lines) and absence (grey line) of rH-NS demonstrating that H-NS binds to
specific sequences in the vah1/plp and rtxB/H intergenic regions, respectively, and
protects against DNase I digestion.

DNA probes were prepared and labeled with

6-FAM, incubated with rH-NS (0 or 3 µM) followed by DNase I, and then analyzed
by DNA fragment analysis as described in the Materials and Methods.
region sequences are indicated by the double black underline.

The binding

The underlined DNA

fragments indicate those that are higher in the presence of rH-NS (black line) than in
its absence (grey line).

The location of each probe is shown in Fig. S1.
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Figure 8.

Intergenic regions of the (A) vah1-plp and (B) rtxACHBDE gene clusters.

The transcriptional start sites are in bold, italicized sequences labeled with +1.

The

-10 and -35 promoter sequences are bolded, italicized sequences labeled with -10 and
-35.

Ribosomal binding sites are bolded, italicized sequences labeled with RBS.

Sequences protected by HlyU are bolded, italicized, and labeled as HlyU protection.
Sequences protected by H-NS are underlined.
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Figure 9.

Fish infection experiment. Survival percentages of rainbow trout injected

IP with NSS only (Mock, gray dashed line) or ~4×105 CFU/fish of wild-type M93Sm
(gray solid line), hns mutant (hns-, black solid line), or hns complement (hns+, black
dashed line).

Each experimental group had n = 10.

suspended in NSS.

V. anguillarum cells were

Asterisks (*) represent P <0.05 between two bracketed strains.

164

165

Table S1. Real time qRT-PCR analysisa
Parameter
and gene
expressed
rtxA
RNA Copy
number

Relative
change (fold)
to M93Smd

Relative
change (fold)
to hlyU-d

Relative
change (fold)
to hns-d

rtxH
RNA Copy
number

Relative
change (fold)
to M93Smd

V.
anguillarum
strainb

Average (±SDc)
Log phase

Stationary phase

hnshns+
hlyUhns-/hlyUhns-/hlyU+
hns+/hlyU-

2.66 × 104 (±3.76 ×
103)6
7.75 × 104 (±1.11 × 104)
9.72 × 102 (±10)
2.38 × 102 (±1.38 × 102)
6.47 × 104 (±9.92 × 103)
1.43 × 105 (±2.00 × 104)
1.24 × 104 (±1.75 × 102)

M93Sm

1.00 (±0.14)

1.00 (±0.04)

hnshns+
hlyU-

2.91 (±0.42)
-27.37 (±0.00)
-11.18 (±0.01)

2.14 (±0.25)
-29.15 (±0.00)
-14.23 (±0.01)

hlyU-

1.00 (±0.06)

1.00 (±0.15)

hns-/hlyUhns+/hlyU-

27.21 (±4.17)
5.22 (±0.07)

20.50 (±2.43)
6.22 (±0.77)

hns-

1.00 (±0.14)

1.00 (±0.12)

hns-/hlyUhns-/hlyU+

-1.20 (±0.13)
1.84 (±0.26)

-1.48 (±0.08)
1.16 (±0.03)

M93Sm

6.80 × 104 (±1.80 × 104)

2.45 × 104 (±3.19 × 103)

hnshns+

3.10 × 105 (±8.58 × 104)
9.43 × 103 (±1.31 × 103)

5.85 × 104 (±3.56 × 103)
8.59 × 103 (±6.12 × 102)

M93Sm

1.00 (±0.26)

1.00 (±0.13)

hnshns+

4.56 (±1.26)
-7.21 (±0.02)

2.39 (±0.15)
-2.85 (±0.02)

M93sm
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8.57 × 103 (±3.60 × 102)
1.83 × 104 (±2.13 × 103)
2.94 × 102 (±19)
6.02 × 102 (±90)
1.23 × 104 (±1.47 × 103)
2.13 × 104 (±4.91 × 102)
3.74 × 103 (±4.65 × 102)

rtxB
RNA Copy
number

Relative
change (fold)
to M93Smd

Relative
change (fold)
to hlyU-d

Relative
change (fold)
to hns-d

vah1
RNA Copy
number

Relative
change (fold)
to M93Smd

M93sm

4.17 × 104 (±4.01 × 103)

1.71 × 104 (±1.23 × 103)

hnshns+
hlyUhns-/hlyUhns-/hlyU+
hns+/hlyU-

5.35 × 104 (±9.58 × 103)
3.89 × 103 (±5.19 × 102)
9.54 × 103 (±5.96 × 102)
7.31 × 104 (±7.23 × 103)
2.92 × 104 (±8.00 × 103)
1.14 × 104 (±1.42 × 103)

2.44 × 104 (±3.10 × 103)
1.59 × 103 (±18)
3.62 × 103 (±1.41 × 102)
3.56 × 104 (±7.66 × 102)
1.85 × 104 (±2.48 × 103)
1.47 × 104 (±5.74 × 102)

M93Sm

1.00 (±0.10)

1.00 (±0.07)

hnshns+
hlyU-

1.28 (±0.23)
-10.72 (±0.01)
-4.37 (±0.01)

1.43 (±0.18)
-10.77 (±0.00)
-4.73 (±0.01)

hlyU-

1.00 (±0.06)

1.00 (±0.04)

hns-/hlyUhns+/hlyU-

7.67 (±0.76)
1.20 (±0.15)

9.84 (±0.21)
4.06 (±0.16)

hns-

1.00 (±0.18)

1.00 (±0.13)

hns-/hlyUhns-/hlyU+

1.37 (±0.14)
-1.83 (±0.15)

1.46 (±0.03)
-1.32 (±0.10)

M93sm

1.40 × 103 (±1.76 × 102)

6.19 × 102 (±94)

hnshns+
hlyUhns-/hlyUhns-/hlyU+
hns+/hlyU-

2.27 × 104 (±6.40 × 103)
1.06 × 103 (±3.62 × 102)
3.24 × 103 (±1.94 × 102)
1.68 × 104 (±3.21 × 103)
1.30 × 104 (±1.48 × 102)
5.34 × 103 (±5.30 × 102)

1.24 × 104 (±2.69 × 103)
1.88 × 102 (±17)
4.74 × 102 (±88)
1.95 × 104 (±2.90 × 103)
3.04 × 104 (±1.93 × 103)
6.45 × 103 (±4.17 × 102)

M93Sm

1.00 (±0.13)

1.00 (±0.15)

hnshns+

16.21 (±4.57)
-1.32 (±0.26)

20.01 (±4.35)
-3.30 (±0.03)
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Relative
change (fold)
to hlyU-d

Relative
change (fold)
to hns-d

plp
RNA Copy
number

Relative
change (fold)
to M93Smd

Relative
change (fold)
to hlyU-d

Relative
change (fold)
to hns-d

hlyU-

2.31 (±0.14)

-1.30 (±0.14)

hlyU-

1.00 (±0.06)

1.00 (±0.19)

hns-/hlyUhns+/hlyU-

5.20 (±0.99)
1.65 (±0.16)

41.02 (±6.11)
13.60 (±0.88)

hns-

1.00 (±0.28)

1.00 (±0.22)

hns-/hlyUhns-/hlyU+

-1.35 (±0.14)
-1.75 (±0.01)

1.57 (±0.23)
2.46 (±0.16)

M93sm

8.50 × 102 (±2.07 × 102)

3.02 × 102 (±8)

hnshns+
hlyUhns-/hlyUhns-/hlyU+
hns+/hlyU-

2.66 × 104 (±4.08 × 103)
4.21 × 102 (±1.08 × 102)
1.14 × 103 (±3.38 × 102)
8.46 × 103 (±1.64 × 103)
8.58 × 103 (±8.21 × 102)
2.02 × 103 (±5.75 × 102)

1.11 × 104 (±2.43 × 102)
3.18 × 102 (±73)
3.46 × 102 (±50)
1.18 × 104 (±2.15 × 103)
2.39 × 104 (±8.47 × 102)
3.58 × 103 (±1.54 × 102)

M93Sm

1.00 (±0.24)

1.00 (±0.03)

hnshns+
hlyU-

31.27 (±4.80)
-2.02 (±0.13)
1.34 (±0.40)

36.88 (±0.81)
1.05 (±0.24)
1.15 (±0.17)

hlyU-

1.00 (±0.30)

1.00 (±0.15)

hns-/hlyUhns+/hlyU-

7.46 (±1.44)
1.78 (±0.51)

34.02 (±6.21)
10.35 (±0.44)

hns-

1.00 (±0.15)

1.00 (±0.02)

hns-/hlyU1.06 (±0.19)
-3.14 (±0.06)
hns-/hlyU+
-3.10 (±0.03)
2.15 (±0.08)
a
The data presented is a representative experiment of two independent experiments.
Each sample is the average of three replicates.
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b

V. anguillarum strains: M93Sm (wild type), hns- (hns mutant, M114), hns+ (hns

complemente, M116), hlyU- (hlyU mutant, S305), hns-/hlyU- (hns/hlyU double
mutant, ES114), hns-/hlyU+ (hns/hlyU double mutant with hlyU complemented,
ES115), hns+/hlyU- (hns/hlyU double mutant with hns complemented, ES116)
c

d

Standard Deviation
Gene expression is up-regulated (positive number) or down-regulated (negative

number) compared to expression in M93Sm.
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Figure S1. Supplement data for Dnase I protection assay. 6-FAM labeled DNA probes
(probes 1-5) used for DNaseI protection studies of the intergenic regions between A)
plp and vah1 and B) rtxH and rtxB were obtained by PCR amplification using the
primers in Table 2.
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A.

B.
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Figure S2. Supplement data for qRT-PCR analysis. Real-time qRT-PCR was
performed to determine A) the expression level of hlyU in the wild-type strain
(M93Sm), hns mutant (hns-), and the hns complement (hns+) during exponential and
stationary growth phases. Each sample is the average of three replicates. The data
presented are the averages of two independent experiments.

B) Expression level of

hns in the wild-type strain (M93Sm) during exponential and stationary growth phases.
Each sample is the average of three replicates.

Statistically significant differences

between samples are marked with a bracket and an * symbol. Error bars represent 1
standard deviation.
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Stationary
Phase

Figure S3. Growth profiles of V. anguillarum strains. A) Growth curve of V.
anguillarum wild type (M93Sm), hns mutant (hns-) and hns complemented (hns+)
strains in LB20. B) Generation time of V. anguillarum wild type (M93Sm), hns
mutant (hns-) and hns complemented (hns+) strains grown in LB20. Statistically
significant differences between samples are marked with a bracket and an * symbol.
Error bars represent 1 standard deviation.
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Abstract

We

have

been

investigating

the

regulation

and

roles

of

the

hemolysin/cytotoxin genes in pathogenesis by V. anguillarum, the causative agent of
vibriosis in fish. We have shown that there are three major hemolysin genes (vah1,
plp and rtxA) and have created an avirulent strain by knocking rtxA. In this study, we
aimed to create avirulent and immunogenic V. anguillarum strains that can be used as
a live vaccine for fish, without knocking out any of the hemolysin genes. For this
purpose, six genes (mdh, icd, sucA, sucC, sdhC, and fumA) encoding enzymes in
tricarboxylic acid (TCA) cycle and one gene (cra) encoding a fructose metabolism
repressor were identified and mutated in wild type V. anguillarum M93Sm (serotype
O2a). Among all mutants, icd mutant showed high attenuation of virulence and lowest
cell density limit in two forms of rich media. All mutants exhibited the same or higher
levels of hemolysin gene expression compared to wild type during exponential phase.
Further, fish that were pre-treated by immersion with icd mutant protected rainbow
trout from the subsequent challenge of V. anguillarum M93Sm; and fish that were
pre-treated injection of icd mutant elicited cross-serotype immunity against the
subsequent challenge of V. anguillarum NB10 (serotype O1). The results suggest the
TCA cycle mutation approach is likely to be an easy method to construct modified live
vaccine for a wide variety of pathogenic bacteria.
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Introduction

Vibrio anguillarum is the causative agent of vibriosis, a fatal hemorrhagic
septicemic disease. V. anguillarum infects more than 50 fresh and salt-water fish
species including various species of economic importance to the larviculture and
aquaculture industries, such as salmon, rainbow trout, turbot, sea bass, sea bream, cod,
eel, and ayu (1). The mortality rate from infections ranges from 30% to 100% (2). V.
anguillarum also causes vibriosis in crustaceans and bivalves (2). Infections by this
bacterium have resulted in severe economic losses to aquaculture worldwide (2). In
Norway, killed vaccines against V. anguillarum are proven successful in salmon
aquaculture. During the 1980s, salmon farming in Norway experienced huge losses
due to vibriosis and cold water vibriosis, and a total crash in the industry was only
prevented by the use of vast amounts of antibiotics (3). Currently, all farmed salmon
and trout in Norway are vaccinated against vibriosis (V. anguillarum), cold-water
vibriosis or Hitra disease (Aliivibrio salmonicida), and furunculosis (Aeromonas
salmonicida), and few reports of vibriosis were observed (4). The success of these
killed vaccines immediately resulted in a decline in the use of antibiotics (3).

Shoemaker (5) reported an example of a successfully commercialized
modified live vaccine (AQUAVAC-ESC) currently used in US catfish industry which
highlights the live vaccine strategy. Modified live vaccines have several advantages
over killed vaccines: First, modified live vaccines can be administered by immersion
(5), which avoids the injection procedure frequently used in killed vaccines and make
it possible to apply the vaccines to the larval or fry stages or some vulnerable species
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(3). Second, modified live vaccines are able to elicite humoral, mucosal and
cell-mediated immunity (6), while killed or subunit vaccines are not effective at
eliciting cellular responses (7). Third, modified live vaccines do not require an
adjuvant, such as mineral oil, which is reported to cause side effects including
decreased growth rates, chronic peritonitis, adhesions, granulomas and pigmentation
in the peritoneal cavity (8). Fourth, due to omission of injection and adjuvant,
modified live bacterial vaccines have a lower cost (7, 9). Currently, there are eight
licensed bacterial vaccines for fish in the United States. Five of them are killed
vaccines and three of them are live cultures (Arthrobacter, Edwardsiella ictaluri and
Flavobacterium columnare) (10). While there is a great need for modified live
vaccines, modification of a specific pathogenic bacterium to result in a live vaccine
strain may require a comprehensive understanding of its pathogenesis.

In vibriosis, V. anguillarum invades its host fish through the intestine and
skin (11, 12). Infected fish usually die within 1-4 days (13-16) with systemic infection
of V. anguillarum. Chemotactic motility and the metalloprotease EmpA were shown to
be important during the invasion stage, while the siderophore anguibactin, flagellin
subunits, lipopolysacharides (LPS), and the MARTX toxin RtxA were shown to be
important at least for the persistence in the host during the post-invasion stage (see
reviews by Frans et al, 2011, and by Naka and Crosa, 2011) (1, 17). Recently, a V.
anguillarum mutant with a global regulator H-NS knocked-out showed attenuation in
virulence when injected intraperitoneally, suggesting bacterial fitness is also a
important factor during the post-invasion stage (15).
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Additionally, it has been demonstrated in Salmonella enterica, an
intracellular bacterial pathogen, that some tricarboxylic acid (TCA) cycle mutant
strains were avirulent and immunogenic for subsequent wild-type S. enterica infection
(18-20). A functional fructose repressor (Cra) is also required for S. enterica (21).
Similar results have also been observed for the uropathogenic Escherichia
coli (UPEC), another intracellular bacterial pathogen (22). The TCA cycle- and
gluconeogenesis-defective strains demonstrate significant fitness reductions during
urinary tract infections (22). These observations suggest that the central metabolism of
pathogens is important for pathogenesis.

The observations concerning the effects of the TCA cycle upon virulence
allowed us to hypothesize that mutations in central metabolism-related genes, such as
those that encode the TCA cycle enzymes could interrupt the infection process in fish.
To test the hypothesis, we identified and created six TCA cycle mutant strains plus
one fructose metabolism mutant strain and tested their virulence against rainbow trout
(Oncorhynchus mykiss). Further, we examined their ability to grow in three different
media, monitored their expression of each of the three hemolysins, performed
infection experiments on rainbow trout to determine the virulence of each mutant, and
performed challenge experiments to demonstrate the ability of the one highly
attenuated (icd) mutant to elicit a protective response against virulent strains of V.
anguillarum.
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Materials and Methods

Identification of genes in V. anguillarum. V. anguillarum M93Sm draft genome
(unpublished data) and V. anguillarum 775 genome (17) were annotated by the RAST
(Rapid

Annotation

using

Subsystem

Technology)

service (http://rast.nmpdr.org/rast.cgi) using the default settings (23).

Bacterial strains, plasmids and growth conditions. V. anguillarum strains (Table 1)
were routinely grown in Lysogeny broth containing 2% NaCl (LB20) (24),
supplemented with the appropriate antibiotic, in a shaking water bath at 27°C.

E.

coli strains (Table 1) were routinely grown in Lysogeny broth containing 1% NaCl
(LB10).

Antibiotics were used at the following concentrations: streptomycin, 200 µg

ml-1 (Sm200); chloramphenicol, 20 µg ml-1 (Cm20) for E. coli and 5 µg ml-1 (Cm5) for
V. anguillarum; kanamycin, 50 µg ml-1 (Km50) for E. coli and 80 µg ml-1 (Km80) for V.
anguillarum. 3M-Glucose [Minimal Marine Medium (25) plus 0.2 % Glucose] and
NSSM (Nine Salts Solution plus fish gastrointestinal mucus) (26) were used in
specific experiments.

Insertional mutagenesis.

Insertional mutations were made by using a modification

of the procedure described by Milton et al. (27). Briefly, primers (Table 2) were
designed based on the target gene sequence of M93Sm.

Then a 200~300 bp DNA

fragment of the target gene was PCR amplified and ligated into the suicide vector
pNQ705-1 (Table 1) after digestion with SacI and XbaI.

The ligation mixture was

introduced into E. coli Sm10 by electroporation using BioRad Gene Pulser II (BioRad,
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Hercules, CA).

Transformants were selected on LB10 Cm20 agar plates.

The

construction of the recombinant pNQ705 was confirmed by both PCR amplification
and restriction analysis.

The mobilizable suicide vector was transferred from E. coli

Sm10 into V. anguillarum strains by conjugation. Transconjugants were selected by
utilizing the chloramphenicol resistance gene located on the suicide plasmid.

The

incorporation of the recombinant pNQ705 was confirmed by PCR amplification.

Bacterial conjugation. Bacterial conjugation were carried out using the procedure
modified from by Varina et al (28). Briefly, 100 µl V. anguillarum overnight was
added into 2.5 ml NSS (Nine Salts Solution) (29); 100 µl E. coli culture overnight was
added into 2.5 ml 10 mM MgSO4. The resulting V. anguillarum and E. coli suspension
was mixed, vacuum filtered onto a autoclaved 0.22-µm-pore-diameter nylon
membrane (Millipore, USA), placed on an LB15 agar plate (LB-plus-1.5% NaCl), and
allowed to incubate overnight at 27°C. Following incubation, the cells were removed
from the filter by vigorous vortexing in 1 ml NSS. Cell suspensions (70 µl) were
spread on LB20 plated with appropriate antibiotics and the plates were incubated at
27°C until V. anguillarum colonies were observed (usually 24 to 48 h).

Hemolytic assay. Single V. anguillarum colonies were transferred onto LB20-fish
blood agar (LB20 agar plus 5% rainbow trout blood with heparin), and hemolytic
activity was determined by measuring the hemolysis zone surrounding the colonies
after incubation at 27°C.
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RNA isolation.

Exponential phase cells (~0.5 × 108 CFU ml-1) of various V.

anguillarum strains were treated with RNAprotect Bacteria Reagent (QIAGEN),
following the manufacturer’s instructions.

Total RNA was isolated using the RNeasy

kit and QIAcube (QIAGEN) following the manufacturer’s instructions.

All purified

RNA samples were quantified spectrophotometrically by measuring absorption at 260
nm and 280 nm using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher
Scientific) and stored at -75ºC for future use.

Real-time quantitative RT-PCR (qRT-PCR).

qRT-PCR was used to quantify

various mRNAs using an LightCycler® 480 Real-Time PCR System (Hoffmann-La
Roche Inc.) and the Brilliant II SYBR Green Single-Step QRT-PCR Master Mix
(Agilent Technologies), with 10 ng of total RNA in 25 µl reaction mixtures.

The

thermal profile was 50°C for 30 min, 95°C for 15 min, and then 40 cycles of 95°C for
30 s and 55°C for 30 s. Fluorescence was measured at the end of the 55°C stage of
each cycle.

Samples were run in triplicate along with the no-reverse-transcriptase

control and the no-template control.

All experiments were repeated at least twice.

Fish infection experiment. Various V. anguillarum strains were tested for virulence
with rainbow trout (Oncorhynchus mykiss) by intraperitoneal (IP) injection or
immersion. Briefly, V. anguillarum cells grown in LB20 supplemented with
appropriate antibiotics for 19 h at 27°C were harvested by centrifugation (9,000 × g, 5
min, 4°C), washed twice in NSS, and resuspended in NSS. NSS suspensions with an
estimated specific cell density were prepared according to the optical density at 600
nm (OD600) of the culture and the conversion equation: cell density (108 CFU ml-1) =
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44.905 × OD600, determined by experiment (Figure S1). The OD600 was determined by
the following method: 100 µl of NSS suspension was transferred into a 96-well plate
with a clear bottom. The OD600 was read by a VersaMax™ Absorbance Microplate
Reader (Molecular Devices). The actual cell density of injection solution was
confirmed by viable count. All fish were examined prior to the start of each
experiment to determine that they were free of disease or injury. For IP injection, fish
were anesthetized by tricaine methanesulfonate (Western Chemical, Ferndale, WA),
with 100 mg L-1 for induction and 52.5 mg L-1 for maintenance. V. anguillarum strains
were IP-injected into fish in 100 µl NSS vehicle. Fish that were between 15 and 25 cm
long were injected with bacteria diluted with NSS to a specific dosage, or NSS only as
negative control. For immersion, 1.5 % Instant Ocean sea salt (Pentair Aquatic
Eco-Systems) water solution at 18 ± 1 ºC was used as immersion liquid. Each
experiment group was provided with 10 L of immersion liquid in a bucket lined with a
new, clean, 13-gallon (50L) household trash bag. After the sea salt was fully dissolved,
10 ml the V. anguillarum suspended in NSS at a specific cell density, or 10 ml NSS
only as the negative control, was added. After V. anguillarum was mixed, fish that
were between 15 and 25 cm long were immersed for 1 h. For both methods, fish
inoculated with different bacterial strains were maintained in separate 10-gallon tanks
with constant water flow (200 ml/min) at 18 ± 1 ºC.
prevent possible cross-contamination.

The tanks were separated to

Death due to vibriosis was determined by the

observation of gross clinical signs and confirmed by the recovery and isolation of V.
anguillarum cells resistant to the appropriate antibiotics from the head kidney of dead
fish.

Observations were made for 14 days.
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All fish used in this research project

were obtained from the URI East Farm Aquaculture Center.

All fish infection

protocols were approved by the URI IACUC.

Statistical analysis. Student's T-tests assuming unequal variances were used for
statistical analyses for all experiments except for the fish infection experiment.
P values of < 0.05 were considered statistically significant. A Kaplan-Meier survival
analysis with log rank significance test was performed on the survival percentage in
the fish infection experiment. P values of < 0.05 were considered statistically
significant.
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Results

Gene identification and mutant construction in V. anguillarum.

The TCA cycle

in Salmonella enterica consists of eight biochemical reactions catalyzed by nine
enzymes/enzyme complexes, encoded by gltA, icd, sucAB, sucCD, sdhCDAB, fumAC,
fumB, and mdh (18-20). Cra (encoded by cra) is a repressor of fruA, fru and fruK,
which are required for fructose metabolism in Salmonella enterica (21). The nine TCA
cycle enzyme genes, plus the cra gene, were examined in the RAST annotation results
of V. anguillarum M93Sm draft genome (unpublished data) and V. anguillarum 775
genome (17). BLASTx was performed on the identified sequences against the NCBI
non-redundant protein sequences database to confirm the accuracy of annotation.
Among the ten examined metabolism associated genes/operons, gltA, icd, sucAB,
sucCD, sdhCDAB, fumA, mdh and cra were identified in V. anguillarum (Fig. 1 and
Table 3). The sequences encoding icd, sucA, sucC, sdhC, fumA, mdh, and cra in V.
anguillarum M93Sm were used to created insertional mutations in V. anguillarum
M93Sm. Seven metabolism mutant strains were obtained and listed in Table 1.

icd mutant is highly attenuated against rainbow trout. To test the hypothesis that
mutation in central metabolism could interrupt the infection process in fish, we tested
the virulence of the seven V. anguillarum metabolism mutants along with the M93Sm
wild type on rainbow trout. Groups of five fish were infected by IP injection as
described in the Materials and Methods with wild type V. anguillarum (M93Sm) cells
or with cells from one of the seven mutant strains: icd (XM420), sucA (XM440), sucC
(XM450), sdhC (XM460), fumA (XM470), mdh (XM410) or cra (XM430) in NSS at a
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dosage of ~2 × 105 CFU/fish, or with NSS only as a negative control (mock). During
the 14-day observation window, 40% of M93Sm infected fish survived.

In

comparison, the sucA mutant, sdhC mutant and icd mutant infected fish all had higher
survival percentages compared to M93Sm (50% for sucA mutant, 80% for sdhC
mutant, and 100% for icd mutant); however, the difference between any of the three
mutants and M93Sm is not statistically significant (P = 0.051 to 0.913) (Fig 2A). The
fish infection experiment was repeated with a higher dose (~4 × 105 CFU/fish) of the
V. anguillarum wild type and the three mutant strains (icd, sucA, and sdhC) that
exhibited some attenuation of virulence in the first experiment. At this higher dose of
V. anguillarum only 20% of fish infected with M93Sm (wild type) survived.
Similarly, fish infected with either sucA or sdhC mutants survived at 0% or 20%,
respectively.

In contrast, fish infected with the icd mutant had a significantly higher

survival percentage (100%) compared to M93Sm (P = 0.013) (Fig 2B). The data
indicate icd mutant is a highly attenuated or avirulent strain in these experimental
conditions.

We then compared the virulence of M93Sm with the icd mutant by another infection
route - immersion. Groups of 10 fish were infected by immersion as described in the
Materials and Methods with either M93Sm or the icd mutant in a 1.5% sea salt
solution at a dose of ~4 × 106 CFU ml-1, or 1.5% sea salt solution without V.
anguillarum as a negative control (mock).

Control experiments showed that neither

the V. anguillarum cells nor the rainbow trout were adversely affected by the 1 h
exposure to 1.5% sea salt solution (Fig. S2A and 2C). During the 14-day experiment,
30% of M93Sm infected fish survived while 90% of icd mutant infected fish survived.
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The difference is statistically significant (P = 0.007) (Fig 2C). Taken together, the two
infection experiments demonstrate that the icd mutant exhibits highly attenuated
virulence against rainbow trout.

Growth rates and growth yields of V. anguillarum wild type and mutant strains.
In order to determine the possible cause of attenuation in the icd mutant, we examined
the growth curves of the wild type and the seven metabolism mutants of V.
anguillarum in one minimal medium (3M-Glucose) and two forms of rich media
(LB20 and NSSM). The cell density in 3M-Glucose and LB20 was measured by
spectrophotometry at 600 nm, while the cell density in NSSM was measured by viable
count.

When cells were grown in Minimal Marine Medium plus 1% Glucose (3M-Glucose),
the icd mutant and the sucA mutant failed to grow, since there is no alternative way to
produce α-ketoglutarate or succinyl-CoA (Fig. 1). The sucC mutant, sdhC mutant,
mdh mutant and cra mutant exhibited similar generation times to M93Sm (P = 0.139
to 0.985), while the fumA mutant exhibited a 33% longer generation time than that of
M93Sm (P = 0.022) (Table S1).

In LB20 broth, M93Sm, icd mutant and cra mutant exhibited a classic bacterial
growth curve with a lag phase, a log phase and a stationary phase, while the other
strains sucA mutant, sucC mutant, sdhC mutant, fumA mutant and mdh mutant
exhibited biphasic growth curves, with a lag phase then a log phase followed by
slower growth (stationary/lag phase), then a second log phase, followed by a
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stationary phase (Fig 3A). The log phase in the first growth stage was named log
phase I and the log phase in the second growth stage was termed log phase II. The
generation times during the log phase(s) of all mutants (52.4 to 115.3 min) were
longer than for M93Sm (44.0 min) (Fig 3B). The generation time of the icd mutant
(55.0 min) was only longer than M93Sm (44.0 min) and sucC mutant log phase I (52.4
min), and shorter than all other mutants - sucA mutant (64.3 and 98.5 min), sdhC
mutant (61.19 and 101.70 min), fumA mutant (73.6 and 89.4 min), mdh mutant (67.1
and 115.3 min), and cra mutant (58.6 and 91.8 min). The maximum OD600 of the icd
mutant was the lowest among all strains (0.75 vs. 0.96-1.10). The log phase generation
time of the icd mutant was 25% longer than M93Sm (55.0 vs. 44.0 min) while the
maximum OD600 was ~70% of that for M93Sm (0.75 vs. 1.10).

To better mimic the colonization environment in fish intestine, we examined the
growth of the wild type (M93Sm) and the icd mutant (XM420) strains in NSS plus
fish gastrointestinal mucus (NSSM) broth by viable count. In these conditions, the
shortest generation time of the icd mutant was only ~5% longer than M93Sm (66 vs.
63 min) while the maximum cell density of the icd mutant was only 24% of that for
M93Sm (3.27 × 108 vs. 1.37 × 109 CFU ml-1). Taken together, these data indicate
that the loss of icd severely limits the growth of V. anguillarum, even in nutrient-rich
media.

Expression of hemolysin genes in mutants and wild type strains. The attenuation in
virulence of the icd mutant could be the result of down-regulation of one or more of
the hemolysin (plp, vah1, and rtxA) genes used by V. anguillarum to promote
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virulence (22). The genes encoding the three hemolysins are expressed most strongly
during log phase (15, 16, 30). To examine this possibility, we determined the
expression of vah1, rtxA and plp during log phase using qRT-PCR (Fig 4A). Data
indicate in all mutants except the icd mutant, expression of vah1 and plp were
up-regulated by 1.77-fold to 16.15-fold compared to M93Sm (P = 0.001 to 0.036). In
the icd mutant, expression of plp was up-regulated by 1.76-fold, while the expression
of vah1 was at approximately the same level as M93Sm (P = 0.083). Expression of
rtxA by all mutants was also at the same level as M93Sm (P = 0.165 to 0.753).
Therefore, all metabolism mutants exhibit the same or higher levels of hemolysin gene
expression compared to the wild type and attenuation of the icd mutant is not due to
reduced expression from the hemolysin genes.

We have observed that Plp is the most efficient of the three hemolysins against fish
erythrocytes (Li et al, unpublished data). Thus, zones of hemolysis on fish blood agar
are primarily the result of Plp activity. The data indicate when compared to the wild
type M93Sm, all TCA cycle mutants (but not the cra mutant) had significantly higher
levels of hemolytic activity after 7 h of incubation on fish blood agar plates.

After 23

h of incubation all TCA cycle mutants and the cra mutant had significantly larger
zones of hemolysis on fish blood agar compared to M93Sm (P = 0.003 to 0.044) (Fig
4B). The hemolysis activity results correspond with the expression data for plp and
vah1 (Fig 4A).

Expression level of hlyU is higher in sucA mutant and mdh mutant than that in
wild type. Previously, we demonstrated that the three hemolysin genes, vah1, rtxA and
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plp, are co-regulated by a repressor (H-NS) and an anti-repressor (HlyU) (15, 30). In
order to examine their possible roles in regulating hemolysin gene expression in the
metabolism mutants, we examined the expression of hlyU and hns during log phase
using qRT-PCR in two TCA cycle mutants – the sucA mutant and mdh mutant (Fig
4C). Data show that both hlyU and hns were expressed at significantly higher levels in
both the sucA and mdh mutant compared to M93Sm (P = 0.015 to 0.018). The
expression of hlyU was 76% (in the sucA mutant) and 63% (in the mdh mutant) higher
than in M93Sm, while the expression of hns was 14% (in the sucA mutant) and 36%
(in the mdh mutant) higher than in M93Sm. Compared to the increase in hlyU
expression, the increase of hns was relatively small (14% vs. 76% in sucA mutant,
36% vs. 63% in mdh mutant), suggesting the possibility that the relative increase in
hlyU expression may be responsible for the increased expression of plp and vah1.

Pre-treatment by immersion with icd mutant protected rainbow trout from the
subsequent challenge of V. anguillarum M93Sm. In order to test whether rainbow
trout previously exposed to the highly attenuated icd mutant by immersion were
protected against vibriosis by the fully virulent wild type M93Sm, we performed an
infection challenge on fish that had been pre-treated with the icd mutant. A group of
five fish that survived from the initial infection experiment by immersion (labeled as
“pre-treated by immersion” in Fig 5A) and group of five “untreated” fish were
immersion-infected by M93Sm at a dosage of ~4 × 106 CFU ml-1 and observed for 14
days. The pre-treated trout were challenged with the wild type cells 6 weeks after the
initial infection with the icd mutant to allow adaptive immunity to develop. In the
untreated group, no fish survived past day 2, while in the “pre-treated by immersion”
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group, all five fish survived for the entire 14-day observation period (Fig 5A). The
difference between the two experimental groups is statistically significant (P = 0.003).
The results indicate that icd mutant elicits protective immunity when fish are
inoculated by immersion.

Pre-treatment by injection of icd mutant elicited cross-serotype immunity against
the subsequent challenge of V. anguillarum NB10. In order to test whether
pre-treatment of fish with the icd mutant was able to provide cross-serotype protection,
we carried out a second infection challenge experiment using the virulent wild type
strain of V. anguillarum NB10 (serotype O1) with a serotype different from that of the
M93Sm-derived icd mutant (serotype O2a), on fish that had been pre-treated with the
icd mutant. A group of three fish that survived the initial infection experiment by
immersion (labeled as “pre-treated by immersion” in Fig 5B), and group of five fish
that survived from the initial infection experiment by injection (labeled as “pre-treated
by injection” in Fig 5B) were infected by immersion with NB10 at a dosage of ~4 ×
106 CFU ml-1 and observed for 14 days. As in the first challenge experiment, the
pre-treated trout were challenged with the wild type cells 6 weeks after the initial
infection with the icd mutant to allow adaptive immunity to develop. A group of four
“untreated” fish were also included as a control. In the untreated group, no fish
survived beyond day 4, while in the “pre-treated by immersion” group, one fish (33%)
survived for the entire 14-day observation period. However, there is no statistically
significant difference between the two experimental groups (P = 0.139). In the
“pre-treated by injection” group, four fish (80%) survived for the entire 14-day
observation period. When compared to the untreated control group, the number of
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survivors is statistically significant (P = 0.007) (Fig 5B). The results indicate icd
mutant elicited cross-serotype immunity against V. anguillarum NB10 at least when
applied by injection.

Discussion

An ideal modified live vaccine would be a strain that retains its invasive
ability but does not cause further damage to the fish host, so that not only humoral but
also cell-mediated immunity would be elicited, by simply applying the vaccine by
immersion. For this purpose, factors that are exclusively required in the post-invasion
stage, rather than the virulence factors that required for the invasive stage of the
pathogen, would be the preferred targets to modify or knock out. We hypothesized that
disrupting the central fueling pathways, such as the TCA cycle enzymes, were likely
to result in defects that would accomplish this goal, especially since other investigators
had success with this approach in both UTI E. coli (22) and Salmonella enterica
(18-20). It has been suggested that intracellular pathogens inside host cell phagosomes
are in nutritionally restricted sites and are likely to be starved for essential nutrients,
especially when central fueling pathways are disrupted (20). However, unlike S.
enterica and UTI E. coli, V. anguillarum is an extracellular pathogen and does not
invade host cells. Thus, it was not clear that disrupting the central fueling pathways
would necessarily result in V. anguillarum mutants unable to persist and grow in the
fish host.

To examine this question, we constructed 7 mutants – six TCA cycle

mutants and one regulatory mutant (cra) and tested the mutants for virulence in
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rainbow trout and, subsequently, tested the attenuated mutant for its ability to protect
the trout against challenge by virulent wild type strains of V. anguillarum.

For all metabolism mutants, there is no correlation between their virulence
and growth rate in LB20, however, there is correlation between virulence and the
maximum cell density since only the icd mutant had both the lowest virulence and the
lowest maximum cell density (compare Fig 2A with Fig 3A), suggesting that a certain
cell density is a prerequisite for a successful systemic infection. It is possible that once
icd mutant cells get into the host fish, they are unable to grow to a high enough density
to overwhelm the host innate immune defenses. Thus the host has time to mount an
effective adaptive immune response.

This raises the question as to whether icd

mutant growth is restricted in the GI tract of the fish and/or after it penetrates the
epithelial cell layer and invades the fish host. Our data suggest that the growth
restrictions may be in both environments.

Specifically, the icd mutant cells grew

with nearly the same doubling time as the M93Sm wild type cells in NSSM, but their
maximum cell density was only 24% that seen in M93Sm, suggesting that the cells
may not reach a critical density necessary for successful invasion of the host.
However, we also injected fish with potentially lethal doses of the icd mutant, but all
injected fish survived (unlike fish IP injected with M93Sm).

This result suggests that

even if icd mutant cells penetrate the epithelial layer and enter the fish host, they are
unable to grow to a high enough density to overwhelm the host immune response.

All mutants constructed in this study exhibited the same or higher levels of
hemolysin gene expression and higher hemolytic activity than M93Sm (Fig 4A and
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4B), ruling out the possibility that the attenuated virulence of the icd mutant is due to
the lack of hemolytic activity. Additionally, we suggest that the presence of secreted
hemolysins will act to further stimulate the inflammatory response (31) and are likely
to serve as antigens to elicit immunity against themselves, which is an advantage of
this TCA cycle mutation approach over constructing avirulent strains containing
mutations in specific virulence genes, such as the avirulent rtxA mutant obtained
previously (14). The increase in expression of vah1-plp gene cluster (for at least the
sucA and mdh mutants) is correlated to the increase in expression of hlyU, the
transcriptional activator/antirepressor of the vah1-plp gene cluster (compare Fig 4A
with Fig 4C). It is unclear how mutations in TCA cycle enzymes trigger increase
expression of hlyU.

Immersion is the preferred method for vaccination in the aquaculture
industry (3, 5, 32). In this study, rainbow trout pre-treated by immersion for 1 h with
the icd mutant were fully protected from subsequent challenge with virulent wild type
V. anguillarum M93Sm (Fig 5A). Moreover, since the TCA cycle exists in all aerobic
organisms, as well as many facultative (like Vibrio) and anaerobic organisms, the
TCA mutation approach is likely to be an easy method for the construction of
modified live vaccines against a wide variety of pathogenic bacteria. Although there is
a residual virulence of the icd mutant, a combination of icd and another TCA cycle
gene mutation is expected to further attenuate the strain. In Samonella enterica, the
combination of a sdhCDA deletion and frdABCD deletion resulted in further
attenuation in virulence than either single gene deletion (19, 20).
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Cross-serotype protection is also highly preferred in vaccine development.
Data indicate the injection of icd mutant that derived from M93Sm (serotype O2a) had
elicited cross-serotype immunity against the subsequent challenge of NB10 (serotype
O1), demonstrating the potential of the TCA cycle mutation approach (Fig 5B).
Although the administration of icd mutant by immersion didn’t show statistically
significant protection against NB10 in this study, it should be noted that there were
only three fish tested. More repeats need to be done to make a more solid conclusion.
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Table 1. Bacterial strains and plasmids used in this study.
Strain or
plasmid

Description

Reference

M93Sm

Spontaneous Smr mutant of M93 (serotype O2a)

(33)

NB10

Clinical isolate from the Sea of Bothnia (serotype
O1)

(34)

V.
anguillarum
strains

XM420

Smr Cmr ; icd insertional mutant

This study

XM440

Smr Cmr ; sucA insertional mutant

This study

XM450

Smr Cmr ; sucC insertional mutant

This study

XM460

Smr Cmr ; sdhC insertional mutant

This study

XM470

Smr Cmr ; fumA insertional mutant

This study

XM410

Smr Cmr ; mdh insertional mutant

This study

XM430

Smr Cmr ; cra insertional mutant

This study

Sm10

thi thr leu tonA lacY supE
recA RP4-2-Tc::Mu::Km (λ pir)

(35)

S100

Kmr; Sm10 containing plasmid pNQ705-1

This study

Q420

Kmr Cmr; Sm10 containing plasmid pNQ706-icd

This study

Q440

Kmr Cmr; Sm10 containing plasmid
pNQ708-sucA

This study

Q450

Kmr Cmr; Sm10 containing plasmid
pNQ709-sucC

This study

Q460

Kmr Cmr; Sm10 containing plasmid
pNQ710-sdhC

This study

Q470

Kmr Cmr; Sm10 containing plasmid
pNQ711-fumA

This study

Q410

Kmr Cmr; Sm10 containing plasmid
pNQ705-mdh

This study

E. coli strains

200

Q430

Kmr Cmr; Sm10 containing plasmid pNQ707-cra

This study

Plasmid
pNQ705-1

Cmr; suicide vector with R6K origin

(36)

Cmr; For icd insertional mutant

This study

Cmr; For sucA insertional mutant

This study

pNQ705-sucC Cmr; For sucC insertional mutant

This study

pNQ705-sdhC Cmr; For sdhC insertional mutant

This study

pNQ705-fumA Cmr; For fumA insertional mutant

This study

pNQ705-icd
pNQ705-sucA

pNQ705-mdh

Cmr; For mdh insertional mutant

This study

pNQ705-cra

Cmr; For cra insertional mutant

This study
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Table 2. Primers used in this study.

Primer

Sequence (5'to3', underlined
sequences are designed
restriction sites)

Description

Reference

pr31

GGTGAGCTCTATTCTTTATTG
CCGATTATC

For icd insertional
mutant, forward, SacI

This study

pr32

AAATCTAGAGTAAGTCGCTT
TAATCGCTTC

For icd insertional
mutant, reverse, XbaI

This study

pr50

AAAGAGCTCGTGATCCAGAT
GTCGATGCTA

For sucA insertional
mutant, forward, SacI

This study

pr51

GGTTCTAGAGTTCAGTGTCG
ATAATGTGCA

For sucA insertional
mutant, reverse, XbaI

This study

pr52

AAAGAGCTCGGTCGGATTAG
TACAGCGAAG

For sucC insertional
mutant, forward, SacI

This study

pr53

GGTTCTAGACTTTTTCAATTT
CCACGCCGC

For sucC insertional
mutant, reverse, XbaI

This study

pr54

AAAGAGCTCATGTTCGTTGC
GGTCGGAATT

For sdhC insertional
mutant, forward, SacI

This study

pr55

GGTTCTAGATCCAACTCTTCA For sdhC insertional
AAGTGGCCC
mutant, reverse, XbaI

This study

pr56

GGTGAGCTCTCCTTGCACCAT For fumA insertional
ATTGATATG
mutant, forward, SacI

This study

pr57

GGGTCTAGAAGGCTTATCAT
CGAGAAGAGAG

For fumA insertional
mutant, reverse, XbaI

This study

pr29

GGTGAGCTCATGCCAGCGTT
AACATTAAAC

For mdh insertional
mutant, forward, SacI

This study

pr30

AAATCTAGAGCTGTATGACA
TCGCACCGGT

For mdh insertional
mutant, reverse, XbaI

This study

pr33

AAAGAGCTCGCGGCGTGAGA
CTAAGGCATC

For cra insertional
mutant, forward, SacI

This study

pr34

AAATCTAGACAATGGCAAAG
CGCAGAAGTA

For cra insertional
mutant, reverse, XbaI

This study
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F vah1
RT
(BF)

GTTTGGTATGGAACACCGCT
CAAG

For vah1 qRT-PCR,
forward

This study

R vah1
RT
(BF)

GGCTCAACCTCTCCTTGTAAC For vah1 qRT-PCR,
CAA
reverse

This study

plpF RT

CAGACGACCACCAGTAACCA
CTAA

For plp qRT-PCR,
forward

(16)

plpR
RT

GCAATCATGATGACCCAGCA
ACAG

For plp qRT-PCR,
reverse

(16)

Pm111

GGAAATTATTCCGCCGACGA
TGGA

For rtxA qRT-PCR,
forward

(14)

Pm112

GCCGATACCGTATCGTTACCT For rtxA qRT-PCR,
GAA
reverse

(14)
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Table 3. Gene identification in V. anguillarum

Gene or
operon

Product

Presence in V.
anguillarum
M93Sm draft
genome

gltA

Type II citrate synthase

Yes

VAA_03416

icd

Isocitrate dehydrogenase

Yes

VAA_02190

sucAB

2-oxoglutarate
dehydrogenase
(E1 component, E2
component)

Yes

VAA_03410,
VAA_03409

sucCD

Succinyl-CoA synthetase
(beta subunit, alpha
subunit)

Yes

VAA_03408,
VAA_03407

sdhCDAB

Succinate dehydrogenase
(cytochrome b556 subunit,
membrane anchor subunit,
flavoprotein subunit,
iron-sulfur protein)

Yes

VAA_03415,
VAA_03414,
VAA_03413,
VAA_03412,

fumAC

Aerobic fumarate hydratase
(class I, class II)

fumA: Yes;
fumC: not found

fumA:
VAA_01430;
fumC: not found

fumB

Anaerobic fumarate
hydratase (class I)

Not found

Not found

mdh

Malate dehydrogenase

Yes

VAA_01685

cra

Fructose repressor protein

Yes

VAA_01008
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Locus tag in V.
anguillarum 775
genome

Figure 1. Glycolysis pathway, gluconeogenic pathway, TCA cycle and metabolism of
fructose as identified from the sequenced genomes of V. anguillarum 775 and
M93Sm. The arrows indicate the physiological directions of the reactions. The gene
symbols of the enzyme for each reaction are listed beside the reaction. Boxed genes
indicate the mutants that were created (Table 1).
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Figure 2. Survival percentage of rainbow trout IP injected with various V.
anguillarum strains at a dosage of A) 2 × 105 CFU/fish and B) 4 × 105 CFU/fish. Five
fish were infected with each strain. C) Immersion infection survival of fish infected
with M93Sm, icd mutant, or mock infected. *Statistically significant difference
compared to M93Sm.
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Figure 3. Growth profiles of V. anguillarum strains. A) Growth curves of various V.
anguillarum strains in LB20. B) Generation time of various V. anguillarum strains in
LB20 grown in LB20. C) Growth curves of V. anguillarum wild type and icd mutant
in NSSM. The data presented are from a representative experiment of two independent
experiments.
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Figure 4. qRT-PCR analysis. A) Real time qRT-PCR analysis of expression of rtxA,
plp and vah1 in various V. anguillarum strains grown in LB20 in logarithmic (log)
phase. B) Hemolytic activity of various V. anguillarum strains grown on fish blood
agar. C) Real time qRT-PCR analysis of expression of hlyU and hns in various V.
anguillarum strains grown in LB20 in log phase. *Statistically significantly higher
than M93Sm.
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Figure 5. Fish infection experiment. A) Survival percentage of untreated or treated
rainbow trout immersed in V. anguillarum M93Sm (4 × 105 CFU ml-1). Five fish were
used for each group. B) Survival percentage of untreated or treated rainbow trout
immersed in V. anguillarum NB10Sm (4 × 105 CFU ml-1). 3~5 fish were used for each
group. *Statistically significant difference compared to untreated fish.
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Table S1. Generation time of various V. anguillarum strains in 3M-Glucose.
Strain

Generation Time (min)

M93sm

78 (±5)

XM420 (icd)

no growth

XM440 (sucA)

no growth

XM450 (sucC)

76 (±12)

XM460 (sdhC)

78 (±10)

XM470 (fumA)

104 (±9)

XM410 (mdh)

77 (±10)

XM430 (cra)

84 (±2)
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Figure S1. Cell density determined by viable count vs. OD600 of various V.
anguillarum strains. The line indicates linear regression.
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Figure S2. Supplement data for fish infection assay. A) Survival curve of V.
anguillarum M93sm starved in water with various NaCl concentrations. B) Survival
percentage of rainbow trout vs. V. anguillarum dosage (in CFU ml-1) in immersion
infection experiment. The line indicates logarithmic regression.
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